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ABSTRACT 
Background. Influenza and pneumococcal vaccinations are important therapies 
supported by national and international guidelines for preventing morbidity and mortality 
from respiratory illnesses in high-risk groups. The responsibility for delivering these 
vaccinations in the United Kingdom lies with primary care. Little is known about how 
rates of influenza and pneumococcal vaccination can be increased in high-risk groups in 
primary care. 
Aim. To research methods of improving rates of influenza and pneumococcal vaccination 
in high-risk groups in primary care. 
Objectives. To investigate the impact of educational interventions for primary care teams 
on influenza and pneumococcal vaccination rates in high-risk groups. 
Method. The research had the following components:  
a. Literature search examining current practice and policy in relation to influenza and 
pneumococcal vaccination and studies undertaken to improve performance, both in 
general and specifically in relation to improving adult vaccination rates.  
b. Pilot study of targeting influenza and pneumococcal vaccination to high-risk groups 
in a single general practice.  
c. Effect of audit and feedback with an information pack to primary care teams on 
influenza and pneumococcal vaccination in primary care: before-and-after 
multipractice study. 
d. Effect of audit and feedback with an information pack to primary care teams, as part 
of a clinical governance programme, on influenza and pneumococcal vaccination in a 
primary care trust: before-and-after multipractice study. 
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e. Randomised controlled study of an educational outreach intervention partly nested 
within primary care trust study with audit, feedback and information (passive 
dissemination of guidelines and recommendations) directed at primary health care 
teams compared with audit feedback and information alone using multifaceted 
interventions to increase influenza and pneumococcal vaccine uptake in high-risk 
groups in primary care.  
Results. The studies demonstrated significant improvements in influenza and 
pneumococcal vaccination rate in high-risk groups in primary care, showed the levels of 
improvement that could be expected from these types of intervention and described how 
primary care teams responded to direct and indirect educational interventions supported 
by measurement of performance. 
Conclusions. Education to multiprofessional teams is an important method for diffusion 
of innovations in the highly professionalised organisations of primary care and general 
practice. Educators need to understand the complex nature of primary care organisations 
and teams, when and how education for teams is likely to be successful, the barriers to 
implementation of new ideas and how to address these. Education when applied 
appropriately can have important effects in improving health care. This is more likely to 
occur when careful assessments are made around the nature of the evidence, clear 
outcomes are sought and measured and the healthcare intervention is understood from the 
perspective of the patient, the healthcare team and other stakeholders. 
 
 15 
 
DECLARATION 
On the basis of the research conducted for this thesis I have published a number of peer 
reviewed articles, letters and conference presentations for which I was the principal 
author. The pilot study and countywide studies began before registration for the degree 
but were continued as part of this work and are therefore included.  
 
Siriwardena, A. N. (1999) Targeting pneumococcal vaccination to high-risk groups: a 
feasibility study in one general practice. Postgrad.Med.J. 75, 208-212. 
Siriwardena, A. N., Rashid, A. & Johnson, M. R. D. Educating for change. eBMJ . 
(created 28-8-2002, accessed 28-8-2002). 
Siriwardena, A. N., Rashid, A., Johnson, M. R. D. & Dewey, M. E. (2002) Cluster 
randomised controlled trial of an educational outreach visit to improve influenza and 
pneumococcal immunisation rates in primary care. Br.J Gen.Pract. 52, 735-740. 
Siriwardena, A. N., Rashid, A., Johnson, M. R. D. & Dewey, M. E. (2002) Education to 
improve vaccination uptake. Br.J Gen.Pract. 52, 1021-1022. 
Siriwardena, A. N., Hazelwood, L., Wilburn, T., Johnson, M. R. D. & Rashid, A. (2003) 
Improving influenza and pneumococcal vaccination uptake in high risk groups in 
Lincolnshire: a quality improvement report from a large rural county. Quality in Primary 
Care 11, 19-28. 
Siriwardena, A. N., Wilburn, T. & Hazelwood, L. (2002) Increasing influenza and 
pneumococcal vaccination rates in high risk groups in one primary care trust as part of a 
 16 
 
clinical governance programme. Accepted for publication by the British Journal of 
Clinical Governance. 
Presentations 
Siriwardena, A. N. Does education of primary health care teams improve patient 
outcomes? Cluster randomised controlled trial of an educational outreach visit to improve 
influenza and pneumococcal vaccination uptake in high-risk groups. Oral presentation at 
WONCA Europe 2002, Queen Elizabeth II Conference Centre, London 9-13 June 2002. 
Siriwardena, A. N., Rashid, A., Johnson, M. R. D. & Dewey, M. Improving influenza and 
pneumococcal vaccination rates in primary care. Poster presentation at the 2nd Asia 
Pacific Forum on Quality Improvement in Health Care, Singapore 11-13 September 
2002. 
 17 
 
CHAPTER 1 INTRODUCTION 
1.1 Aim 
This thesis explores the interrelationship between education, quality of care and 
performance in health care. It seeks to illuminate the processes of continual professional 
development, quality improvement and change in practice by examining the delivery of 
influenza and pneumococcal vaccinations to high-risk patients in primary care. Education 
includes the various processes by which individual health workers and healthcare 
organisations continue to learn and develop their craft. Quality is the drive to apply 
evidence in health care to improve patient and population outcomes, to enhance the 
consumer experience of health, to lessen inequalities and to reduce unacceptable 
variations in care. Performance describes the measured outcomes of health care activity 
whether these are qualitative or quantitative. The quality agenda is a key priority in 
today’s health service and defining the methods to improve quality and performance 
continues to be a central theme (Department of Health 1998a; NHS Executive 1998).  
 
The research question proposed is: “How and to what extent do educational interventions 
improve the performance of primary healthcare teams in increasing influenza and 
pneumococcal vaccination rates in high-risk groups?”  
 
The background to influenza and pneumococcal vaccination in terms of the scientific 
basis of the health technology and the organisational structures needed to promote its 
implementation is described. This draws on evidence of interventions to improve 
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professional practice in general, and to implement effective vaccination strategies in 
particular. In a series of field studies a number of strategies to improve influenza and 
pneumococcal vaccination rates in high-risk groups are investigated in the primary care 
setting. 
1.2 Rationale 
Influenza and pneumococcal vaccination are important therapeutic strategies supported 
by national guidelines for preventing morbidity and mortality in high-risk groups. The 
responsibility for delivering influenza and pneumococcal vaccination in the United 
Kingdom, as set out through national guidance and recommendations, lies predominantly 
with primary care, through primary care organisations, general practices and the teams of 
doctors and nurses working in them. Because of the considerable overlap between risk 
groups for influenza and pneumococcal vaccination it seemed appropriate to look at both 
these vaccinations in conjunction. There has been a limited amount of previous research 
on how rates of influenza and pneumococcal vaccination can be effectively increased in 
high-risk groups in primary care in the United Kingdom. This work sets out to explore the 
technical, structural and behavioural factors underlying influenza and pneumococcal 
vaccination programmes and how rates for these vaccinations can be improved in 
practice. 
1.3 Background 
Despite guidelines for delivery of influenza and pneumococcal vaccination from the 
Department of Health there was evidence of poor coverage of high-risk groups and 
limited evidence on practical methods of improving vaccinations rates in the late 1990s 
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when this work began. Less than a quarter of those at risk were being vaccinated for 
influenza (Watkins 1997) in the United Kingdom and surveys here around the same time 
also showed very low uptakes of pneumococcal vaccination (McDonald et al. 1997a). 
This situation may have been due partly to poor knowledge and negative attitudes 
amongst doctors and patients (Wiselka 1994) but it seemed likely that many other factors 
were involved.  
 
At the start of this work I had been a general practitioner for over ten years, working in a 
group practice in Lincoln. Lincoln is a cathedral city in the large rural county of 
Lincolnshire, which is situated in the East Midlands of the United Kingdom. My interest 
in influenza and pneumococcal vaccination began whilst undertaking a survey of 
vaccination rates across Lincolnshire practices during my tenure, initially as a member 
and subsequently as chair of Lincolnshire Medical Audit Advisory Group, an 
organisation set up in the early 1990s and tasked with improving the quality of primary 
care in the county. Medical Audit Advisory Groups (MAAGs) at that time formed part of 
every Family Health Services Authority (FHSA), the body that coordinated practice 
activity and funding. MAAGs were “accountable to the FHSA for the institution of 
regular and systematic medical audit in which all practitioners take part” (Department of 
Health 1990).  
 
The survey revealed large variations in influenza and pneumococcal vaccination, and 
poor average immunisation rates across practices. I was therefore interested in 
understanding why this should be and how this situation could be improved. After 
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reviewing the literature, I decided to look at the practical strategies for improvement of 
vaccine uptake through a series of field studies. Initially this would take place in my own 
practice and later investigations would focus on whether and how this experience could 
be transferred to other practices. 
 
The origins of this work therefore lie partly in the quality initiatives in the health service 
that began in 1990 with the new contract (Department of Health and Welsh Office 1989), 
the preceding white papers which laid the groundwork for it (Secretaries of State for 
Health 1987; Secretaries of State for Health 1989a; Secretaries of State for Health 1989b) 
and the introduction of medical audit in primary care (Secretaries of State for Health 
1989c; Department of Health 1990).  
 
Although the effects of clinical audit in improving quality of care have been intensely 
debated (Lord and Littlejohns 1997), spin offs from systematic audit have included 
recognition of issues of data quality (Scobie et al. 1995), appropriate design of 
multipractice audits (Khunti et al. 1999), benchmarking and routine feedback of 
performance (Kendall et al. 1999; Pringle 1991). These issues are also explored in this 
thesis. 
 
Recent National Service Frameworks for Coronary Heart Disease (Department of Health 
2000a) and the Elderly (Department of Health 2001b), both of which refer to influenza 
and pneumococcal vaccination for over 65 year olds and high-risk patients, are part of the 
most recent health service reforms (Department of Health 1998a) which have continued 
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the movement towards improving quality and reducing variations in health. With the 
introduction of clinical governance,* which incorporates a number of quality and 
regulatory frameworks including the National Service Frameworks, quality assurance, 
lifelong learning and accountability for standards of clinical care, education as a means of 
improving quality has come to the forefront of the health research agenda. In particular 
the problems of shifting continuing professional development to being multidisciplinary 
and translating directly into benefits for patient care have been highlighted (Department 
of Health 1998b; Elwyn 1998) and these are key themes which run through this thesis. 
1.4 Structure 
The literature review consists of two chapters. The first, Chapter 2, focuses on influenza 
and pneumococcal vaccines, including the reasons behind their development and 
promotion, together with evidence of their effectiveness and adverse effects. An analysis 
of current guidelines for vaccination and the rationale behind targeting of high-risk 
groups leads to international comparisons of vaccination policies and targets. The second 
part of the literature review, Chapter 3, examines the literature on barriers to and 
promoters of vaccination, including physician and patient attitudes. This lays the 
foundation for a review of strategies to improve professional performance, vaccination 
rates in general and influenza and pneumococcal vaccination uptake in particular. The 
behavioural and organisational perspectives of vaccination implementation are considered 
in relation to patient-directed, provider-orientated, systems-mediated and combined 
strategies. 
 
* “A system through which NHS organisations are accountable for continuously improving the quality of 
their services and safeguarding high standards of care, by creating an environment in which clinical 
excellence will flourish.” Definition taken from ‘A first class service – quality in the new NHS’ 
(Department of Health 1998a). 
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The fieldwork is described in the succeeding chapters in terms of methodology (Chapter 
4) and results (Chapter 5). The fieldwork begins with the pilot study that looks at 
improving influenza and pneumococcal vaccination rates in a single general practice and 
which explores patient, provider and organisational factors affecting vaccination uptake 
in this setting. This knowledge is applied to two uncontrolled before and after studies 
investigating improvements in vaccination rates across groups of practices. The first of 
these examines the effect of audit, feedback and written advice on vaccination behaviour 
and rates in volunteer practices across one English county. The second looks at 
vaccination rates in a single primary care organisation when audit, feedback and written 
advice are used but additionally underpinned by clinical governance. Finally an 
experimental study that uses lessons learned from the literature search, pilot study and 
observational studies is undertaken. This was a cluster randomised controlled study to 
investigate the effect of an educational outreach intervention directed at primary health 
care teams on vaccination rates in high-risk groups compared with audit, feedback and 
passive dissemination of guidelines and information alone.  
 
In the discussion (Chapter 6), these studies are analysed in relation to existing conceptual 
frameworks in order to develop a new model for understanding, analysing and predicting 
the effects of educational interventions designed to improve quality of care and 
performance in primary health care. The discussion also explores areas for future study. 
 
The conclusion (Chapter 7) summarises the work and examines the relevance of this 
thesis to future health education policy. 
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CHAPTER 2 INFLUENZA AND PNEUMOCOCCAL VACCINES: 
LITERATURE REVIEW (I) 
2.1 Introduction 
This chapter reviews the literature relating to influenza and pneumococcal vaccination. 
The review demonstrates the scarcity of work done in the field of adult vaccinations in 
British general practice despite its current importance in government policy. It seeks to 
establish that respiratory infections, and in particular those due to influenza and 
pneumococcal infections, are important causes of morbidity and mortality with 
considerable implications for patients, populations and both primary and secondary health 
care systems. It explores the importance of influenza and pneumococcal vaccination in 
preventive health policy, both generally and specifically today, in the management of 
winter pressures. It examines possibilities to treat or prevent influenza and pneumococcal 
infections, including the relative effectiveness of different strategies, and looks at the 
evidence of benefits, harms and cost-effectiveness of vaccination. The chapter draws on 
the evidence for vaccination of high-risk groups*, how these high-risk groups have been 
determined, whether vaccination is effective in high-risk groups and considers other 
groups, not currently considered high-risk, who may benefit from vaccination. An 
analysis of guidelines on vaccinating high-risk groups and international variations in 
recommendations is undertaken.  
 
The review will include the following sections: sources and methodology; a historical 
 
* These are groups of patients at higher risk of developing or succumbing to these infections. 
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perspective of the importance of influenza and pneumococcal infections on health; 
epidemiology discussing the impact of influenza and pneumococcal infections on health 
and social care systems; the place of antibiotics and antivirals; and how antibiotic 
resistance and ineffectiveness and the limitations of newer antiviral drugs impacts on the 
importance of vaccination as a strategy to prevent infection. There are also sections on 
influenza and pneumococcal vaccines and their development; evidence of effectiveness of 
influenza and pneumococcal vaccination including an evaluation of meta-analyses, 
randomised controlled studies, case control and cohort studies and their relevance; cost 
analysis studies exploring whether influenza and pneumococcal vaccinations are cost 
effective; side effects of the vaccinations; evidence on what constitutes a high-risk group 
and on vaccine efficacy in high-risk groups; vaccination uptake rates in high-risk groups 
in the United Kingdom and international comparisons.  
2.2 Sources 
The articles for this review came from a range of sources including computerised 
searches of the MEDLINE database from 1976 to 2002; EMBASE database; the 
Cochrane Database of Systematic Reviews; Database of Abstracts of Reviews of 
Effectiveness (DARE); Health Management Consortium Database on CD-ROM which 
combines the Department of Health, King’s Fund and Health Management Information 
Centre at Leeds University databases; Health Promis - database of the Health Education 
Authority; English National Board (ENB) for Nursing Midwifery and Health Visiting 
database; CINAHL (Cumulative Index to Nursing and Allied Health Literature) database 
on the Internet; National Centre for Clinical Audit database on the Internet; recent 
articles, letters and reviews from the British Medical Journal, British Journal of General 
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Practice, Postgraduate Medical Journal and the Lancet; citations in the articles found 
above; citations provided by my supervisor and other colleagues. 
2.3 Method 
Searches were carried out on computerised databases using the following search terms as 
Medical Subject Headings or keywords: Streptococcus pneumoniae; pneumonia, 
pneumococcal; pneumococcal infections; pneumococcal pneumonia; influenza; 
vaccination, immunization, immunization programs, immunization schedule; risk factors, 
utilisation, cost-effectiveness. In addition, pneumococcal or influenza vaccine or 
vaccination was used as a free text search. Abstracts from the searches were examined for 
relevance and stored on an electronic database (Reference Manager). 
2.4 Historical perspective 
Influenza has been a cause of epidemics and massive pandemics throughout history. An 
epidemic is defined as a case rate of 100 per 100,000 population whereas a pandemic 
involves epidemics across more than one country. Pandemics have had devastating 
consequences. Influenza was responsible for the decimation of native populations in the 
New World (Sessa et al. 1999) as well as more recent pandemics, notably the Spanish flu 
pandemic in 1918-19 which caused 40 million deaths worldwide, more than deaths from 
the First World War. Closer to the present day the most recent epidemic in the United 
Kingdom, during the winter of 1989-90, was estimated to be responsible for twenty-nine 
thousand excess deaths (Ashley et al. 1991). Due to influenza A, B and C viruses, 
epidemics are due to significant minor alterations in the virus termed antigenic drift, 
whereas pandemics are caused by larger genetic transformations called antigenic shift. It 
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is the ability of the virus to change, which reduces the capacity of the body’s immune 
system to recognise it, and causes the characteristics patterns of infections (Fry 1969). 
Influenza is often complicated by pneumonia, including pneumococcal pneumonia, and 
this is often fatal.  
 
At the turn of the century, the mortality from pneumococcal pneumonia was said to be 
seventy five per cent. Optochin (a drug which was toxic to the eyes), pneumococcal 
antisera from horse, sulpha drugs and oxygen improved this situation (Macfarlane 1995), 
but it was penicillin, introduced in 1940, that reduced mortality from pneumococcal 
pneumonia to its current level of twenty five per cent. There has been no improvement in 
this mortality rate in the past five decades despite the development of new antibiotics and 
other medical advances (Obaro et al. 1996) and this is an important reason for the 
continuing interest in preventing pneumococcal infection by vaccination.  
2.5 Epidemiology 
Respiratory infections, such as influenza and pneumonia, are the commonest cause of 
presentation to British general practitioners with over thirty per cent of the population 
consulting with this group of illnesses at least once each year. Rates of illness vary from 
just under one in five per annum in those aged 45 to 64 years to almost two thirds of 
under fives consulting each year. In a study of the United Kingdom general practice 
research database, 20 per cent of consultations were for minor respiratory illness, 13 per 
cent for moderate illness and 6 per cent for more severe conditions with a proportion of 
patients presenting with a combination of these (McCormick et al. 1995).  
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Influenza is a common winter pathogen*. In one prospective study it was responsible for 
almost a third of cases of winter respiratory infections in general practice, with influenza 
B accounting for 22 per cent and influenza A for 9 per cent of cases. No pathogen was 
found in a third of cases, in common with other studies, with multiple pathogens in 
another third (Lieberman et al. 1998). Patterns of influenza and influenza-like illness are 
determined in the United Kingdom using ‘spotter’† practices of the Royal College of 
General Practitioners (RCGP) (Campbell et al. 1988), mortality data from the Office of 
Population Census and Surveys (OPCS) and weekly reports from the Public Health 
Laboratory Service (PHLS) (Chakraverty 1994). Weekly returns (Fleming 1999) from 
these practices identify whether influenza like illness exceeds 100 consultations per 
100,000 population per week, which is the definition of an epidemic. This compares with 
the reported baseline rate of influenza-like illness of 28 per 100,000 per week. During 
epidemics consultations increase, peaking at four weeks and lasting ten weeks each 
winter with 1.7% of the population consulting in 1989/1990 compared to 0.4% in 1991/2 
(Fleming et al. 1999). Many countries both in Europe and the United States use similar 
systems of sentinel practices with laboratory backup (Uphoff 1998; Carrat et al. 1998; 
Schattner et al. 1992) to detect epidemics. 
 
Pneumococcal respiratory infections are common in general practice accounting for a 
quarter of cases of community acquired pneumonia and over one third of severe 
pneumonia admissions (MacFarlane et al. 1982). The greatest morbidity and mortality 
arises from Streptococcus pneumoniae bacteraemia which has an incidence of 8.7 per 
 
* A pathogen is a germ producing infection. 
† ‘Spotter practices’ are general practices that collect data on influenza. 
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thousand per year, 92% from bacteraemic pneumococcal pneumonia (George 1995) with 
the most of the rest from pneumococcal meningitis and less commonly other infections 
such as osteomyelitis, septic arthritis, sinusitis, bronchitis and middle ear infection.  
 
Complications of both influenza and pneumococcal sepsis* are commoner in elderly 
people and those with pre-existing disease. For influenza, complications include lower 
respiratory infections particularly bronchitis which affects up to a fifth of patients 
presenting to general practitioners (Connolly et al. 1993). Less common complications 
include influenza viral pneumonitis, secondary bacterial pneumonia due to Streptococcus 
pneumoniae, Haemophilus influenzae and Staphylococcus aureus and middle ear 
infections as well as a number of rarer sequelae including febrile convulsions, toxic 
shock, cardiac, neurological and other complications.  
 
Pneumonia as a consequence of influenza has a high mortality reaching almost forty per 
cent in one series (Jones et al. 1991). The last large epidemic in the winter of 1989/90 
was estimated to have caused almost thirty thousand deaths (Ashley et al. 1991). 
Influenza also leads to disability, particularly in elderly at-risk patients. A case control 
study of elderly nursing home patients before and four months after an influenza 
epidemic showed that 25 per cent of those with serologically confirmed influenza 
suffered a major functional loss in bathing, dressing or mobility compared to 15.7 per 
cent in control subjects (Barker et al. 1998). Hospital admissions are also increased 
because of influenza epidemics although actual rates are dependent on the size of the 
epidemic and the virulence of the organism. One prospective study of epidemics in the 
 
* Sepsis is another term for infection. 
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United States between 1970-78 showed an average excess of about 172,000 
hospitalisations per epidemic at a cost in excess of $300 million (Barker 1986). 
 
Pneumonia in a British multicentre study (Macfarlane 1995) was responsible for seven 
per cent of adult admissions and a median hospital stay of 11 days. A quarter of those 
affected were unable to return to normal activity by six weeks. It results in a mortality 
rate of three per cent rising to eleven per cent with bacteraemia (British Thoracic Society 
and Public Health Laboratory Service 1987) and is the fifth most common cause of death 
in England and Wales. There is also a higher risk of death for some time following 
recovery (Koivula et al. 1999). The mortality rate from bacteraemic pneumococcal 
pneumonia has remained unchanged over the last fifty years (Obaro et al. 1996). 
 
The huge burden of illness and death from influenza and pneumococcal infection has 
stimulated research into treatment and prevention of these conditions. 
2.6 Treatment 
Influenza can be treated with antiviral agents like amantadine and rimantidine, so called 
ion channel inhibitors, which are active against influenza A. They are hampered in their 
use by problems with viral resistance and side effects (Nicholson 1996) and a reluctance 
of practitioners to use them because of these problems and through lack of awareness. 
More recently the neuraminidase inhibitors, zanamivir (Relenza) (Hayden et al. 1997) 
and oseltamivir have been shown to be effective against influenza. They are active 
against both influenza A and B reducing clinical cases by 74% (95% confidence interval: 
50 to 87%), laboratory cases by 60% (33 to 76%), duration of symptoms by one day (0.6 
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to 1.3 days) and time to return to normal activities by half a day (0.1 to 1.1. days) in 
laboratory confirmed cases (Jefferson et al. 2000). In influenza positive patients over the 
age of fifty or in high-risk groups they reduce symptoms by up to three days (Monto et al. 
1999). The National Institute of Clinical Effectiveness* in England has approved the use 
of zanamivir for use in at-risk individuals during near epidemic rates of illness equivalent 
to 50 consultations per 100,000 population per week. There are potential problems with 
arranging for patients to receive a prescription within the 36 hours required for the drug 
to be effective due to increased workload, a lack of resources and capacity during an 
epidemic and doubts over accuracy of diagnosis or the efficacy of the drug (Nguyen-Van-
Tam 1999). Also, only 11 per cent of respiratory infections during influenza epidemics 
have been found in community surveillance studies to be due to influenza, the rest being 
caused by other organisms including respiratory syncytial, parainfluenza and other 
viruses (Barker et al. 1995), even in hospitalised elderly people (Falsey et al. 1995). 
Considerable uncertainty therefore exists about the feasibility of using neuraminidase 
inhibitors in general practice. Antibacterials have also been used to prevent secondary 
infection during influenza epidemics and were shown to reduce rates of pneumonia in a 
randomised placebo controlled study from 16.3% in the placebo group to 2.4% in the 
antibiotic group (Maeda et al. 1999). These problems of diagnosis and treatment have 
resulted in influenza vaccination emerging as the chief public health strategy to combat 
influenza. 
 
 
* The National Institute of Clinical Effectiveness (NICE) is a national body set up to produce guidance for 
doctors in England and Wales to reduce unacceptable variations in care and prevent postcode (or area 
specific) prescribing. 
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Although most pneumococcal infections in this country were still sensitive to antibiotics, 
particularly penicillin and erythromycin, the problems of increasing bacterial resistance 
(see 2.7), a static mortality rate of bacteraemic pneumonia of up to twenty five per cent 
(Kramer et al. 1987), and the large burden of illness, hospitalisation and mortality from 
pneumococcal pneumonia encouraged the use of vaccination as a preventative measure.  
2.7 Antibiotic resistance 
Penicillin resistant strains were recognised in vitro in 1940 but first appeared in vivo in 
1960 in the United States. The problem of increasing antibiotic resistance was another 
significant reason for the interest in vaccination to prevent pneumococcal infections 
(Butler et al. 1998; Sanford 1994; Nuorti et al. 1998). Surveys of pneumococcal isolates 
from public health laboratories in England and Wales showed that resistance of 
pneumococci to antibiotics was increasing. Penicillin resistance, either full or 
intermediate (Ward 1981), increased from 1.5% in 1990 to 3.9% in 1995 whereas 
erythromycin resistance increased from 2.8% to 8.6% in pneumococcal isolates (Johnson 
et al. 1996). In some areas of the United Kingdom, the problem was even greater. For 
example, in East London for a six-month period between 1994 and 1995 12% of isolates 
were found to be resistant to penicillin. The prevalence of penicillin resistance is greater 
in the United States, with 30% of pneumococcal isolates resistant in some areas 
(Moolenaar et al. 2000), France with resistance rates over 40% (Geslin et al. 1998) and 
with resistance endemic in Spain (57% of isolates) presumably due to greater availability 
and use of antibiotics (Linares et al. 1992). Although penicillin in adequate doses was 
still effective for many partially resistant infections (Wilson et al. 1996) antibiotic 
resistance continued to be an important concern whereas ninety six per cent of 
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pneumococcal isolates sent to the PHLS in England and Wales belonged to the serotypes 
contained in the current vaccine (George et al. 1997). 
2.8 Influenza vaccine 
Influenza virus consists of a single-stranded segmented ribonucleic acid genome with 
eight genes. Six of these genes code for viral proteins in the core and the other two for the 
surface antigens, haemagglutinin (H) and neuraminidase (N). These glycoproteins 
attached to the lipid coat effectively mediate virulence and antibody response. It is this 
structure that allows exchange of genes between different strains of the virus leading to 
antigenic shift as well as smaller genetic mutations leading to antigenic drift (Shann 
1990). Salk first used killed vaccine using whole virus treated with formalin in 1945 
(Wiselka 1994). Later subunit virion vaccines were produced consisting of only the 
surface antigens H and N. The newer split virion vaccines use a solvent such as ether to 
disrupt the viral envelope. They are usually trivalent, containing two subtypes of 
influenza A and one of influenza B and produce a rapid antibody response that lasts three 
to six months. This decline in antibodies and the need to vary the composition of the 
vaccine depending on the subtypes prevalent each year are the reasons for annual 
revaccination. Apart from these killed or inactivated vaccines, live vaccines have been 
trialled but are unlicensed.  
2.9 Pneumococcal vaccine 
There are at least ninety different serotypes of pneumococcus differentiated by typing of 
the polysaccharide capsule of the diplococcus (Kalin 1998). The vaccine contains 
bacterial capsular polysaccharides and induces antibodies against the protective capsule, 
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which allow opsonisation (preparation) and phagocytosis (ingestion by white blood cells) 
of invading pneumococci. Neufeld and Rimpeau first discovered the idea of vaccination 
against pneumococcus in 1904 when they found the bacterium more susceptible to attack 
after injecting the serum of animals injected with killed pneumococci (Taussig 1979). 
Early studies showed trivalent, hexavalent, 12 and 13-valent vaccines to be effective at 
preventing pneumococcal pneumonia and are summarised in an earlier review (Requejo 
1993). Antibodies were found to persist for up to eight years in vaccinees (Heidelberger 
et al. 1950). The antibody response is likely to be lower and attenuate more quickly in the 
elderly and patients with splenectomy but advice on reimmunisation is inconsistent (Bird 
1995). The first of these vaccines in common use, the 14-valent pneumococcal vaccine, 
which contained capsular polysaccharides from the fourteen commonest infecting strains 
of the bacterium, was first introduced in 1977 and licensed in 1978. The 23-valent 
vaccine replaced this in 1983 (Fiebach and Beckett 1994). It was first recommended in 
the United Kingdom in 1992 (Begg and Salisbury 1992). The current vaccines, 
Pneumovax II (Merck, Sharpe & Dohme) and Pnu-Immune 23 (Lederle-Praxis) consists 
of purified capsular polysaccharide from 23 serotypes of pneumococci, types 1, 2, 3, 4, 5, 
6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F and 33F. 
Most pneumococcal isolates from the Public Health Laboratory Service in England and 
Wales (92% in 1995) were from serotypes or serogroups included in the current 23 valent 
vaccine (Johnson et al. 1996). 
 
An important advance was the development of new conjugate vaccines, in which the 
polysaccharide component is linked to a protein, resulting in greater immunogenicity and 
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effectiveness, particularly in children (Hattotuwa and Hind 1997; Shann 1990) and 
possibly in the immunocompromised. This innovation has not yet been translated into the 
current adult vaccine. 
2.10 Effectiveness of influenza vaccination 
The evidence for effectiveness of influenza vaccination comes largely from systematic 
reviews and meta-analyses in adults and elderly people. More recent evidence from 
observational studies also suggests greater effectiveness of repeated influenza 
vaccination. These studies are described in more detail below. The issue of influenza 
vaccine effectiveness in high-risk groups is explored later (see 2.14). 
 
Systematic reviews and meta-analysis are methods for systematically collating, assessing, 
combining and presenting results from more than one study. The advantages of this 
approach are to enable a more transparent and objective review of the data, to combine 
data to reduce the possibility of false negative results due to inadequate power, and to 
generate questions and sample sizes for future research, particularly when the evidence is 
unclear or controversial (Egger and Smith 1997). There are a number of potential 
problems with this methodology. These include heterogeneity, with differences in study 
populations, geographical location, timing, treatments and outcomes of studies. 
Publication bias involves English language and positive studies, particularly randomised 
controlled studies, being more likely to be published and therefore included in a 
systematic review whereas negative studies are less likely to appear in print or more 
likely to be delayed. Salami publication may result in data being included more than once 
in a meta-analysis because of duplicate publication of data. Poor quality, small and 
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methodologically weak studies can also lead to bias (Naylor 1997; Greenhalgh 1997; 
Hopayian 2001). Some of these problems can lead to false conclusions but others may 
sometimes be avoided by careful quality assessment (Sterne et al. 2001). 
 
In a meta-analysis of influenza vaccine effectiveness in young adults (Demicheli et al. 
2000), 14 randomised or quasi-randomised studies of sufficient quality were included. 
The study subjects were healthy adults aged 14 to 60 years and the outcome used was 
confirmed or clinical influenza compared against placebo or non-influenza vaccine. 
Inactivated vaccine reduced cases of clinical influenza A with virological confirmation 
(serologically or with viral isolation or both) by 68% (95% confidence interval 49 
to79%). Vaccines that matched the circulating strain were more effective. The vaccine 
was less effective (with an efficacy of 24%) in reducing cases of flu-like illness without 
virological confirmation. Vaccination also significantly reduced time off work, but only 
by 0.4 days (0. 1 to 0.8 days). The absolute risk of clinically defined influenza was 
1034/5953 (17%) with influenza vaccine and 791/2798 (28%) in controls. The number 
needed to treat, which is a measure of the number of persons needing to vaccinated to 
prevent one case of clinical influenza, was calculated as the inverse of the absolute risk 
reduction to be 9.1.*
 
The systematic review by Gross of vaccine effectiveness in elderly adults (Gross et al. 
1995) included patients of sixty-five years or older and incorporated the findings from 
studies of adequate quality including twenty cohort studies with mortality data, three case 
 
* Number needed to treat (NNT) = one divided by absolute risk reduction (1/ARR or 100/ARR%) or, in the 
example quoted, 1 divided by 0.11. 
 36 
 
control studies and a single randomised controlled study. The outcomes included death, 
hospital admission, pneumonia or respiratory illness. A meta-analysis of the cohort 
studies showed percentage reductions of 56% (95% confidence interval 39 to 68%) for 
respiratory illness, 53% (35 to 66%) for pneumonia, 50% (28 to 65%) for hospitalisation 
and 68% (56 to 76%) for death in vaccinated compared to non-vaccinated subjects. These 
studies were subject to confounding factors from using patients refusing vaccine as 
controls, lack of matching of the vaccine and virus strain and failure to confirm the 
diagnosis of influenza with serological tests. A further retrospective cohort study has 
been carried out in the United Kingdom since this meta-analysis. Using computerised 
general practitioner records on nearly 10,000 patients aged 55 years and over during the 
1989-90 epidemic and after adjusting for confounding factors the investigators found that 
recent influenza vaccination conferred a protective effect of 75% (95% confidence 
interval: 21 to 92%) against death. This effect was present irrespective of age or the 
presence of underlying chronic disease (Fleming et al. 1995). 
 
The three case control studies in the meta-analysis by Gross showed comparable rates of 
vaccine efficacy, ranging from 32 to 45% to prevent hospitalisation, 31 to 65% for 
reduction in deaths from influenza and pneumonia and 27 to 30% for all deaths from all 
causes. A subsequent case control study of influenza deaths from Leicestershire used 
primary care records for 315 patients who died of influenza and 777 controls, matched for 
age, sex and area of residence that died within a year of the 1989-90 epidemic. It showed 
that influenza vaccination reduced mortality by 41% (95% confidence interval 13 to 60%) 
for all subjects, 9% (0 to 59%) for first time vaccinees and 75% (31 to 91%) in those who 
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had been vaccinated on more than one occasion. The vaccine was as effective in subjects 
who lived in institutions or in community and for those with high-risk medical conditions 
as those without (Ahmed et al. 1995). The same group of investigators undertook a case 
control study of hospital admissions with influenza and related respiratory conditions 
including pneumonia, bronchitis and emphysema (Ahmed et al. 1997b). The researchers 
looked at 156 admissions and 289 controls matched for age and sex. The odds ratio for 
hospital admission among vaccinees was 0.67 (95% confidence interval 0.39 to 1.12) 
giving an estimate of vaccine effectiveness of 33% (95% confidence interval 0 to 61%). 
In institutionalised and chronically ill patients, the effect was even greater with influenza 
vaccination reducing hospital admissions by 63% (17- 84%).  
 
A single randomised controlled trial that was carried out in general practice in the 
Netherlands with previously vaccinated healthy adults aged over sixty gave the best 
measure of influenza vaccine effectiveness in the elderly. Inactivated vaccine was 
compared with intramuscular saline with nine hundred patients in each group. The 
outcome used was influenza-like illness up to five months after vaccination, whether self-
reported influenza in postal questionnaires or influenza confirmed by serology. The 
incidence of serological influenza was 4% in the vaccine group and 9% in the placebo 
group (relative risk [RR] 0.50, 95% confidence interval [CI] 0.35 to 0.61) and for clinical 
influenza 2% and 3%, respectively (RR 0.53, 95% CI 0.39 to 0.73). This gave a number 
to treat (inverse of the absolute risk reduction) of 20 for serologically proven and 100 for 
clinical influenza respectively (Govaert et al. 1994).  
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A recent systematic review and meta-analysis looked at studies for influenza vaccine 
effectiveness for elderly people aged sixty-five and over living in the community but 
excluding institutionalised elderly. This again showed vaccine efficacy in preventing 
influenza-like illness (35%, 95% confidence interval 19 to 47%), hospitalisation for 
influenza or pneumonia (33%, 27 to 38%), mortality following hospitalisation (47%, 25 
to 62%) and all cause mortality (50%, 45 to 56%) (Vu et al. 2002). 
 
The possibility that influenza vaccination may have other benefits, such as protection 
against stroke has been raised by a case-control study from France (Lavallee et al. 2002). 
In this study, elderly patients admitted to Paris hospitals with cerebral infarction were 
compared with controls, matched for age, sex and residency. Vaccination, either in the 
previous season or in the previous five years was associated with a reduced incidence of 
stroke. However, a healthy user effect may have been a confounding factor here. 
2.11 Effectiveness of pneumococcal vaccine 
There have already been four published meta-analyses of randomised controlled studies 
(Fine et al. 1994; Hutchison et al. 1999; Moore et al. 2000; Cornu et al. 2001) and a 
protocol for a further systematic review on pneumococcal vaccine was available in the 
Cochrane Database of Systematic Reviews (Holden et al. 1997). It is beyond the remit of 
this review to repeat this work. However, it may be useful to comment on the findings of 
these meta-analyses in the context of pneumococcal vaccination use in United Kingdom 
primary care.  
 
The meta-analysis of Fine et al. from 1994 reviewed 164 articles from a comprehensive 
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review of the literature. Articles were identified from a rigorous search of MEDLINE and 
articles identified by lead authors of the randomised controlled and case control trials as 
well as the vaccine manufacturers. Randomised controlled trials using vaccine valences 
of four or fewer, case control, observational, cost-effectiveness studies, and review 
articles were excluded. The authors subjected all articles to independent review and 
assessed them for quality assigning each a quality score. The final list included nine 
randomised controlled trials, three of which had two distinct vaccine and study groups 
producing twelve studies in all for analysis. The meta-analysis looked at ten outcomes. 
These were definitive pneumococcal pneumonia, definitive pneumococcal pneumonia for 
vaccine serotypes, presumptive pneumococcal pneumonia, presumptive pneumococcal 
pneumonia for vaccine serotypes, and pneumococcal disease (bacteraemia), which five 
were referred to as pneumococcal infection related outcomes. The other five outcomes 
were pneumonia (all causes), bronchitis, all cause mortality, pneumonia mortality and 
pneumococcal infection mortality. The analysis of effectiveness was based on odds ratios 
(ratio of the odds of the study outcome in the vaccine group compared to the study 
outcome in the control group) and rate differences (probability of having an outcome in 
the control group minus probability of the same outcome in the vaccine group). The 
authors found a statistically significant protective effect for the first four pneumococcal 
infection related outcomes, that is definitive or presumptive pneumococcal pneumonia for 
all serotypes or vaccine types only. They found no effect in preventing pneumococcal 
bacteraemia, pneumonia, bronchitis or mortality. Subgroup analysis in this meta-analysis 
also showed that the benefit was for low-risk rather than high-risk patients.  
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A subsequent Canadian meta-analysis summarised the thirteen randomised and quasi-
randomised trials involving over 65,000 patients published before 1996 that were of 
sufficient quality. The paper concluded that pneumococcal polysaccharide vaccine could 
be expected to reduce the risk of systemic infection due to pneumococcal types included 
in the vaccine by 83% and systemic infection due to all pneumococci by 73%. It also 
found no evidence that the vaccine was less effective for the elderly, institutionalised, or 
those with chronic disease. It also gave a number needed to treat of 2520 to prevent one 
case of pneumococcal bacteraemia per year (Hutchison et al. 1999). 
 
The next review included only recent randomised controlled trials and excluded some of 
the earlier randomised controlled trials because they used atypical populations of young 
adults with high-risk of pneumococcal pneumonia (Moore et al. 2000). These early 
studies were conducted on healthy South African gold miners (Austrian 1980; Smit et al. 
1977) and New Guinea subsistence farmers (Riley et al. 1977) and despite the poor 
quality of these studies they provided the evidence for licensing of pneumococcal 
vaccination in the United States. These three early studies using atypical populations 
showed most benefit from pneumococcal vaccine and may have had a disproportionate 
effect on the earlier meta-analyses. They showed that pneumococcal vaccination was 
effective in reducing the incidence of all-cause pneumonia (relative risk 0.56, 95% 
confidence interval 0.47 to 0.66), pneumococcal pneumonia (0.16, 0.11 to 0.23), 
pneumonia deaths (0.70, 0.50 to 0.96) and bacteraemia (0.18, 0.09 to 0.34) (Moore et al. 
2000). 
Outcome Summary odds* 
ratios  
(95% CI) 
Summary rate 
differences†
for all patients 
(95% CI) 
Summary odds 
ratios‡ for low risk§
(95% CI) 
Summary rate 
differences for low risk 
(95% CI) 
Summary odds ratios 
for high-risk 
(95% CI) 
Summary rate 
differences for high-risk 
(95% CI) 
       
Definitive pneumococcal 
pneumonia 
0.34  
(0.24 to 0.48) 
4 
(0 to 7) 
0.32 
(0.22 to 0.46) 
11 
(2 to 19) 
1.23 
(0.28 to 5.43) 
0 
(-1 to 2) 
Definitive pneumococcal 
pneumonia (vaccine 
types only) 
0.17 
(0.09 to 0.33) 
8 
(1 to 16) 
0.16 
(0.09 to 0.31) 
15 
(-14 to 45) 
1.00 
(0.06 to 16.06)  
0 
(-2 to 2) 
Presumptive 
pneumococcal 
pneumonia 
0.47 
(0.35 to 0.63) 
13 
(21 to 47) 
0.40 
(0.29 to 0.56) 
41 
(29 to 54) 
0.98 
(0.51 to 1.89) 
-3 
(-21 to 15) 
Presumptive 
pneumococcal 
pneumonia (vaccine 
types only) 
0.39 
(0.26 to 0.59) 
16 
(-3 to 35) 
0.35 
(0.23 to 0.55)  
25 
(15 to 35) 
0.86 
(0.29 to 2.56) 
1 
(-5 to 7) 
Pneumonia (all causes) 0.9 
(0.77 to 1.04) 
6 
(-1 to 13) 
0.89 
(0.76 to 1.05) 
6 
(-2 to 14) 
0.92 
(0.63 to 1.35) 
5 
(-5 to 16) 
Bronchitis 0.84 
(0.69 to 1.02) 
6 
(0 to 15) 
0.84 
(0.69 to 1.02) 
8 
(0 to 15) 
- - 
Mortality (all causes) 1.02 
(0.90 to 1.14) 
1 
(-6 to 8) 
0.84 
(0.70 to 1.01) 
2 
(-2 to 7) 
1.16 
(1.00 to 1.35) 
-18 
(-47 to 11) 
Mortality (due to 
pneumonia) 
0.78 
(0.57 to 1.06) 
2 
(-2 to 5) 
0.79 
(0.57 to 1.08) 
2 
(-2 to 5) 
0.51 
(0.09 to 2.92) 
 
Mortality (due to 
pneumococcal infection) 
4.59 
(0.54 to 38.81) 
-3 
(-6 to 0) 
  4.59 
(0.54 to 38.81) 
-3 
(-6 to 0) 
Table 1: Conclusions from the meta-analysis of randomised controlled trials of pneumococcal vaccine efficacy in adults 
(adapted from Fine et al. 1994) 
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* Confidence intervals straddling 0 for rate differences and 1 for odds ratios are not significant at p=0.05. 
† Rate differences and confidence intervals expressed as number per 1000. 
‡ The odds ratio is the ratio of odds of the outcome with vaccination to the odds without vaccination.  
§ For definitions of low and high risk see 2.13. 
 
Two of the early studies were quasi-randomised, by alternate allocation, and so were not 
randomised studies in the true sense. They were carried out with relatively low valence 
vaccines (6 to 13 pneumococcal serotypes) compared to the current vaccine. This may 
have underestimated their effectiveness compared to the 23-valent vaccine.  
 
The characteristics of the patients in these early studies, young immunocompetent adults, 
were too unlike United Kingdom patients within the current recommendations to allow a 
useful comparison. Indeed there have been no studies of patients from this country. The 
miners in particular suffered from high rates of pneumococcal pneumonia due to dust 
inhalation and overcrowding. Moore et al. (2000) therefore excluded these earlier trials or 
those that did not look at true outcomes and only included trials after 1996 in their meta-
analysis. It showed that in the ten later studies of over 24,000 people who were elderly or 
likely to have impaired immune systems, pneumococcal vaccination had no effect for 
important clinical outcomes, such as rates of pneumonia, pneumococcal pneumonia, 
lower respiratory tract infections, pneumonia deaths or bacteraemia.  
 
The fourth and latest meta-analysis looked at randomised controlled trials in 
immunocompetent adults (Cornu et al. 2001). In the fourteen trials totalling 48,837 
patients retrieved, pneumococcal vaccination prevented definite pneumococcal 
pneumonia by 71%, presumptive pneumococcal pneumonia by 40%, and mortality due to 
pneumonia by 32%, but not all-cause pneumonia or death. The authors found no 
preventive effect in the subgroup of patients aged 55 years or more and argued that this 
may have been due to lack of statistical power. 
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In support of these four meta-analyses, the constituent randomised controlled trials 
minimised bias due to patient selection, subject migration, vaccine exposure and 
ascertainment of vaccination status and outcome (Shapiro and Clemens 1984). However 
these meta-analyses may have introduced other forms of bias including publication bias 
such as duplicate publication, non-publication or delayed publication of negative results, 
language bias, problems with heterogeneity, matching and pooling with different 
populations, interventions, settings and time periods (Egger et al. 1997). Individual trials 
included in these meta-analyses have also been criticised. For example, the Swedish study 
(Ortqvist et al. 1998) which showed no evidence of efficacy was criticised for lack of 
statistical power, low numbers (339 vaccinees and 352 controls), problems with case 
ascertainment, failure to assess blinding and an underestimate of immunocompromised 
patients subjected to the vaccine. The study was stopped after two years because of lack 
of efficacy although post hoc analysis showed that it was underpowered. It led to a wealth 
of critical correspondence (Butler et al. 1998b; (Steinhoff et al. 1998; Hak et al. 1998b; 
Gold 1998; Obaro 1998) In comparison, a Finnish study, which used larger numbers of 
patients, showed a beneficial effect, over and above influenza vaccine alone (Koivula et 
al. 1997). Patients in high-risk groups given pneumococcal vaccination in addition to 
influenza vaccine benefited from protective efficacy of 59% (95% confidence interval, 
6% to 82%). Another potential weakness was that studies other than randomised 
controlled trials were excluded (Hasselblad et al. 1995). Because these studies contribute 
to the evidence, the observational studies, both case control and cohort studies, are 
described below. 
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There have been six case control studies of pneumococcal vaccine efficacy; one of these 
was a follow-up investigation of an earlier study. These investigations were carried out in 
four different sites in the United States and all involved cases admitted to hospital. They 
used different inclusion criteria (see Table 2), slightly different definitions of at-risk 
groups (see Table 3), and patients were vaccinated with either the 14 or 23-valent 
vaccine. All the studies defined cases as patients with systemic pneumococcal infections 
diagnosed on blood culture or culture of other sterile body fluids, e.g. cerebrospinal fluid 
or joint aspirate. It is worth describing the salient points of the different studies in this 
group. 
 
The New Haven study (Shapiro and Clemens 1984) excluded younger patients aged 
between 2 and 17 years. The initial results were published in 1984 and a follow up report 
in 1988. Patients were divided into three groups according to underlying illness for 
matching controls. These were highest-risk immunocompromised (including asplenia, 
malignancy and SLE), moderately increased risk immunocompetent (chronic pulmonary 
disease, chronic heart failure, diabetes, alcoholism, chronic renal failure requiring 
dialysis) and mildly increased risk (including age ≥ 55). The results showed the vaccine 
to be very effective overall (61%, confidence interval 42 to 73%) and in those with 
moderately increased risk (60%, 37 to 75%) but not in patients aged 55 years and above 
with no other risk factors (64%, -5 to 87%). Subgroup analysis in the initial study also 
showed that the vaccine was not effective in the highest-risk immunocompromised group 
(efficacy 0 %, -1228 to 93%). The effect was specific to vaccine serotypes in that for non-
vaccine type infections the protective efficacy was -11%. Influenza vaccine had been 
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administered in similar proportions to both cases (30%) and controls (33%).  
 
The Colorado study showed no effect of pneumococcal vaccination (vaccine efficacy  
–21%, -221 to 55%). Controls were matched for age, admission date and underlying 
illness. However, the study may not have had sufficient power to eliminate type 2 errors 
(false negative results) because of the small numbers used. This study examined the older 
14-valent vaccine (containing 14 pneumococcal serotypes), which was subsequently 
replaced by the 23-valent vaccine (Forrester et al. 1987). 
 
The study by Sims et al. from Philadelphia used two controls per patient, matched 
according to date of admission, hospital site and underlying illness. Exclusion criteria 
included age less than 55 years, immunosuppressive disease (dysglobulinaemia, 
lymphoma, haematological malignancies, organ transplantation, nephrotic syndrome), 
immunosuppressive drugs (chemotherapy, steroids>20mg/day of prednisolone or 
equivalent within a year of inclusion) or incomplete medical records (23%). Vaccine 
efficacy in this study of low risk older patients was 70% (37 to 86%) (Sims et al. 1988). 
These results may be an overestimate because of exclusion due to incomplete records.  
Study Vaccine Number  Case selection Pneumococcal strain Vaccine efficacy (95% 
CI) 
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Table 2: Case control studies reviewed listed by author etc. 
New Haven, Connecticut 
(Shapiro and Clemens 1984) 
 
14-valent* 543 cases, 543 controls Positive sterile body fluid 
or blood culture 
Vaccine serotype & 
related 
61 (42,73) 
Denver, Colorado (Forrester 
et al. 1987) 
  
14-valent 89 cases, 89 matched 
controls 
Positive blood culture Vaccine serotype & 
related 
-21 (-221,55) 
Philadelphia (Sims et al. 
1988) 
14 & 23 valent 122 cases, 244 matched 
controls  
Positive sterile body fluid 
culture, hospitalised, aged 
>55, immunocompetent, 
complete records 
All serotypes 70 (37,86) 
Connecticut (Shapiro et al. 
1991)  
14 & 23 valent 1054 cases, 1054 controls 
matched for age, hospital site 
and underlying illness  
Positive sterile body fluid 
culture, hospital-based, 
>18, at-risk groups 
Vaccine serotypes & 
related 
All serotypes 
 
Immunocompromised 
Not vaccine serotypes 
47 (30,59) 
 
 
56 (42,67) 
61 (47,72) 
21 (-55,60) 
 
-73 (-263,18) 
Charlottesville, Virginia (Farr 
et al. 1995) 
14 & 23 valent 85 cases, 152 matched 
controls 
Positive blood culture, 
hospitalised patients, > 65 
or >2 with risk factor  
All serotypes 81 (34,94) 
Alaska (unpublished 
observations) (Davidson et 
al. 1994) 
 
14 & 23 valent 87 cases, 87 controls 
 
159 cases, 159 controls 
 Vaccine serotype & 
related 
All serotypes 
79 (45,92) 
 
64 (32,81) 
 
* 14-valent refers to the number of pneumococcal strains contained within the vaccine  
 
Table 3 Risk groups used in case control studies*
 DHSS risk 
groups for 
pneumococcal 
vaccination  
Shapiro et al, 
New Haven, 
Connecticut 
1984 
Forrester et al, 
Denver, 
Colorado 1987 
Sims et al, 
Philadelphia 
1988 
Shapiro et al, 
Connecticut 
1991 
Farr et al, 
Charlottesville, 
Virginia 1995 
Asplenia / 
splenectomy 
      
Chronic renal 
disease 
      
Immuno-
suppression 
      
HIV 
 
      
Chronic heart 
disease 
 †    ‡
Chronic lung 
disease 
      
Diabetes        
Chronic liver 
disease 
      
Alcoholism       
Age ≥ 65       
Age ≥ 55       
Stroke       
Dementia       
Disseminated 
cancer 
      
Local cancer       §
Lymphoma       
Myeloma       
Leukaemia       
Lupus 
erythematosus 
      
Rheumatoid 
disease 
      
 
* Shaded areas signify which risk groups were included in the guideline or study. 
† Chronic heart failure. 
‡ Includes coronary disease, congestive heart failure, and valvular heart disease. 
§ Lung cancer 
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A follow up study in Connecticut excluded young patients between 2 and 17 years. Again 
patients were divided into two groups according to underlying illness for matching 
controls, highest-risk immunocompromised (including asplenia, malignancy and SLE) or 
moderately increased-risk immunocompetent (age ≥ 55, chronic pulmonary disease, 
chronic heart failure, diabetes, alcoholism, chronic renal failure requiring dialysis). 
Subgroup analysis showed that vaccine was not effective in the immunocompromised 
group (efficacy 21%, -55 to 60%), patients aged ≥ 55 with no other risk factors (efficacy 
40%, -23 to 71%) and those not infected by vaccine type viruses (Shapiro et al. 1991). 
 
In another study (Farr et al. 1995), patients over 65 years or over 2 years with a risk 
factor admitted to hospital were selected as cases. The investigators used three matched 
controls for each case with matching for eight variables: admission date, age, sex, race, 
type and duration of major risk factor (categorised into high, moderate and low risk), 
number of vaccine indications, number of hospitalisations since pneumococcal vaccine 
licensed and type of primary medical care. They used matching to ensure that cases and 
controls had an equal likelihood of exposure to pneumococcal vaccine. Vaccine efficacy 
was 81% (34 to 94%) in this study. 
 
An unpublished study from Alaska investigating the 14-valent vaccine with 87 cases and 
87 controls showed a vaccine efficacy in vaccine and vaccine-related serotypes of 79% 
(45 to 92%). The investigators subsequently found a vaccine efficacy of 64% (32 to 81%) 
in all serotypes with the 23-valent vaccine (Davidson et al. 1994). 
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In summary five out of six case control studies demonstrated a protective effect of the 
vaccine. The smallest study, which lacked power, was the only negative study. These five 
studies showed a positive effect of pneumococcal vaccine, from pneumococcal serotypes 
contained in the vaccine, in low risk elderly. They used the older 14-valent vaccine 
(which has since been superseded), although the four later studies, which used both the 14 
and 23-valent vaccines, also showed a benefit of vaccination. Case control studies, 
although having a greater power to detect effects of interventions on rare events, are more 
susceptible to bias due to ascertainment and selection. However, the consistent finding of 
benefit from these case control studies supported a protective effect of vaccination. This 
influenced the policy decisions taken in both the United States and United Kingdom to 
implement national recommendations for pneumococcal vaccination. Although this 
included low risk elderly in the United States, the recommendation was to vaccinate high-
risk patients, including the elderly, in the United Kingdom. 
 
There have been four cohort studies of pneumococcal vaccination and these also showed 
a beneficial effect of pneumococcal vaccination (Table 4). The CDC studies and cohort 
study of Butler at al. (1993) used surveillance data from blood and cerebrospinal fluid 
cultures sent to United States laboratories and submitted to the Centers for Disease 
Control over several years. They compared rates of positive cultures in vaccinated as 
opposed to unvaccinated subjects. The study by Christenson et al. (2001) was a 3-year 
prospective study following an influenza and pneumococcal vaccination programme for 
all patients aged 65 years or older (259,627) in Stockholm County, Sweden. Patients aged 
65 years and over admitted to hospital in Stockholm County with influenza and 
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pneumonia related diagnoses were identified over a six-month period. The incidence (per 
100,000 inhabitants per year) of hospital treatment was lower in the vaccinated than in 
the unvaccinated cohort for all outcomes including influenza, pneumonia, pneumococcal 
pneumonia and invasive pneumococcal disease. The total mortality was 57% (55 to 60%) 
lower in vaccinated than in unvaccinated individuals (15.1 vs. 34.7 deaths per 1000 
inhabitants) giving a number needed to treat (see page 36) of 51 (Christenson et al. 2001). 
 
Pneumococcal vaccination was therefore shown to be effective in immunocompetent 
patients in systematic reviews and meta-analyses of randomised controlled studies. There 
was also supportive evidence for efficacy in immunocompetent and high-risk groups 
from some case-control and cohort studies. Pneumococcal vaccination had effects 
additional to influenza vaccination in preventing pneumococcal bacteraemia (Honkanen 
et al. 1999) particularly in high-risk groups (Koivula et al. 1997). There was also good 
evidence from observational studies that it protected healthy adults against pneumonia 
and bacteraemia whilst shielding high-risk groups against bacteraemia (Nguyen-Van-Tam 
and Neal 1999), hospitalisation and death (Nichol et al. 1999b). Uncertainty about 
effectiveness may have persisted because of the negative results from some studies, lack 
of generalisability of older studies and inherent weaknesses in case control and cohort 
study methods. In particular, it was unclear whether pneumococcal vaccine was effective 
in elderly or younger people in high-risk groups.  
Study Vaccine Subjects Pneumococcal strain Vaccine efficacy  
(95% CI) 
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Table 4 Cohort studies of pneumococcal vaccine 
CDC*-1 (Bolan et al. 1986)  
 
14 valent 249 vaccinated,  
1638 unvaccinated 
 
Vaccine type only 64 (47,76) 
CDC-2 (Spika et al. 1990) 14 valent 240 vaccinated,  
1527 unvaccinated 
 
Vaccine type only 60 (45,70) 
Indirect cohort (Butler et al. 
1993) 
 
14 & 23 valent 515 vaccinated, 
2322 unvaccinated 
Vaccine type and 
vaccine related 
57 (45,66) 
Swedish Pospective Study 
(Christenson et al. 2001) 
23 valent and 
influenza 
100,242 vaccinated 
159,385 unvaccinated 
Hospital admission for: 
Influenza 
Pneumonia 
Pneumococcal 
pneumonia  
Invasive pneumococcal 
disease 
Death 
 
46 (34,56) 
29 (24,34) 
36 (3,58) 
  
52 (1,77) 
 
57 (55,60) 
 
 
* Communicable Disease Centers 
 
 
Ethical problems were considered a barrier to conducting new randomised controlled 
trials (McDonald et al. 1997b) since national guidelines were already in place for 
pneumococcal vaccination of high-risk groups (Begg and Salisbury 1996). However, the 
uncertainty over efficacy for high-risk groups did lead to reasoned arguments for a well 
designed randomised controlled study of pneumococcal vaccination in at-risk groups in 
the United Kingdom but also the healthy elderly who were, in any case, being routinely 
vaccinated in other countries. 
2.12 Side effects of influenza and pneumococcal vaccination 
Safety was another very important aspect for successful introduction of vaccines and 
considerable research has been carried out in this area for both immunisations. Influenza 
vaccination has low side effect rates despite patient concerns about side effects. Initial 
evidence from one observational study suggested that the vaccine might be associated 
with an increased rate of influenza-like illness. The study compared side effects in 
patients within one week of influenza vaccination and three weeks after vaccination. The 
frequency of fever (5.3% versus 5.1%, p = 0.91) was similar in the two groups but a 
significantly higher proportion of subjects reported a flu-like illness within seven days of 
vaccination compared to the group interviewed 3 weeks later (14.2% versus 8.7%, p = 
0.03) (Margolis et al. 1990b). This gave a number needed to harm (NNH) of 18.* This 
study may have been flawed because of lack of blinding and recall bias, since those 
questioned closer to their vaccination date may have been more likely to recall possible 
side effects.  
 
* The number needed to harm (NNH) is analogous to the NNT but for adverse events and is the inverse of 
the absolute increase in risk (1/ARI or 100/ARI%). 
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Three randomised placebo controlled studies later confirmed a low rate of adverse 
effects. One, a randomised crossover trial, compared influenza vaccine with saline 
placebo in 336 outpatients aged sixty-five years or over. Patients were recruited by post 
and were randomised to receive vaccine followed two weeks later by placebo injection or 
placebo followed two weeks later by vaccine and there was no significant difference in 
disability or systemic symptoms such as fever, malaise, fatigue, muscle pain or headache 
(Nichol et al. 1996b). A randomised double blind placebo controlled study in Dutch 
general practice with eighteen hundred patients aged sixty or older looked at postal 
questionnaire reporting of side effects completed four weeks after vaccination. Twenty 
three per cent of patients given vaccine reported one or more adverse reactions compared 
with 14% given placebo. Local reactions, such as redness or soreness at the injection site, 
were significantly greater (17.5% vs. 7.3%, p<0.001) in the vaccine group but there was 
no difference in systemic reactions (11% vs. 9.4%, p = 0.34) (Govaert et al. 1993). An 
earlier randomised placebo controlled crossover study showed a rate of side effects of 
less than five per cent and no difference in side effects compared to placebo (Margolis et 
al. 1990a).  
 
Researchers have also looked at side effects in specific groups of patients. Nicholson and 
co-workers looked at possible side effects of influenza vaccination in asthmatics. 
Although initial studies showed no effect (Nicholson et al. 1977; Ahmed et al. 1997a), a 
randomised placebo-controlled crossover trial found a small increase in exacerbations of 
asthma (defined as fall of over 20% in peak flow rate within 72 hours of injection) in 
those asthmatics receiving influenza vaccine for the first time (Nicholson et al. 1998). 
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Occasional rare side effects such as vasculitis (Kelsall et al. 1997) or Guillain-Barre 
syndrome (Piyasirisilp and Hemachudha 2002) have been described in case reports 
(Mader et al. 1993). Drug interactions have been postulated for influenza vaccine, which 
as an interferon-inducer could inactivate liver enzymes (specifically the hepatic 
cytochrome P-450 system) causing reduced metabolism and clearance of drugs such as 
warfarin (an anticoagulant), theophyllines (used for asthma or chronic obstructive lung 
disease), and phenytoin (used for epilepsy) (D'Arcy 1984). However, there was no 
evidence for this in studies involving warfarin (Farrow and Nicholson 1984) or 
theophyllines (Jonkman 1986). Paracetamol, used to treat fever post-vaccination, also did 
not impair (or improve) the immune response (Gross et al. 1994). One recent case report 
linked influenza vaccination to carbamazepine (another antiepileptic drug) toxicity 
(Robertson, Jr. 2002). These side effects are potential problems for anyone receiving 
influenza vaccine, but particularly in some risk groups, such as asthma, and also elderly 
people who are more likely to be on several drugs. 
 
Reactions to pneumococcal vaccine tended to be mild discomfort or fever and short-lived 
lasting from 4 hours to 4 days with more severe local reactions of redness, pain, 
induration at the injection site or fever being much less common. Local reactions 
occurred in 28% but in 9 out of 10 patients these were mild and did not affect use of the 
arm (Nichol et al. 1997). Two studies showed little difference in reaction from 
simultaneous administration of influenza and pneumococcal vaccine at different sites. In 
one large study in the elderly over 65 years, the rate of local reactions was 28.4% in an 
influenza-vaccinated group compared to 44.1% with simultaneous vaccination (Govaert 
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et al. 1993). Fever was over twice as common with simultaneous vaccination, 2.4% 
compared to 1.4% with influenza alone. In another study of patients with chronic lung 
disease comparing simultaneous vaccination with influenza vaccine followed three weeks 
later by pneumococcal vaccination local reactions occurred in 38% and 36% of patients 
respectively (Fletcher et al. 1997). 
 
Revaccination within five years had little benefit in terms of raising antibody titres and 
was more likely to lead to local reactions (Hilleman et al. 1981). Revaccination after five 
years was reported in one study to cause a similar rate of reaction to initial vaccination 
although the rates quoted of 4-8% for systemic and 40-60% for local reactions did seem 
higher than those quoted by other sources (Rodriguez and Dyer 1995). A small case 
control study showed no evidence that revaccination led to an increase in hospitalisation 
(Snow et al. 1995). In general, reactions to influenza or pneumococcal vaccination tend to 
be minor, although their frequency would tend to deter patients from being vaccinated or 
revaccinated. 
2.13 High-risk groups for influenza and pneumococcal vaccination 
The elderly and those with specific diseases, particularly chronic heart and lung disease, 
had been identified as high-risk for respiratory illness, hospital admission and death from 
influenza and pneumococcal infections (Barker and Mullooly 1980) and this led to the 
notion that certain groups might benefit more than others from influenza and 
pneumococcal vaccination. For example, in one study of hospitalisations (310 patients) 
and deaths (38) from a large group practice in Rochester, New York State (United States) 
30 patients who died (79%) had flu-like symptoms, 26 patients (68%) were older than 65 
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years and 36 patients (95%) had chronic disease. Death from pneumonia and influenza 
ranged from fewer than 10 per 100,000 in healthy adults to more than 600 per 100,000 in 
chronically ill patients. The highest rates (870 per 100,000) occurred in persons with both 
cardiovascular and pulmonary disease (Barker and Mullooly 1982). Patients with these 
and other high-risk conditions were therefore recommended for influenza and 
pneumococcal vaccination in national guidelines. However, practitioners were unsure 
about risk groups for vaccination (James 2000) and guidelines varied in their definition of 
high-risk groups (Siriwardena 1997). It was therefore important (Walters and Weightman 
1997) to look at the research base for selection of high-risk groups.  
 
A prospective cohort study in the Finnish town of Varkhaus to determine which 
conditions were independent risk factors for pneumonia, pneumonia hospitalisations and 
pneumonia deaths (Koivula et al. 1994) found six conditions which were independent 
risk factors for pneumonia. These were lung disease (chronic obstructive airways disease, 
bronchiectasis, pulmonary fibrosis, lung cancer), heart disease (heart failure, valvular or 
congenital heart disease associated with pulmonary hypertension, cor pulmonale), asthma 
(on medication), immunosuppression (with steroids, cytotoxics or radiotherapy), 
institutionalisation (in residential or hospital care) and alcoholism (see Table 5). In 
addition, two thirds of pneumonia sufferers were over seventy years of age. This study 
did not show an increased risk of pneumonia in diabetes or ischaemic heart disease in the 
absence of heart failure. One third of the population fell into a risk group but forty five 
per cent of those who contracted pneumonia did not fall into one of these.  
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A case control study in over three thousand clinic patients from Seattle identified 63 men 
with serologically proven pneumococcal infection and compared 130 non-infected 
controls. The study found that dementia (relative risk, 5.82), epilepsy (4.38), current 
smoking (4.00) congestive cardiac failure (3.83), cerebrovascular disease (3.82), 
institutionalisation (3.13) and chronic obstructive pulmonary disease (2.38) were 
statistically significant independent risk factors for pneumonia. Lung cancer (2.24), 
previous smoking (2.14), corticosteroid use (1.81), alcoholism (1.35), diabetes (0.99) and 
ischaemic heart disease (0.58) had a non-significant or no increase in relative risk (Lipsky 
et al. 1986). 
 
Another prospective cohort study showed that diabetes and myocardial infarction as well 
as congestive cardiac failure, chronic obstructive pulmonary disease in smokers, stroke, 
cancer and age over sixty five years were associated with higher death or hospitalisation 
rates (LaCroix et al. 1989). A systematic review of factors affecting mortality from 
radiographically confirmed community-acquired pneumonia showed that mortality was 
associated with diabetes, cancers and neurological conditions (Fine et al. 1996).  
 
One group known to be at particular risk of severe pneumococcal infections were those 
patients who had had their spleen removed by surgery, termed splenectomy (Deodhar et 
al. 1993), or because they had a disease that caused the spleen to stop functioning 
normally, so-called functional asplenia (Kobel et al. 2000). This is because the spleen 
forms an important component of the immune system and prevents bacterial infection 
particularly from capsulated bacteria such as pneumococcus. 
Risk factor Pneumonia Pneumonia admission Pneumonia death 
 RR* 95% CI† RR 95% CI RR 95% CI 
       
Lung disease 3.0 2.3-3.9 5.0 3.4-7.3 NS‡  
Heart disease 1.9 1.7-2.3 1.2 1.1-1.3 5.0 2.9-8.6 
Asthma 4.2 3.3-5.4 6.0 4.1-9.0 NS  
Alcoholism 9.0 5.1-16.2 NS  NS  
Immunosuppressants 3.1 1.9-5.1 6.8 3.8-12.3 13.5 5.1-35.9 
Institutionalisation NS  NA  9.0 5.0-16.3 
Age 1.07 1.04-1.09 1.07 1.05-1.10 1.08 1.01-1.17 
Table 5 Risk factors for pneumonia, pneumonia admissions and death (adapted from Koivula et al. 1994) 
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* Relative risk 
† Confidence interval 
‡ Not significant 
 
The effect of an absent or dysfunctional spleen in such patients was therefore the 
susceptibility to overwhelming bacterial infection, so called overwhelming post-
splenectomy infection (OPSI) (Waghorn and Mayon-White 1997), The infection was 
most often due to pneumococcus but also other microbial organisms such as salmonella 
(Workman et al. 1996). This was known to have a mortality of forty-five per cent and 
could be prevented by pneumococcal vaccination as well as other measures such as 
regular antibiotic prophylaxis with penicillin.  
 
A study in Leicestershire, England during the 1989-90 influenza epidemic showed that 
influenza deaths occurred predominantly in very elderly people, those in residential care 
and in patients with underlying diseases, particularly cardiac and respiratory disease. The 
risk increased substantially with the number of underlying medical conditions, which also 
tended to increase with age. Institutionalised patients, particularly in nursing and 
residential homes formed an important risk group, partly because of age but also due to 
increased morbidity, often with multiple illnesses and also because of the increased 
likelihood of close contact and spread in this setting (Nguyen-Van-Tam and Nicholson 
1992). 
 
In addition to these factors nursing home and long stay patients were at increased risk 
from respiratory complications, particularly nosocomial (institution acquired) pneumonia, 
with failing general health, poor nutrition, confusion, diminished level of consciousness, 
aspiration and upper respiratory infections (Harkness et al. 1990). Similar factors, 
particularly poor nutrition, neuromuscular disease leading to weakness, reduced 
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consciousness and aspiration, were risk factors for nosocomial pneumonia in hospital 
populations (Hanson et al. 1992). 
 
Age was an independent risk factor for pneumococcal infection. Age was associated with 
increased risk in the studies of Koivula et al. (1994) and Lipsky at al. (1996) described 
above. A small retrospective survey from East Sussex looked at records of 125 patients 
with microbiologically proven pneumococcal infection (over ninety per cent with 
septicaemia) and found seventy per cent of cases in patients over 65 years, two thirds of 
these not having any other disease risk factors. Most patients (over eight out of ten) had a 
reasonable quality of life before infection. The case fatality rate was forty per cent 
whether or not a risk factor was present and the authors therefore argued that an age-
based policy would be more appropriate than one based on pre-existing disease (Steven 
and Wright 1992). However, this was a very small survey, with patients identified from 
hospital laboratory records over a relatively long period of eight years, who may have 
been unrepresentative of the general population. Analysis of another retrospective cohort 
study of pneumococcal infections also suggested that age had an independent association 
with risk of pneumococcal infections (Sims et al. 1992). This small study (63 cases and 
126 controls) suggested a linear increase in risk with increasing age for patients aged 50 
years and above. Those over 80 years old were at particularly high risk compared with 
patients under 50 (odds ratio 4.3, p<0.03) and the likelihood of pneumococcal infection 
increased by an estimated factor of 1.33 (95% confidence interval 1.03 to 1.71) for each 
decade increase in age. When the researchers tried to control for other risk factors this did 
not alter the overall effect of age, but statistical significance was lost suggesting that a 
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proportion of patients over 50 are at increased risk because of disease risk factors.  
 
The contradictory findings arising from these different studies explain the confusion 
amongst general practitioners about whom to vaccinate and the differences in risk groups 
between published studies and current United Kingdom guidelines (see Table 6). Because 
at-risk groups have a higher incidence of morbidity, mortality and hospitalisation from 
pneumococcal infections it has been advocated that influenza and pneumococcal vaccine 
should be administered to these groups (Bruyn 1992). If these vaccines were equally 
effective in high-risk groups, it would be more cost effective to vaccinate these patients 
because of greater absolute reductions in adverse outcomes.  
 
Influenza vaccine has now been offered to patients over 65 years in the United Kingdom 
because of the evidence of age-related risk and efficacy in this age group. It has also been 
argued that it would also be better to offer pneumococcal vaccination to all those over 
sixty five in the United Kingdom (Neal 1993), as already happens in the United States, 
rather than just those in disease risk groups. This is because of the age-related risk, the 
fact that the case fatality rate for patients over sixty five is equivalent to those with high-
risk diseases and because most episodes (up to 64% in one small series) of clinically 
proven pneumococcal disease occur in healthy elderly (Steven and Wright 1992). This 
policy has already been introduced in some areas of the United Kingdom (Elton and 
Panigrahi 1992) but has not been advocated by the Department of Health. 
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Table 6 Risk factors for pneumonia, pneumonia admissions and death from 
research compared to United Kingdom (DHSS) guidelines 
 
Indication Varkaus  
(Koivula 1994) 
Seattle 
Lipsky 1989) 
NIH 
(LaCroix, 1989) 
DHSS 
Pneumococcal 
DHSS 
Influenza 
 P* H† D‡ P H D P H D   
Age +§ + + +    + + 0 + 
Chronic heart disease** + + 0 +    + +/- + + 
Ischaemic heart disease 0 0 0 0    +  + + 
Chronic lung disease + + + +     + + + 
Asthma + + 0       0 + 
Diabetes  0 0 0 0    0 +/- + + 
Asplenia/splenectomy          + + 
Chronic renal disease 0 0 0       + + 
Immunosuppressants + + + +/-      + + 
HIV          + + 
Chronic liver disease          + + 
Alcoholism + 0 0 +/-      0 0 
Institutionalised + + + +      0 + 
Lung cancer    +/-        
Other cancers 0 0 0 0     +/-   
Hypertension 0 0 0     0    
Thyroid dysfunction 0 0 0         
Stroke    +     +/-   
Dementia    +        
Radiotherapy            
Epilepsy    +        
Hip fracture         +   
Cigarette smoking    +    +    
Black American    0        
 
 
* Pneumonia or pneumococcal infection. 
† Hospitalisation. 
‡ Death. 
§ + Indicates a positive association (or indication for vaccination), 0 lack of an association (or indication) 
and +/- a possible association. 
** Congestive cardiac failure, valvular heart disease, cor pulmonale. 
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 Other evidence exists for possible target groups for influenza and pneumococcal 
vaccination that has not yet been translated into policy recommendations in the United 
Kingdom. Previously hospitalised patients, particularly those admitted with respiratory 
illnesses, are one such high-risk group. A retrospective cohort study using data from 
Oxford showed that hospital admission in the previous five years was also an important 
risk factor for subsequent pneumonia deaths and hospitalisation (Fedson and Baldwin 
1982) and these findings were supported by the study of LaCroix et al. (1989). Acquired 
immune deficiency syndrome (AIDS) is another risk factor for influenza and pneumonia 
(Lin and Nichol 2001). Another intriguing possibility is to vaccinate those who may not 
be at increased risk themselves but who may, as vectors, infect older people. In Japan, a 
policy of vaccinating children against influenza was introduced from 1962 to 1987 and 
this led to most Japanese schoolchildren being vaccinated. This policy was withdrawn in 
1994 and vaccination rates fell. During the school vaccination program, excess mortality 
rates in elderly Japanese dropped from three to four times those in the United States to 
values similar to those in the United States. By vaccinating children there may have been 
increased herd immunity and the policy may have reduced the likelihood of children to 
act as vectors, infecting grandparents and other unsuspecting elderly contacts. This 
programme was estimated to prevent about 37,000 to 49,000 deaths per year, or about 
one death for every 420 children vaccinated. Since the policy was revoked the mortality 
rate amongst elderly people from influenza in Japan has increased to previous levels 
(Reichert et al. 2001). 
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Health workers caring for elderly and high-risk patients are considered another potential 
target group for influenza vaccination. This is because they are key staff at times of 
epidemics and also because they are potential vectors of influenza. It has been argued that 
vaccinating healthcare workers against influenza may lead to benefits in terms of reduced 
morbidity and mortality in elderly and at-risk patients as well as reduced sickness absence 
amongst staff and there is some, albeit limited, evidence for this. One randomised 
controlled trial from Baltimore in health workers showed a reduction in serologically 
confirmed influenza A and B, with 24 (13.4%) of 179 control subjects and 3 (1.7%) of 
180 influenza vaccine recipients affected during three years. There was also a reduction 
of reported febrile respiratory illness, 28.7 per 100 subjects vs. 40.6 per 100 subjects in 
controls (p = 0.57) and days of absence, 9.9 per 100 subjects vs. 21.1 per 100 subjects in 
controls (p = 0.41). The failure to show significant differences in sickness absence may 
have been due to lack of statistical power from an inadequate sample size. In a 
randomised controlled study from Glasgow, influenza vaccination of staff in long stay 
geriatric wards was associated with reduced mortality from 17% to 10% in elderly long 
stay patients (Potter et al. 1997). In another randomised controlled study of influenza 
vaccination in long stay geriatric facilities, health care workers were randomised to 
influenza vaccine (fifty per cent uptake) or control (5 per cent uptake). Over a six-month 
period the mortality rate amongst patients was 102 of 749 (13.6%) in vaccine hospitals 
compared with 154 of 688 (22.4%) in no-vaccine hospitals (odds ratio 0.58, 95% 
confidence interval 0.40-0.84, p=0.014). This difference occurred despite the two groups 
having a similar proportion of patients positive for influenza infection (5.4% and 6.7%, 
respectively) (Carman et al. 2000). The Department of Health has commissioned a series 
 65
of studies to investigate the evidence for vaccinating this group (personal 
communication). 
2.14 Evidence for influenza vaccine efficacy in high-risk groups 
A cohort study in a health maintenance organisation in the United States demonstrated 
that influenza vaccination was associated with reductions in hospitalisations for 
influenza, pneumonia and other respiratory conditions in high-risk groups. Vaccination 
resulted in significant reductions in mortality for high-risk groups. Vaccination was also 
associated with direct and total cost savings for both healthy and at-risk elderly aged 65 
to 74 years (Nichol and Goodman 1999). Studies have also revealed reduced illness, 
hospitalisation and death in chronic lung disease (Nichol et al. 1999a) and diabetes 
(Colquhoun et al. 1997). Influenza vaccination was also effective for nursing home 
patients. In a Japanese study of nursing home residents there were 950 cases of influenza 
infection diagnosed clinically, with virus isolation or serology in a six-month period. 
There were statistically significantly fewer cases of influenza, hospital admissions due to 
severe infection and deaths due to influenza in the vaccinated cohort (256 cases, 32 
hospital admissions, 1 death) than in the unvaccinated controls (694 cases, 150 hospital 
admissions, 5 deaths) with rate reductions of 59.8%, 76.9% and 79.1% for the three 
outcomes respectively (Deguchi et al. 2000). 
2.15 Evidence for pneumococcal vaccine efficacy in high-risk groups 
A number of studies have also shown that pneumococcal vaccination is effective in high-
risk groups. 
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A quasi-cohort (or indirect cohort) study comparing pneumococcal serotypes in 
vaccinated and unvaccinated patients suffering from invasive pneumococcal disease 
showed vaccine efficacy in high-risk patients. This study showed that in patients over 65 
years with diabetes, chronic heart disease and pulmonary disease, efficacy was 61% (95% 
confidence interval 1 to 85%) (Bolan et al. 1986). Another indirect cohort study provided 
further evidence of vaccine effectiveness in high-risk groups (Butler et al. 1993). This 
study showed vaccine efficacy overall of 57% (95% confidence interval, 45 to 66%) and 
also demonstrated efficacy for disease groups included diabetes (84%, 50 to 95%), 
ischaemic heart disease (73%, 23 to 90%), congestive cardiac failure (69%, 17 to 88%), 
chronic obstructive pulmonary disease (65%, 26 to 83%), splenectomy (77%, 14 to 95%) 
and immunocompetent patients over 65 years (75%, 57 to 85%). The study did not 
demonstrate vaccine efficacy for patients with alcoholism, cirrhosis, sickle cell disease, 
chronic renal failure, leukaemia, lymphoma or myeloma but had insufficient power to do 
so. 
 
An initial study (Shapiro and Clemens 1984) and subsequent New Haven case control 
study (Shapiro et al. 1991) showed that the vaccine was effective in a subgroup of 
patients with chronic lung or heart disease, alcoholism or diabetes with an efficacy of 
61% (47 to 72%). Other studies have shown effectiveness of pneumococcal vaccination 
in specific diseases, for example chronic lung disease (Nichol et al. 1999b). 
2.16 Guidelines for influenza and pneumococcal vaccination  
Guidelines are ‘systematically developed statements to assist practitioner and patient 
decisions about appropriate healthcare for specific clinical circumstances’ (Effective 
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Health Care 1994). Although the various guidelines for influenza and pneumococcal 
vaccination are broadly similar, there are important differences in indications for the two 
vaccines, international differences in high-risk groups targeted, and several areas of 
confusion in the guidelines on disease groups recommended for immunisation (Table 7).  
 
For influenza vaccination the most significant differences relate to age based policies. 
The Advisory Committee on Immunisation Practices (ACIP) in the United States 
(Centers for Disease Control 1989) and the World Health Organisation (WHO) (Fedson 
et al. 1989) have recommended vaccinating healthy elderly as well as high-risk groups 
against influenza and pneumococcal infection for over a decade. The Department of 
Health (DOH) in the United Kingdom (Begg and Salisbury 1996) until recently had a 
policy for vaccinating only high-risk groups although this has changed recently for 
influenza vaccination. The DOH guidance to vaccinate patients of 75 years and over 
against influenza was introduced in August 1998 (Department of Health 1998c) and this 
was reduced to age 65 years and over in May 2000 (Department of Health 2000c). The 
advice was reiterated more recently in the National Service Framework for Older People 
(Department of Health 2001b). In the latest guidance, there was also a recommendation to 
achieve a target of 60% uptake in patients over 65 in the year 2000 and 65% in the year 
2001 (Department of Health 2001a). This compared with the Year 2000 target set in the 
United States in 1989 of 60% of patients over 65 years and the Year 2010 target of 90% 
for patients over 50 set in 2001 (Zimmerman 1999). The reasons for these differences are 
complex.  
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It is interesting to compare national policy for influenza and pneumococcal vaccination in 
the United Kingdom with that in the United States. The United States began their age-
based policy for influenza vaccine funded by Medicare after the successful nationwide 
demonstration projects in the 1980s (Barker et al. 1999). The Healthy People 2000 targets 
in the United States were published in 1990. These set national targets for vaccinating the 
elderly (aged sixty-five and over) aiming for sixty per cent coverage (or eighty per cent in 
institutionalised elderly) and were identical for influenza and pneumococcal vaccine. The 
Healthy People 2010 goal set in the year 2000 was ninety per cent coverage for both 
vaccines. For pneumococcal vaccine, the age to be targeted is still sixty-five and over but 
for influenza the lower age has dropped to fifty years. The main reason for this is the low 
influenza vaccination rate in high-risk adults aged fifty to sixty-four and the greater 
likelihood of an age based policy improving this situation. Some American public health 
experts believe that universal flu vaccination is the future policy direction for the United 
States and predict that this will be introduced within the next decade (Nancy Bennett – 
personal communication).  
 
The difficulties of achieving these targets for influenza vaccination are not to be 
underestimated given worldwide vaccine shortages due to manufacturing problems, 
problems with patient and population registers as well as implementation research 
suggesting that there is an upper ceiling to vaccination rates which falls below this ninety 
per cent level (Buffington and LaForce 1991). 
 
 69
The 1996 guidance on pneumococcal vaccination of high-risk groups was underlined by 
the Chief Medical Officer’s update in the Autumn of 1997 (Department of Health 1977) 
which recommended simultaneous administration of pneumococcal vaccine to ‘those for 
whom it is indicated and who have not already been immunised.’ In the United Kingdom 
this did not include pneumococcal vaccination of institutionalised elderly or those over 65 
years in contradistinction to the ACIP or WHO guidelines. The 1989 WHO 
recommendations defined elderly as patients older than 60-65 and included all persons at 
high-risk but did not specify these other than referring to chronic heart and lung disease, 
institutionalised elderly and asplenia as specific risk groups.  
 
Even within the risk categories, there is considerable scope for confusion about who 
should be given pneumococcal vaccine. With chronic heart disease some authors 
translated this to include patients with ischaemic heart disease and congestive heart 
failure (McDonald et al. 1997a) whereas other authorities interpreted this to mean only 
patients with congestive cardiac failure on regular medication (Bro Taf Audit Group 
1996). The National Service Framework for coronary heart disease (Department of 
Health 2000a) also advises pneumococcal vaccination for chronic heart failure but not 
other forms of heart disease. 
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Table 7 Comparison of clinical indications for pneumococcal and influenza 
vaccination in clinical guidelines and recommendations*
 
Indication ACIP 2001 
Pneumococcal 
ACIP 2001 
Influenza 
WHO 1989 
Pneumococcal 
DHSS 2001 
Pneumococcal 
DHSS 2001 
Influenza 
Chronic heart 
disease 
     
Chronic lung disease     †
Diabetes       
Splenectomy      
Chronic renal disease      
Immunosuppression      
HIV      
Chronic liver disease      
Alcoholism      
Age ≥ 65      
Age ≥ 50      
Institutionalised      
CSF fluid leaks      
Stroke      
Dementia      
Radiotherapy      
Disseminated cancer      
Local cancer      
Lymphoma      
Myeloma      
Leukaemia      
 
 
 
* Shaded areas signify which risk groups are included in the corresponding guideline. 
† Includes asthma 
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In the case of chronic lung disease the Department of Health guidelines did not specify 
pneumococcal vaccination for asthmatics (whereas it did for influenza vaccination). In 
contrast, most United States authorities did include asthma as an indication for 
pneumococcal vaccination (Fiebach and Beckett 1994). With the overlap between chronic 
asthma and chronic obstructive airways disease (COAD), underdiagnosis of the latter due 
to poor access to lung function testing and misclassification of chronic obstructive 
airways disease as asthma on chronic disease registers excluding asthma as an indication 
for pneumococcal vaccination is a debatable policy (Siriwardena 1997). 
 
Hodgkin’s disease is another example where there is confusion. The ACIP 
recommendations include Hodgkin’s disease. The DOH includes immunosuppression as 
an indication but comments that the vaccine is less effective in immunocompromised 
patients including those with Hodgkin’s disease, especially during treatment. The vaccine 
datasheet cites as a contraindication patients with Hodgkin’s disease who have been 
treated with extensive chemotherapy, nodal irradiation or both (Walters and Weightman 
1997). DOH and ACIP guidelines advise pneumococcal vaccination at least two weeks 
before splenectomy, chemotherapy or radiotherapy. If this is not possible, the DOH 
recommends vaccination as soon as possible after splenectomy or after at least six months 
after completing chemotherapy or radiotherapy.  
2.17 Cost effectiveness of influenza and pneumococcal vaccination 
A number of studies have demonstrated the cost effectiveness of influenza vaccination in 
the elderly (Mullooly et al. 1994) and even shown cost savings when compared with the 
higher costs of hospitalisation in the United States (Nichol et al. 1994). A recent study 
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from the Netherlands showed costs of 1820 euro per life year gained (Postma et al. 1999). 
This figure hid cost savings in high-risk elderly and higher costs (6900 euro) in low risk 
older patients. Some analyses have even suggested cost savings in healthy working adults 
from annual influenza vaccination but this was based on United States costs and highly 
dependent on wages, absenteeism and influenza attack rates (Nichol 2001). Similar 
analyses using United Kingdom data have failed to show definite cost-benefit for 
influenza vaccination of young adults (Demicheli et al. 2000). Earlier studies from the 
United States also suggested that pneumococcal vaccination might be cost saving, but 
these were based on the assumption that the vaccine prevented pneumonia (Gable et al. 
1990; Willems 1982; Willems et al. 1980). This flaw was also apparent in more recent 
European studies (Ament et al. 2000; De Graeve et al. 2000). With increasing evidence 
that the vaccine prevented pneumococcal bacteraemia rather than non-bacteraemic 
illness, a re-evaluation of cost-effectiveness took place (Simberkoff 1993). Although the 
absolute benefits for pneumococcal vaccine are smaller than those for influenza vaccine, 
the greater costs of hospitalisation for pneumococcal bacteraemia and pneumonia (even 
pneumonia with bacteraemia) mean that pneumococcal vaccine has also been shown to be 
cost-effective, particularly in the elderly aged sixty-five years and over (Fedson 1993). 
Sisk estimated that the overall savings for elderly vaccinees would amount to $8.30 with 
1.2 life years gained (Sisk et al. 1997). Comparable studies in European countries have 
also shown cost-effectiveness of pneumococcal vaccination for prevention of invasive 
disease alone with estimates of 10000 (6000 to 16000) euro per life year gained (Postma 
et al. 2001) and other studies have also shown cost savings in patients with chronic lung 
disease (Nichol et al. 1999b; Hak et al. 1998a). There was also evidence that the cost-
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effectiveness of both vaccines, but particularly pneumococcal vaccine, could be increased 
by delivering the vaccines together (Weaver et al. 2001). 
2.18 Conclusion 
Influenza and pneumococcal vaccines were introduced to address the significant burden 
of respiratory illness in the community, particularly in high-risk groups including the 
elderly. The studies reviewed have demonstrated the efficacy, safety, and cost-
effectiveness of both influenza and pneumococcal vaccines in elderly people (aged over 
sixty-five years) and high-risk populations. Recommendations on eligibility for the two 
vaccines were similar but not identical. There were important differences in national and 
international recommendations for both of these vaccines but these differences did not 
always relate to the evidence or practical issues for implementation. Because of the 
different incidence and severity of influenza and pneumococcal infections there were also 
important differences in vaccine effectiveness in terms of absolute risk reductions for 
outcomes, numbers needed to treat and costs prevented, such as hospitalisation. These 
differences, as well as some of the negative individual studies and systematic reviews 
may have caused some confusion and uncertainty amongst practitioners about who to 
vaccinate. Combined administration of influenza and pneumococcal vaccination had been 
advocated in national guidance, particularly as a means of improving uptake of 
pneumococcal vaccine and was shown to be safe and more cost-effective than giving 
vaccines separately. 
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CHAPTER 3 IMPROVING VACCINATION RATES: 
 LITERATURE REVIEW (II) 
3.1 Introduction 
This chapter reviews the literature on variations in vaccination rates, barriers and 
facilitators (also termed enablers or incentives) to vaccination and methods to improve 
vaccination rates in high-risk groups. Barriers and facilitators, including doctor and 
patient attitudes to vaccination, and how they influence vaccination uptake are explored. 
The range of methods used to improve vaccination rates and the evidence of effectiveness 
of these techniques is reviewed within the more general context of studies of methods 
designed to improve professional performance. A detailed discussion of educational 
interventions to improve performance, particularly educational outreach (or academic 
detailing) is presented below (see 3.10). 
3.2 Sources 
The articles for this review came from a range of sources including computerised 
searches of the MEDLINE database from 1976 to 2002; EMBASE database; the 
Cochrane Database of Systematic Reviews; Database of Abstracts of Reviews of 
Effectiveness (DARE); Health Management Consortium Database on CD-ROM which 
combines the Department of Health, King’s Fund and Health Management Information 
Centre at Leeds University databases; Health Promis - database of the Health Education 
Authority; English National Board (ENB) for Nursing Midwifery and Health Visiting 
database; CINAHL (Cumulative Index to Nursing and Allied Health Literature) database 
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on the Internet; National Centre for Clinical Audit database on the Internet; recent 
articles, letters and reviews from the British Medical Journal, British Journal of General 
Practice, Postgraduate Medical Journal and the Lancet; citations in the articles found 
above; citations provided by my supervisors and other colleagues. 
3.3 Method 
Searches were carried out on computerised databases using the following search terms as 
Medical Subject Headings or keywords: Streptococcus pneumoniae, pneumonia, 
pneumococcal, pneumococcal infections, pneumococcal pneumonia, influenza 
vaccination, immunization, immunization programs, immunization schedule; risk factors, 
utilisation, cost-effectiveness, evaluation studies; attitudes; organization development, 
organization and administration, organizational case studies, organizational change, 
organizational culture, organizational effectiveness, organizational innovation, 
organizational objectives, organizational efficiency and organizational policy; patient 
education, compliance; education, learning, interprofessional relations, nursing, models, 
motivation, practice guidelines; evaluation studies, outcome and process assessment 
(health care), program development, program evaluation; primary health care. Abstracts 
from the searches were examined for relevance and stored on an electronic database 
(Reference Manager). 
3.4 Vaccination rates in high-risk groups 
There have been a number of studies looking at influenza and pneumococcal vaccination 
rates in the various high-risk groups (see also 2.13). This section examines major surveys 
carried out in the United Kingdom before and around the time that the field studies in this 
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thesis were conducted. In the early 1990s, influenza and pneumococcal vaccination rates 
were generally low in high-risk groups in the United Kingdom, running below fifty per 
cent overall, although this figure was higher in some groups of patients. Rates have 
increased since then due to a number of initiatives that were introduced, partly as a result 
of this research, and more generally due to wider national initiatives to improve 
vaccination uptake. These initiatives will be described in later chapters.  
 
Many surveys of vaccination uptake depended on patients remembering whether they had 
been vaccinated or on vaccine records. These were unreliable methods due to recall bias, 
forgetfulness or poor recording. Self-reported vaccination history has been shown to be a 
highly sensitive but only moderately specific guide to vaccination status, i.e. if patients 
reported that they had been vaccinated they were very likely to have been; but a 
proportion of those who reported that they had not been vaccinated had been. In one 
study the proportion of patients who had been vaccinated despite believing that they had 
not varied between 20 to 30% for influenza vaccination and 30 to 40% for pneumococcal 
vaccination, the latter rate being partly dependent on length of time from immunisation 
(MacDonald R. et al. 1999). Vaccination rates quoted in the studies reviewed below need 
to be interpreted in light of this. 
 
Overall, vaccination rates in high-risk groups were disappointing. A survey of sixty-four 
computerised practices in Gwent in the United Kingdom in 1994 showed that less than 
50% overall of those patients at high-risk were receiving influenza vaccine. This 
investigation showed vaccination rates of 63% for heart disease, 39% for patients with 
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diabetes, 41% for asthma sufferers and 33% in elderly aged 75 years and over (Watkins 
1997). Although rates have gradually increased since then, younger high-risk patients 
were less likely to receive vaccination than those elderly people aged sixty-five years or 
over. A national survey conducted between 1989 and 1997 showed vaccination rates from 
33.2% to 43.9% in high-risk patients aged 65 years and over, but rates of 10% to 12.4% 
in high-risk patients under 65 years and 19.2% to 23% in high-risk individuals more 
generally (Irish et al. 1998). Both of these surveys were carried out before the age related 
targets for vaccination of the elderly were introduced in the United Kingdom.  
 
Studies of vaccination rates in individual disease groups showed similar deficiencies. A 
survey of vaccine coverage for serious heart disease at around the same time (just before 
1990) showed very poor results. Influenza vaccination rates were 17% in the previous 
five years for patients on waiting lists for heart surgery in Leicester (Kurinczuk and 
Nicholson 1989). Patients attending secondary care with diabetes in the Northern Region 
of the United Kingdom showed slightly higher rates of vaccine uptake. However, despite 
the ten-year gap between these studies, only 35% (93 of 268) of patients with diabetes 
received both influenza and pneumococcal vaccines, 24% (64 of 268) received only 
influenza vaccine, and none received pneumococcal vaccine alone. Vaccination rates 
improved with increasing age and the presence of chronic pulmonary disease (Wahid et 
al. 2001). Encouragingly, studies in patients with diabetes have shown gradual increases 
in vaccination rates since then, at least for influenza vaccination (Lewis-Parmar and 
McCann 2002).  
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The importance of pneumococcal vaccination in patients with an absent or poorly 
functioning spleen was described above (see 2.13). Despite this, in one survey, only 36% 
of patients post-splenectomy had received pneumococcal vaccination (Deodhar et al. 
1993). Given the clear guidelines for vaccination post-splenectomy (Working Party of the 
British Committee for Standards in Haematology Clinical Haematology Task Force 
1996), the harm resulting from failure to vaccinate (Waghorn and Mayon-White 1997) 
and the likelihood of litigation in cases where vaccination had not been undertaken this 
represented worrying underperformance. 
 
Nursing and residential home patients were another important high-risk group. A survey 
from Nottingham in 1993 showed influenza vaccine uptake of around 40 per cent 
(Warren et al. 1995). Nursing and residential home patients in South Wales in 1991-2 
fared better with influenza vaccination rates of 67% for all homes, 65% for residential, 
76% for dual registered and 82% for nursing homes (Evans and Wilkinson 1995).  
 
High-risk hospitalised patients were a further group that frequently failed to have 
influenza or pneumococcal vaccination. A survey of patients discharged from medical 
wards showed that 40% (161 of 400) were in a high-risk group for pneumococcal 
vaccination but only half had been vaccinated (Turner and Finch 1999). Another small 
survey of a random sample of patients admitted to hospital with severe chronic 
obstructive pulmonary disease showed that only 14% (4 out of 28) had been offered 
pneumococcal vaccine (Doherty et al. 1997). 
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Co-morbidity was associated in some studies with increased vaccination rates. In 
diabetics influenza vaccination rates doubled (odds ratio 1.99, confidence interval 1.07-
14.12) and pneumococcal vaccination almost quadrupled when chronic pulmonary 
disease was also present (odds ratio 3.77, confidence interval 1.69-21.76) (Wahid et al. 
2001). 
 
Rural communities may be expected to have particular problems with adult vaccination 
programmes due to geographical spread of the population and the resultant problems of 
access to healthcare. There was little evidence from the literature that the particular 
problem of rurality had been addressed, although one study from rural Canada did note a 
very low level of pneumococcal vaccination in high-risk patients who were admitted to 
hospital (Doyle et al. 2001) but another study from rural Alberta, also in Canada, showed 
a higher rate of influenza vaccination than urban populations (Russell 1997). 
 
In summary, these studies showed marked variations in vaccination rates and poor uptake 
of influenza and pneumococcal vaccines overall in these groups of high-risk patients, 
with rates for pneumococcal vaccination being generally lower than those for influenza 
vaccination.  
3.5 Barriers and facilitators of vaccination 
To understand why vaccination rates were low and why there was a wide variation in 
rates it is important to appreciate the barriers and facilitators to improving rates. The main 
barriers and facilitators of vaccination were knowledge and attitudes of patients and 
healthcare workers about influenza and pneumococcal vaccination, together with logistic 
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considerations such as the ability of the healthcare provider to have adequate vaccine 
supplies, storage facilities and systems to encourage vaccination (Mieczkowski and 
Wilson 2002). Such systems included practice protocols, reminders to doctors and nurses, 
special clinics and home vaccination of housebound elderly people, at-risk registers and 
patient reminders through call and recall systems amongst others. These barriers and 
facilitators are discussed in detail below.  
3.6 Patient knowledge, attitudes and behaviour to vaccination 
Patients failed to take up influenza or pneumococcal vaccination because of lack of 
awareness, a perception that they may not be at risk and negative beliefs including 
worries about safety. A consistent finding from the literature was that patients were far 
less aware of pneumococcal vaccine compared with influenza vaccine.  
 
For example, in a study of geriatric admissions from Aberdeen (Findlay et al. 2000) most 
patients (74%) had heard of influenza vaccination but only few (13%) knew of 
pneumococcal vaccination. Many patients were ambivalent about vaccination. Most of 
those surveyed (87%) considered influenza a serious infection but only half the patients 
thought that were at risk from it. Many patients (72%) thought that the vaccination was 
effective but half also thought that they would become ill because of the vaccine.  
 
This perception amongst the elderly that they were healthy, and therefore not at risk from 
influenza, together with fear of side effects was a potent cause of non-vaccination 
(Cornford and Morgan 1999; van Essen et al. 1997). Some elderly patients were 
uncertain whether they fell into a risk group (Nexoe 1998). A particular concern for many 
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patients was that the influenza vaccine might cause ‘flu’ itself (Bedford et al. 1997). A 
lack of belief in the vaccine or perception that a health care worker had not recommended 
it were also strongly associated with refusal of vaccination (Bedford et al. 1997; Fiebach 
and Viscoli 1991). Although most elderly individuals were aware of influenza vaccine, 
fewer patients realised that influenza vaccine was indicated for high-risk groups of any 
age and in particular in younger age groups (Russell 1997), thereby leading to poorer 
vaccination rates in the latter.  
 
There were no studies of ethnic differences in vaccination rates from the United Kingdom 
but ethnicity had been shown to affect vaccine uptake, for example in African-American 
(Marin et al. 2002; Armstrong et al. 2001), Hispanic (Centers for Disease Control 1997) 
and Native American (Buchwald et al. 2000) populations in the United States. A 
particular concern amongst low income African Americans was in relation to undisclosed 
substances in the vaccine as well as more universal concerns such as inconvenience, fear 
of pain and previous side effects, all of which predicted failure to be vaccinated. Social 
factors such as poverty, lack of health insurance, reduced access to health care and poor 
education leading to lower awareness of vaccines also contributed to lower vaccination 
rates in these minority groups. 
 
Elderly patients who used primary care facilities less frequently were also less aware of 
the benefits of vaccination (Hershey and Karuza 1997). Reduced access may also have 
been associated with risk taking behaviour such as smoking, since smokers also had 
lower vaccine uptake even in well-organised managed care systems (Fowles and Beebe 
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1998). Where age based policies were in place, as was the case in North America, 
patients were usually more aware of age as an indication for vaccination than other 
disease risk groups (Russell 1997). Financial factors were also a deterrent to vaccination 
in healthcare systems where patients were expected to pay for vaccination (Nexoe 1998), 
although this was not relevant to the United Kingdom. Interestingly, factors such as 
perception of low risk, confidence of fighting off the infection naturally and doubts about 
the efficacy of the vaccine were also barriers for some healthcare workers who were 
recommended for vaccination (Harbarth et al. 1998).  
 
Conversely, a number of factors predicted increased vaccine uptake. These factors 
included previous vaccination, prior knowledge of the vaccine, positive attitudes to 
vaccination, perceived need (perception of risk), intention to be immunised and most 
importantly recommendation from a general practitioner or other health care worker 
(Kyaw et al. 1999; Armstrong et al. 2001; Honkanen et al. 1996; Gianino et al. 1996; 
Nichol et al. 1996a; Ganguly and Webster 1995; Duclos and Hatcher 1993; Gene et al. 
1992; Nichol et al. 1992). Portrayal of side effects positively (as a proportion of patients 
who remain free from side effects) or negatively (proportion who develop side effects) 
did not seem to affect vaccine uptake but in one study did affect expectation of side 
effects, systemic effects and absenteeism (O'Connor et al. 1996). Unfortunately, many 
patients could not remember being recommended pneumococcal vaccination by their 
doctor or nurse (Mieczkowski and Wilson 2002). 
 
This delicate balance of perceived benefits, barriers, risk and severity has been shown to 
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predict the likelihood that patients would accept vaccination (Nexoe et al. 1999). 
3.7 Practitioner knowledge, attitudes and behaviour to vaccination 
Practitioners were generally supportive of influenza vaccination (Meynaar et al. 1992). 
There were a number of reasons why this may have been so. The evidence for 
effectiveness of influenza vaccination had been widely publicised. This was achieved 
through the literature (DiGuiseppi 1996), national guidance (Begg and Salisbury 1996), 
regular updates from the Chief Medical Officer (Department of Health 2001a), evidence 
based journals which were known to be widely read by general practitioners (Coleman 
and Nicholl 2001) such as Effectiveness Matters (NHS Centre for Reviews and 
Dissemination 1996), Bandolier (Moore 1995) and Clinical Evidence (Marrie 2001) as 
well as the mass media. There was some dissention to these views including the argument 
that influenza may comprise only a small proportion of winter respiratory infections 
responsible for illness, admission or death compared with other viruses (Long et al. 1997; 
Nicholson et al. 1997) or that excess winter deaths could be due more to the effect of cold 
weather than to influenza (Donaldson and Keatinge 2002).  
 
There was less support amongst practitioners for pneumococcal compared to influenza 
vaccination (Kyaw et al. 2001; Bovier 2002). Whilst national guidance promoted 
pneumococcal vaccination (Begg and Salisbury 1996), and advice issued from the Chief 
Medical Officer to give pneumococcal vaccination together with influenza vaccine 
(Department of Health 1997) this direction was contradicted by the suggestion that there 
was little evidence to pursue the policy of pneumococcal vaccination (British Thoracic 
Society 2001), advice that was also publicised in evidence based journals such as 
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Bandolier* (Moore 2000) and peer-reviewed journals (Keeley 2002).  
 
The benefits of influenza vaccine had been publicised in Bandolier using the concept of 
numbers needed to treat (Moore 1995). For elderly patients aged 60 years and over, 
between 9 and 20 patients needed to be vaccinated to prevent one case of influenza. In 
contrast, the incidence of pneumococcal infection, particularly so-called invasive 
pneumococcal infection, such as bacteraemia or septicaemia was known to be much 
smaller. As a result, although relative risk reductions with pneumococcal vaccination 
were comparable or even greater in some studies compared with influenza vaccination the 
absolute benefits were at least two orders of magnitude smaller. In the Canadian 
systematic review for example, risk reductions for vaccine-type pneumonia and systemic 
pneumococcal infections were 73% but because the baseline risk of pneumococcal 
bacteraemia was much lower, at around 50 cases per 100,000 people over 65 years of age, 
the number needed to treat† was considerably higher. Hutchison calculated that 2520 
elderly people would need to be vaccinated to prevent one case of pneumococcal 
bacteraemia each year (Hutchison et al. 1999). This meant that assuming vaccine costs of 
£10 per pneumococcal vaccine compared to £5 per influenza vaccine the cost per case 
prevented was £25,000 and £40 respectively. This illustration excluded hospital and other 
indirect costs which were often much greater for a case of pneumococcal bacteraemia 
because this was a more severe illness, likely to require more time in hospital and require 
greater resources, such as intensive care, for treatment. However, this calculation 
 
* Bandolier is particularly quoted here because it was one of the flagship periodicals of the evidence based 
medicine movement and the debate on the efficacy of pneumococcal vaccination highlighted here. 
† The number needed to treat is calculated as the inverse of the absolute risk reduction and is a useful 
standardised and readily understandable measure of clinical effectiveness because it incorporates disease 
prevalence. 
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strikingly demonstrated the basis for the broad difference in perceptions about the cost-
effectiveness of the two vaccines. 
 
Despite the importance of patient and practitioner barriers, such as knowledge and 
attitudes to vaccination, positive attitudes were not always translated into improvements 
in care (Hulscher et al. 1997a). Another important reason for failure to vaccinate was a 
lack of systems to identify or contact those patients who were eligible for vaccination 
(Bedford et al. 1997). One common reason why doctors and nurses did not vaccinate 
patients was that they forgot to. Indeed, in one study this factor correlated most closely 
with the doctor’s vaccination rate (Metersky et al. 1998). Vaccination was forgotten for 
two main reasons. Firstly, practitioners believed they were vaccinating more patients than 
they actually were, so were overconfident in their estimate of how well they were doing 
and this reduced the pressure to vaccinate. Practitioners’ overestimation of their own 
performance has been a consistent finding from many audit studies looking at a variety of 
health care activities. Secondly, practitioners’ attention was diverted away from the issue 
of vaccination by the presenting medical problem (Noe and Markson 1998) or other more 
important clinical issues (Hershey and Karuza 1997; Rushton et al. 1994). Another reason 
for practitioners being unable to vaccinate was that the problem presented to the doctor 
by the patient was an acute illness which necessitated postponing vaccination (Szilagyi et 
al. 1994). There were also many occasions when the patient refused vaccination (Hershey 
and Karuza 1997; Metersky et al. 1998) for the various reasons cited above (see 3.6) 
despite practitioners attempts to persuade them of the benefits.  
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Some health care workers were also concerned about side effects of influenza and 
pneumococcal vaccine and uncertain about guidelines or vaccine effectiveness (Ballada et 
al. 1994), negative attitudes which were prevalent even amongst respiratory physicians 
(Sockrider et al. 1998). These negative attitudes may have reduced the likelihood that 
health workers offered vaccination to their patients and such attitudes were also shown to 
adversely affect vaccine uptake amongst health care staff themselves (Nafziger and 
Herwaldt 1994; Beguin et al. 1998; Yassi et al. 1994; Watanakunakorn et al. 1993). 
There were also differences between influenza and pneumococcal vaccination in this 
respect with less support amongst practitioners for pneumococcal than influenza 
vaccination (Kyaw et al. 2001; Bovier 2002). 
3.8 Organisational, social and behavioural models to improve 
performance 
The dynamics of change in healthcare organisations have been extensively studied. There 
are a number of organisational, social, behavioural and psychological theories, which 
applied to both individuals and groups, are valuable to understanding and successfully 
implementing change in healthcare. These theories encompass different components of 
change such as the receiver, source, innovation and information channel (Lomas 1991). 
 
Early epidemiological models of improving performance, which assumed that 
practitioners (or receivers) wished to change their behaviour in light of sound evidence or 
credible evidence-based guidelines, focused on providing information to bridge gaps in 
practitioner knowledge but were spectacularly unsuccessful in bringing about change 
(Kanouse and Jacoby 1988). 
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The influential work of Rogers on innovation diffusion (Rogers 1962) has been 
developed and extended more recently to present day healthcare organisations (Fitzgerald 
et al. 1999; Ferlie et al. 2000). Innovation diffusion has been defined as “the intentional 
introduction and application within a role, group or organisation, of ideas, processes, 
products or procedures, new to the relevant unit of adoption, designed to significantly 
benefit the individual, the group, or wider society” (West and Wallace 1991). Rogers’ 
original model of innovation diffusion was a linear five-step model from acquisition of 
knowledge, persuasion and decision to adopt a change, through implementation and 
finally confirmation of the innovation. The propensity to adopt change was expressed in 
this model as adopter type, which ranged from those most likely to adopt, so-called 
innovators, through early adopter, early majority, and late majority to laggards or those 
least likely to change. Other factors, such as the information source or agent of change 
and the nature of the innovation including its advantages, complexity, trialability (or the 
extent to which it could be tried out, modified, adapted or reinvented) and outcomes were 
also recognised as important. Despite the simplicity and attractiveness of this model, it 
failed to adequately describe the complexity of many of the processes involved in 
innovation diffusion in healthcare and other settings (Rogers 1995). A number of other 
complementary models have been developed to try to describe the varied interplay of 
human processes which affect the translation of knowledge into improvements in 
performance (West and Farr 1990) and the more recent edition of Rogers’ seminal work 
acknowledged this.  
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Another useful paradigm is the transtheoretical model, which describes the psychological 
process of behaviour change in terms of different motivational states during adoption of 
an innovation. The process begins with precontemplation (not yet ready for change) and 
progresses through contemplation (thinking about change), preparation (for change), 
action (to implement change) and finally maintenance of change (Prochaska and 
Diclemente 1983). Although this model was largely used to describe behaviour change in 
relation to individual addictive behaviours, such as smoking, it also helps us to 
understand the behaviour of individuals and organisations involved in change 
management. An adaptation of the transtheoretical model was used to describe 
psychological stages of professional change in primary care, from orientation (awareness 
and information), insight (understanding and awareness of gaps), acceptance (positive 
attitude, intention to change and confidence in a successful outcome), change 
(implementation and experimentation with change) and finally maintenance of change 
(Grol 1992).  
 
Learning theory includes adult educational theory, which emphasises the importance of 
competence-driven motivation, and the value of interactive problem-based learning 
methods to stimulate this (Knowles 1990). In a wider sense, learning also encompasses 
social cognition theory, which recognises personal and environmental factors in 
determining ability to change depending on attitudes, beliefs and intentions (Conner and 
Norman 1996) and the social influence or interaction model, which stresses the 
importance of peer influence and modelling in the learning process (Mittman et al. 1992). 
Finally, behavioural theory recognises the importance of environmental cues such as 
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feedback and reminders to reinforce and maintain behaviour (Skinner 1938). Marketing 
models describe the importance of the source, channel, content, receiver characteristics 
and setting in communicating change rather than awareness, with change being more 
readily brought about by influential sources delivering a personalised message, based on 
experience to opinion leaders in an informal environment (Kotler and Roberto 1989). 
 
From an organisational behavioural perspective, recent large-scale health service reforms 
have also employed a number of key theoretical concepts to effect change including the 
use of a broad brush approach at the developmental stage, emphasis on local leadership, 
utilising test sites and focusing on sites that were likely to be more receptive to change to 
begin with (Ferlie 1997).  
 
An understanding of barriers and facilitators of change at individual and organisational 
level and utilising a combination of approaches using the models described above tailored 
to address barriers to change, has been advocated on theoretical grounds (Grol 1992; Grol 
1997) and a protocol for a systematic review for this is available on the Cochrane 
Database (Baker et al. 1999). 
 
These models suggested various strategies to improve performance, such as elucidating 
barriers to change, identifying with the concerns of practitioners and patients, using 
practice-based active and motivational learning methods, delivered by opinion leaders 
preferably peers, utilising collaboration and teamwork, and employing reinforcing 
strategies such as reminders to maintain change (Moulding et al. 1999). 
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In broad terms, interventions to improve performance may be classified as patient-
directed, provider-orientated, systems-mediated and mixed or multifaceted interventions. 
Patient-directed interventions include health promotion and education directly to patients 
in the form of media campaigns, reminders, leaflets and posters and strategies such as 
financial incentives. Provider-orientated interventions include educational strategies, 
financial and other incentives or sanctions. Systems-mediated interventions include 
guidelines, practitioner reminders, computerised decision support and recall systems. 
There is often considerable overlap between these interventions in relation to their 
intended target, which target they do affect and how they ultimately cause change. 
Multifaceted interventions include various combinations of the above. These intervention 
types are now considered in more detail, initially looking at studies and reviews to 
improve performance in general, and then to improve vaccination rates in particular. 
3.9 Patient directed interventions to improve performance 
Direct approaches to patients, providing health information, health promotion and 
specific advice to access particular health interventions is an important potential method 
for increasing awareness of healthcare amongst patients, which in turn can influence 
demand for and subsequent uptake of healthcare. A recent Cochrane review showed 
significant benefits of patient education through mass media campaigns on patients’ 
uptake of health care. Mass media include newspaper, television, Internet, large fixed 
public posters, posters on vehicles or other methods of advertising health care to a large 
audience, either nationally or locally. The seventeen studies that were included in the 
review used interrupted time series designs and were mainly focused around 
immunisation or cancer screening. However, they were often of poor quality with thirteen 
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of the studies having absent or flawed statistical analyses. All but one of the studies 
showed increased patient uptake of preventive health care. The authors reanalysed the 
data using studies of higher quality and this showed positive effects of mass media 
campaigns (Grilli et al. 2000).  
 
A variety of financial incentives to patients including money, vouchers, lottery tickets or 
gifts were shown in another systematic review of eleven randomised controlled studies to 
improve patient compliance with medical advice or therapy (Giuffrida and Torgerson 
1997). Patient directed interventions to improve vaccination rates are described in greater 
detail below (see 3.14). 
3.10 Provider orientated interventions to improve professional 
performance 
3.10.1 Types of provider orientated interventions 
A number of individual studies and systematic reviews have investigated methods that 
can effectively improve professional practice. These studies have looked at a broad range 
of healthcare workers and methods, which can be broadly termed educational 
interventions. These have used a diverse range of techniques such as educational 
materials, conferences, educational outreach visits and marketing (academic detailing), 
local opinion leaders, local consensus processes, interprofessional learning and audit and 
feedback. Provider prompts and recall systems although sometimes directed at individual 
practitioners are often used across a local health system or team, involving several 
doctors, nurses or administrative staff and therefore will be primarily discussed under 
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systems mediated interventions. The same is true for financial incentives for providers. 
Multifaceted interventions may be defined as a combination of any two of the above 
(Oxman et al. 1995). These educational interventions are based on a number of 
theoretical models.  
 
It is worth outlining these methods in more detail before describing their effects. 
Educational materials for health practitioners include printed or published 
recommendations, clinical guidelines, audiovisual materials and electronic publications. 
Conferences consist of group education involving lectures, workshops, seminars or skills 
training outside practice settings. Educational outreach (or academic detailing) visits are 
contacts by a trained visitor who meets with practitioners in their practice to provide 
information on specific issues and sometimes feedback on performance in relation to 
these. Local opinion leaders are influential colleagues who are identified by their 
colleagues as being educationally influential. Audit and feedback has been a popular way 
to return information on performance to general practice since the inception of Medical 
Audit Advisory Groups (Department of Health 1990), which arose from the 1990 New 
Contract for Primary Care (Department of Health and Welsh Office 1989). The method of 
feedback involves supplying information obtained from clinical audit processes about 
practitioners’ performance and comparing this with the performance of others, with or 
without recommendations on how to improve practice. This may include reminder 
systems, which may be either manual (such as tagging or labelling of medical records) or 
computerised prompts that trigger a particular treatment action or advice from the 
practitioner. Marketing describes the use of personal interviews, group discussion or a 
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questionnaire survey of practitioners to identify barriers to change and methods of 
overcoming these. A particular type of marketing, termed educational outreach (or 
academic detailing) is described in more detail below. Local consensus processes entail 
the participation of providers in a discussion to establish the importance of a particular 
health problem and agree an appropriate intervention to tackle it. 
3.10.2 Passive versus active educational methods 
Printed educational materials including published guidelines, when delivered passively, 
seemed to have no effect on the behaviour of doctors or the health outcomes of their 
patients in a recent systematic review (Freemantle et al. 2000). Traditional continuing 
medical educational methods alone also seemed to have little effect on health outcomes 
or the performance of doctors, and this lack of effect is probably also true for other 
professional groups (Davis et al. 1995). In general, passive approaches appeared to have 
limited effects, a finding which has been confirmed in experimental studies (Flottorp et 
al. 2002), whereas active learning, which is essentially interactive and participatory, has 
been shown to be more effective in producing change. Systematic reviews have also 
shown that interactive educational activities were more likely to improve practitioner 
performance and patient health whereas passive didactic lectures had little effect (Davis 
et al. 1999). 
 
This has been a well-known problem with continuing medical education and is 
summarised in the concept of the competence-performance gap or Miller’s pyramid (van 
der Vleuten 2000) (Figure 1). Simply stated this is the notion that education to increase 
knowledge (‘knows’) often does not translate into improved performance (‘does’). 
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Locally delivered strategies such as educational outreach (academic detailing), and 
practice initiatives such as reminders to practitioners or patients or multifaceted 
interventions were successful, whilst audit with feedback was weaker and formal 
conferences and educational materials without other strategies had little impact (Davis 
1998).  
 
 
 
Figure 1 Miller’s pyramid of competence 
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3.10.3 Educational outreach (academic detailing) 
Educational outreach, sometimes termed academic detailing, is the use of an educator 
who meets with learners in their work setting to provide information about a particular 
topic using a number of specific techniques. This method has been shown to have 
positive effects on clinical behaviour of doctors and other health workers. Based on the 
work of Soumerai and Avorn and developed in a number of later studies, the principles of 
this approach include an assessment of baseline behaviour and attitudes, focusing on all 
the stakeholders within an organisation to produce an educational process with clearly 
defined learning and behavioural objectives. The technique also depends on the academic 
credibility of those delivering the education, provision of reliable and unbiased 
information, presenting both sides of controversial issues, encouraging active learning, 
using simple educational materials such as graphs, emphasising the essential messages, 
and providing positive reinforcement of improved performance in follow-up visits 
(Soumerai and Avorn 1990). A systematic review of educational outreach included 
eighteen studies all of which had positive effects. Thirteen showed a reduction in 
inappropriate prescribing; three showed increased preventive activities such as smoking 
cessation and the others improved management of common clinical problems such as 
asthma. The outreach visits in these studies usually included discussion and educational 
materials and some included practitioner reminders, audit or feedback. However, only 
one study measured a patient outcome and none evaluated cost-effectiveness (Thomson 
O'Brien et al. 2000c). Since this systematic review two further studies have shown 
academic detailing to improve prescribing (Ilett et al. 2000; van Eijk et al. 2001).  
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Although evidence from the literature was largely in favour of educational outreach 
(Grimshaw et al. 2001) there was also some contradictory evidence. Some studies failed 
to show any improvement in practitioner performance (Watson et al. 2001), whilst others 
revealed a lack of a sustained benefit (Smeele et al. 1999; Lin et al. 1997). One study 
suggested that educational outreach was more costly than simpler alternatives (Gomel et 
al. 1998). In some settings the method was ineffective in improving patient outcomes. A 
landmark study teaching cognitive-behavioural therapy skills to general practitioners, for 
example, failed to improve depression scores in patients at six months (King et al. 2002). 
Several features characterised these studies in which educational outreach was less 
effective. These included the complexity of the educational intervention and the outcome 
that it was aimed at improving. Cognitive-behavioural therapy, for example, was a 
complex process, which may have been difficult to teach or learn (Spira 2002) and 
despite the enthusiasm of practitioners for this treatment, it may have been difficult to 
implement in primary care perhaps because of competing demands for time or other 
constraints within the traditional consultation. Many other factors, such as therapeutic 
relationship with the doctor, social factors or secular trends may have also affected 
patient outcomes in this study.  
 
Unidisciplinary education was used in the majority of previous studies. Although it could 
have been argued that unidisciplinary education was appropriate to some of the 
interventions being tested, the reduced the opportunity for a team approach, particularly 
important in preventive health and chronic disease management, may have prevented the 
improvements in care that were sought. Finally, the perceived lack of benefit over 
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existing practices, a failure to address barriers to implementation or lack of opportunity to 
observe or try innovations before adopting them may have been other reasons for failure 
(Rogers 1995).  
 
Most of these studies were conducted in North America and there has been little research 
into their effectiveness or cost-effectiveness in this country or in the primary care setting. 
The educator in educational outreach can be an educationalist, a professional change 
agent such as a manager or external consultant or a local opinion leader and each may 
have varying effects on performance. The use of educational outreach and local opinion 
leaders were partly based on social intervention theory, which argues that factors such as 
local norms and peer acceptance are important drivers for change (Mittman et al. 1992). 
3.10.4 Opinion leaders  
Local opinion leaders have been shown to have variable effects on outcomes. A local 
opinion leader may be defined as an educationally influential individual who is well 
respected in their social system and who has a high degree of credibility amongst peers, 
due to factors such as technical competence or a position of leadership within the locality 
(Rogers 1995). Despite this apparently clear definition, researchers have often found it 
difficult to identify opinion leaders or the characteristics that distinguish them from other 
individuals in their local networks. Early adopters of an innovation who are also local 
opinion leaders are likely to have a beneficial effect on adoption by others, a fact which is 
extensively used by the pharmaceutical industry to promote their products. Opinion 
leaders who oppose innovations are likely to have the opposite effect. A systematic 
review identified eight methodologically acceptable studies and found variable effects of 
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opinion leaders on the performance of doctors and on patient outcomes (Thomson 
O'Brien et al. 2000d). Six out of seven trials that measured practice performance 
demonstrated some improvement for at least one variable, but only two trials had results 
that were statistically significant and clinically important. In the three trials that measured 
patient outcomes only one, showing a higher vaginal birth rate after previous caesarean 
section, achieved practically useful results. It was also not clear from many of the studies 
what exactly was done by the opinion leader and the authors felt that further research was 
needed into identifying local opinion leaders and seeing how they might improve 
performance of their peers in a reproducible way.  
3.10.5 Audit and feedback 
Audit and feedback may also be considered a systems-mediated intervention but is 
discussed here with other educational interventions since important components of audit 
include learning and the implementation of change. Audit may be defined as the 
“systematic, critical analysis of the quality of medical care, including the procedures used 
for diagnosis and treatment, the use of resources and the resulting outcome for the 
patient” (Secretaries of State for Health 1989c). Audit requires the establishment of 
criteria and standards against which performance can be measured (Donabedian 1966) 
but the audit cycle critically requires change to be implemented for improvements in 
performance to occur. Feedback is an integral part of the audit process and involves the 
presentation of summary information about performance to those whose performance is 
being measured. Studies of audit and feedback have been hampered by failure to correctly 
address various key aspects of methodology such as randomisation, statistical power and 
data analysis. An early review found no evidence of benefit (Mugford et al. 1991). A 
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further systematic review of feedback, specifically benchmarking against peers (termed 
physician profiling), had a statistically significant but clinically unimportant effect on 
performance (Balas et al. 1996). Thirty-seven studies were included in a recent Cochrane 
review looking at a range of performance including diagnostic test ordering, prescribing, 
preventive care, and management of common conditions, for example hypertension. 
Twenty-eight studies measured physician performance, one study examined patient 
outcomes in diabetes and the remaining eight studies measured both performance and 
patient outcomes. Many of these studies showed improvements in performance or 
outcomes but the clinical importance of these improvements was not always clear. The 
authors concluded that the effects were small to moderate and potentially worthwhile but 
that audit and feedback probably should not be used alone as a method of improving 
performance (Thomson O'Brien et al. 2000b). A further review found little evidence of 
additional benefit in adding another complementary intervention to audit and feedback 
(Thomson O'Brien et al. 2000a). Whether feedback was graphical or tabular also made no 
difference (Szczepura et al. 1994). The current evidence is that there is limited evidence 
of benefit of audit and feedback by itself for improving professional performance. 
However, it could be argued that this is because the most important aspect of the audit 
process, which is the change instigated to produce improvement, has been neglected 
because of the excessive focus on measurement and feedback. 
3.10.6 Addressing barriers to change 
One randomised controlled trial addressing barriers to change (Cranney et al. 1999) 
showed improvements in self-reported thresholds for treating hypertension in the elderly 
but failed to demonstrate improvements in performance. Baker showed that educational 
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methods that addressed barriers to change could be effective in modifying individual 
practitioner behaviour and patient outcomes for managing depression (Baker et al. 2001). 
This type of tailored outreach has also been used successfully in the Netherlands to 
improve preventive care for coronary heart disease (Hulscher et al. 1998). Both groups 
went on to suggest that addressing obstacles to change at team and organisational levels 
might also be important (Hulscher et al. 1997a). Multifaceted interventions involving 
more than one diffusion strategy have been argued to be more effective than single 
interventions because theoretically they may overcome more barriers to change. An early 
systematic review appeared to confirm this view (Wensing and Grol 1994) and more 
recently a Cochrane review of fifty five randomised controlled, before-and-after 
controlled, and interrupted time series studies showed improvements in preventive care 
with increasing effectiveness when comparing group education, reminders and 
multifaceted interventions. However, there were substantial variations in the 
improvements achieved, which were typically small or moderate. Multifaceted 
interventions appeared to be more effective than single interventions, perhaps because 
barriers to change were more readily addressed. The authors suggested that future studies 
should explore how particular interventions relate to specific barriers and should include 
an economic analysis since more complex interventions were also likely to be more 
costly (Hulscher et al. 2001). 
3.10.7 Interprofessional learning 
Interprofessional learning in health care is generally taken to mean learning that takes 
place involving one or more professional groups, aimed at increasing interprofessional 
understanding, collaboration and ultimately improvement in patient outcomes. This 
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definition excludes passive methods, such as lectures, or dissemination of educational 
materials (paper or electronic) that do not involve interaction between professionals. 
Many studies of interprofessional education in healthcare were found, in a recent 
systematic review, to be weak in design, to originate from North America and to use 
proxy outcomes such as learner satisfaction, change in attitude, knowledge or skill and 
behavioural or organisational change rather than true patient outcomes (Freeth et al. 
2002). Half the studies showed that interprofessional learning led to organisational 
change and a handful demonstrated change in patient outcomes, such as satisfaction. Only 
one study used a specific clinical outcome (Glanz et al. 1992). The bias towards before-
and-after designs called into doubt any conclusions about cause and affect. The 
predominance of studies from the United States prevented any true extrapolation of these 
findings to the United Kingdom, particularly in primary care, with its different traditions 
and structures.  
3.10.8 Learning in primary care settings 
When one focuses on primary care as a substrate for educational interventions, the 
research evidence is more limited. One systematic review of educational interventions 
found fifty-one studies of which twenty-six satisfied methodological criteria for inclusion 
(Freudenstein and Howe 1999). These studies included a wide range of interventions such 
as mailed guidelines or educational materials, educational visits, small group teaching, 
facilitators attached to practices and identification and training of local opinion leaders. 
Most of the studies used volunteer practitioners or particular geographical locations. 
Again economic analyses were lacking in these studies and the authors argued that future 
studies should include costs, target geographical areas, use patient outcomes and employ 
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an ‘intention to educate’ analysis. The latter is likely to be difficult to achieve given that 
practices that do not volunteer to participate would be unlikely to submit data for this 
type of study. This would necessitate reliance on externally available data, for example 
prescribing information or hospital admission figures. 
 
In summary, traditional didactic education and mailings were weak, audit and feedback, 
teaching delivered by peers or opinion leaders moderately effective and reminder 
systems, educational outreach and multifaceted strategies relatively stronger in their 
effects on practitioner behaviour and patient outcome (Davis and Taylor-Vaisey 1997). 
However all these strategies were varied in their outcomes and highly dependent on the 
setting and individual circumstances of each study.  
3.11 Systems mediated interventions to improve performance 
Systems-mediated interventions are those that are primarily directed at healthcare 
organisations or systems. They include guidelines (or protocols) and standing orders, 
practitioner reminders and recall systems, computerised decision support, as well as audit 
and feedback. Other strategies to improve access to care such as expanding access 
through reorganised services are discussed below (see 3.16). 
3.11.1 Guidelines, protocols and standing orders 
A systematic review of guidelines showed that most (55 out of 59) improved the process 
of care (Grimshaw and Russell 1993). The effect sizes were very variable, probably due 
to the different implementation strategies employed. In the United States and Canada, the 
term ‘standing order’ is used to describe guidelines for nurse practitioners, nurses or 
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healthcare assistants and these have been successfully used to administer treatments to 
patients including vaccines in the absence or direct recommendation of a doctor (Centers 
for Disease Control and Prevention 2000). The nearest equivalent of this in the United 
Kingdom is the ‘patient group directive.’  
3.11.2 Prompts, reminders and recall systems 
Prompts for doctors, nurses and administrative staff to indicate to patients that a 
procedure is due or overdue have been tried using a variety of methods. Prompts are 
sometimes classified according to whether the preventive measure is due (reminders) or 
overdue (recall) although these terms are used interchangeably. Prompts include paper 
reminders (stickers on case notes, printed checklists), computerised prompts and mailed 
recall lists. The detailed content and presentation of these methods can also vary. Prompts 
were more effective when they were specific and giving advice relating to individual 
patients (Wyatt 2002). Reminders to practitioners have been shown to improve preventive 
care in randomised controlled studies. In a systematic review, Wyatt (2002) showed that 
manual reminders were very effective and although manual systems were easily 
implemented, they run contrary to plans for a paperless health system in the United 
Kingdom. Computerised reminders have also been shown to improve preventive care, 
including vaccinations, in primary care settings (Shea et al. 1996). Computerised prompts 
are sometimes contained within decision support systems which were also shown to 
improve the performance of clinicians (Johnston et al. 1994). 
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3.12 Studies to improve influenza and pneumococcal vaccination uptake 
3.12.1 Rationale for conducting a review 
The aim of this review is to summarise and appraise the research on improving influenza 
and pneumococcal vaccination uptake. This examines current practice, variations in 
practice and interventions that are likely to lead to increases in vaccine uptake. The 
review informs the methodology of the single practice pilot study, multipractice audit 
studies and randomised controlled study for improving influenza and pneumococcal 
vaccination rates. 
3.12.2 Deciding to conduct a review 
A number of previous reviews (Gyorkos et al. 1994; Hulscher et al. 1999; Hulscher et al. 
2001; Briss et al. 2000; Stone et al. 2002) have been published. The reviews have varied 
in content and emphasis, looking at prevention overall, immunization alone, or 
immunization and screening. They have examined different settings from primary care 
alone, to a variety of primary care, community and secondary care. Many of the 
constituent studies have come from North America, reducing the applicability of the 
findings to the United Kingdom. The bias towards North America reflects its larger 
geographical and population size, a greater number of researchers, better funding for 
research, more peer reviewed publications, language bias, journals abstracted by Medline 
and CINAHL, as well as the greater tendency to evaluation in the United States compared 
to Europe and elsewhere. Many of the larger and higher quality studies were also from 
the United States and Canada. The emphasis, in these reviews, on interventions more 
appropriate to the United States system of medical care, and failure to include recent 
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work from and models appropriate to the United Kingdom was a drawback of these 
reviews. The various reviews also used slightly different criteria and arrived at conflicting 
conclusions. It was therefore important to reappraise the evidence with an emphasis on 
interventions relevant to British primary care to arrive at an appropriate conceptual model 
for use here.  
3.12.3 Existing or ongoing reviews – grey literature 
Apart from the aforementioned reviews, a search for ongoing reviews or related work in 
the Cochrane Database of Systematic Reviews (The Cochrane Collaboration 1995), the 
CRD Database of Abstracts of Reviews of Effectiveness (The NHS Centre for Reviews 
and Dissemination. 1995) and the NHS National Research Register (a database of 
commissioned research which was accessed through the National Institute of Clinical 
Excellence database) was conducted. The search terms influenza or pneumococcal alone 
and influenza or pneumococcal and vaccination were used. No similar reviews were 
being undertaken although there were a number of studies being undertaken into 
pneumococcal vaccination (Table 8).  
3.13 Reviews of methods to improve vaccination uptake – overall findings 
A Canadian systematic review of vaccine delivery studies (Gyorkos et al. 1994) found 
that system-orientated (e.g. standing orders for nurses) and provider-orientated 
interventions (education and/or reminders for doctors and nurses) were more effective at 
improving vaccination rates than patient-directed interventions (leaflets, posters and 
mailshots to patients) for influenza vaccination. Patient-directed interventions were more 
effective for pneumococcal vaccine studies presumably because of the lack of awareness 
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of pneumococcal vaccination amongst patients relative to influenza vaccination. The 
strength of this review was that it appraised the evidence for each vaccine individually, 
including influenza and pneumococcal vaccine, individually and separately listed all the 
studies that were included. However, this was review of predominantly North American 
studies before 1991 and, despite some attempt at assessment of study quality, included 
several studies with weak design such non-randomised studies or before-and-after studies 
without a control group. 
 
Hulscher et al. from the Netherlands reviewed studies of preventive services in primary 
care, including immunisation (Hulscher et al. 1999) and this was updated in a Cochrane 
review (Hulscher et al. 2001). Studies were categorised according to the type of 
intervention employed. These were classified into professional interventions such as 
passive information transfer (with educational materials, and off-site educational 
activities), locally sensitive educational approaches (through educational outreach, quality 
improvement groups and opinion leaders), feedback, reminders and other organisation, 
financial and regulatory methods. Fifty-five studies were included in the Cochrane 
review. The clear message from this systematic review was that effect sizes were small to 
moderate whichever intervention was being used. It was also unclear whether and in what 
circumstances a particular strategy was likely to be successful. 
Title Research question Methodology Lead researcher Status 
     
Missed opportunities for 
pneumococcal and influenza 
vaccination 
Are we missing opportunities in hospital to 
vaccinate elderly patients against influenza and 
pneumococcus? 
 
Retrospective case-
note study 
Questionnaires to 
doctors. 
 
Mrs Jackie Colligan  
North Tyneside General Hospital, Rake 
Lane 
North Shields 
Tyne & Wear NE29 8NH 
Complete 
A study of the safety and 
immunogenicity of combining a 
pneumococcal conjugate vaccine other 
vaccines. 
Is the immunogenicity of pneumococcal conjugate 
vaccines compromised when administered in 
infancy simultaneously with other vaccines or does 
the pneumococcal conjugate vaccine interfere with 
the immunogenicity of existing childhood 
vaccines? 
 
Randomised 
controlled trial.  
 
Dr D Goldblatt 
Immunobiology Unit 
Institute of Child Health  
London WC1N 1EH  
Ongoing 
Pneumococcal vaccination among 
patients admitted as acute medical 
emergencies: a survey of risk factors 
and vaccine uptake. 
 
( 1 ) To identify the proportion of patients admitted 
to hospital as medical emergencies who could be 
regarded as high-risk for pneumococcal disease.  
( 2 ) To quantify vaccine uptake in this group of 
patients and to explore the reasons for acceptance 
or non - receipt. 
 
Descriptive study. Mr MH Kyaw 
General Medicine 
Queen Elizabeth Hospital 
Birmingham B15 2TH 
Telephone: 0121 472 1311 
 
 
Complete 
Study of burden of illness from 
influenza and pneumococcal disease. 
 
What is the burden of illness from flu and 
pneumonia to patients and health services? What is 
the value of vaccination 
X sectional study 
 
Dr P Mangtani  
London School of Hygiene and Tropic 
London WC1E 7HT 
 
Ongoing 
Detection of susceptibilities to severe 
invasive pneumococcal disease. 
 
As title. Immunological 
parameters. 
Antibody/cellular 
levels and functions. 
 
Dr DC Henderson 
Immunology 
Chelsea & Westminster Hospital  
London SW10 9NH 
 
Ongoing 
Table 8 Ongoing studies on pneumococcal vaccination from the National Research Register 
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The authors felt that tailoring interventions to barriers, particular using multifaceted 
interventions, was more likely to be effective than using single generic interventions. In 
favour of this review was that it examined research from primary care and included 
European as well as North American studies, including studies published in Dutch and 
German. Despite this, almost ninety per cent of those studies that were included were 
from the United States or Canada. On the negative side, the review concentrated on 
studies of interventions directed at clinicians and therefore excluded important patient-
orientated approaches. Many of the studies suffered from bias such as allocation bias, 
lack of blinding, and failure to account for clustering and contamination in the analysis, 
which latter would have resulted in inflated effect sizes. 
 
Briss et al. undertook an extensive and comprehensive review of interventions to improve 
vaccinations in different age groups for the United States Task Force on Community 
Preventive Services (Briss et al. 2000). They categorised interventions according to 
whether they increased community demand (patient-oriented), enhanced access (systems-
oriented) or focused on providers. The interventions relevant to influenza and 
pneumococcal vaccination that were effective included patient-orientated strategies such 
as patient education as part of multifaceted interventions and patient reminder and recall 
systems. Enhanced access using extra clinics, evening or weekend or drop-in clinics and 
clinics attached to other providers (such as emergency departments) as part of 
multifaceted interventions improved vaccination rates. Home visiting and the reduction of 
out-of-pocket expenses for patients to attend clinics were also effective. Provider-
orientated interventions such as provider reminders or audit and feedback were effective 
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too. Interventions that showed little or no evidence of effectiveness included community 
education alone, practice based education, direct financial incentives for patients, patient-
held vaccine records, and stand-alone provider education.  
 
The most recent review by Stone et al. reviewed interventions that were used to improve 
cancer screening or influenza and pneumococcal vaccination rates. It identified 
interventions according to three features (Stone et al. 2002). These included the target of 
the intervention (patient, provider, organisation or community), the type of intervention 
(reminders, feedback, education, financial incentive, regulation, organisational change or 
media campaign) and the theoretical basis for the intervention (social influence, 
marketing and outreach, visual appeal, teamwork, barriers and incentives, management 
support and active learning strategies). The studies included here were of higher quality, 
mainly randomised controlled studies or controlled trials, but they again suffered from 
failure to take clustering into account. The analysis also failed to identify influenza and 
pneumococcal vaccination separately.  
 
Previous reviewers were unable to tease out the effect of individual interventions in many 
of the studies that used multiple interventions whereas Stone used complex statistical 
techniques to evaluate the effect of individual components in multifaceted interventions, a 
very useful feature of his review. It is helpful to examine some of these strategies in 
detail. 
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3.14 Patient directed strategies to improve vaccination rates 
Patient-directed vaccine strategies are those methods that are designed to lead to greater 
patient awareness and demand for vaccination. 
3.14.1 Patient education 
Raising awareness and educating patients about vaccinations can be undertaken using 
national or local mass media or in healthcare settings using leaflets or posters. There were 
few studies looking at the effect of media campaigns for influenza and pneumococcal 
vaccination or other types of vaccination and all five of these were of insufficient quality 
to provide evidence. One study of a health clinic based education failed to show 
significant effects of combined provider education and educational leaflets or education 
alone to improve influenza or pneumococcal vaccination in elderly patients (Herman et 
al. 1994). As a result, there was not enough evidence to support community-wide 
education or practice-based education and information campaigns alone. In contrast, 
education as part of a multifaceted intervention had been shown to be effective for 
improving influenza and pneumococcal vaccination in primary care settings (Briss et al. 
2000) suggesting that the positive effect of awareness raising methods needs to be 
combined with other methods to make a significant difference to vaccination rates. 
3.14.2 Patient reminder/recall 
Szilagyi et al. in a Cochrane systematic review found strong evidence that patient 
reminders increased immunisation rates (Szilagyi et al. 2000). Out of 41 randomised 
controlled studies, before-and-after controlled studies and interrupted time series studies 
in English language journals that met the inclusion criteria for this review, 33 (80%) 
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showed that patient reminder systems were effective. Reminders were equally effective in 
a variety of settings including primary care, in children or adults, with different baseline 
immunisations rates and common vaccines, including influenza vaccination and 
pneumococcal vaccination for patients at risk. The eight studies that showed no 
significant improvement in immunisation rates used mail reminders in seven and an 
autodialer in one. They had methodological problems including inadequate power, 
reminders focusing on a range of preventive measures rather than vaccination alone and 
ceiling effects (high influenza immunisation rates in controls). On closer inspection, it 
was apparent that changes in immunisation rates varied considerably and that reminders 
were less effective for older patients with chronic illness for influenza and pneumococcal 
vaccination (Table 9). Telephone reminders were most effective but also more costly than 
mailings and this was also true for repeated or more intensive reminders.  
 
A range of reminder systems was used in these studies including postcards, letters and 
telephone or autodialer calls. The autodialer was a computerised system designed to 
generate multiple telephone calls over a short period. The relative effectiveness of the 
different methods for influenza vaccination is shown below (Table 10). Despite the 
appearance that telephone reminders were more effective than mailed reminders, in the 
two studies that directly compared these methods there was no difference in performance 
(Brimberry 1988; McDowell et al. 1986). Reminders that were specific (to a single 
preventive measure), personalised and signed by a doctor were more likely to be effective 
(Briss et al. 2000). Reminders require a comprehensive database of patients at high-risk 
including age-sex and disease registers and administrative support to implement them. 
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Whilst successful in improving vaccination rates, a negative effect of patient reminders 
was that over a period of time patients became dependent on them, and this was 
particularly so in older patients at highest risk (McDowell et al. 1990). 
3.14.3 Patient incentives 
Direct financial incentives have not found favour in the United Kingdom, for both ethical 
and financial reasons. A number of incentives have been tried in the United States such as 
cash, discount coupons or lottery type gifts. Only one study looked at incentives for 
influenza vaccination, comparing an educational brochure, a lottery-type incentive for a 
$50 grocery voucher (on vaccination), both together or control. The educational brochure 
was more effective than the lottery ticket, each being significantly more effective than the 
control group but both together being no more effective than the control (Moran et al. 
1996). In countries where patients are charged for services, up to ten per cent of patients 
will refuse influenza vaccination because of cost (Merkel and Caputo 1994) and the 
provision of free vaccines is one factor which has been shown to improve vaccination 
rates for influenza and pneumococcal vaccines (Bennett et al. 1994; Satterthwaite 1997). 
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Table 9 Effectiveness of patient reminder/recall for influenza and pneumococcal 
vaccination (adapted from Szilagyi et al. 2000) 
Patient 
characteristics 
Number of 
Studies 
Odds ratio 
(95% Confidence 
Interval) 
% Change in 
immunisation rates, 
median (range) 
    
Children (influenza) 2 4.25 (2.10, 8.60) 24.5 (23.0 to 26.0) 
Adults (influenza):    
≥ 65years 11 2.25 (1.45, 3.50) 17.0 (-2.5 to 36.0) 
With chronic illness 7 3.11 (2.50, 3.86) 14.5 (-5.9 to 47.0) 
≤ 65years with 
chronic illness 
 
3 1.42 (0.70, 2.87) 4.4 (-8.5 to 31.2) 
Adults 
(pneumococcal) 
 
2 2.79 (0.85, 9.12) 10.0 (0.0 to 20) 
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 Table 10 Effectiveness of different types of patient reminder/recall for influenza 
vaccination (adapted from Szilagyi et al. 2000) 
Reminder types  Number of 
Studies 
Odds ratio 
(95% Confidence 
Interval) 
% Change in 
immunisation rates, 
median (range) 
    
Children (influenza)    
Vaccination letter 
reminder 
2 4.25 (2.10, 8.60) 24.5 (23.0 to 26.0) 
Adults (influenza)    
Postcard 5 1.82 (1.12, 2.98) 10.6 (2.9 to 31.2) 
Letter 11 2.25 (1.53, 3.32) 7.0 (-8.5 to 47.0) 
Telephone 5 4.27 (2.99, 6.08) 25.6 (5.5 to 27.2) 
All reminder/recall 
systems 
18 2.29 (1.69, 3.10) 7.0 (-8.5 to 47.0) 
Patient and 
practitioner 
reminders 
2 3.42 (2.11, 5.54) 22.5 (16.0 to 28.9) 
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3.15 Provider orientated strategies to improve vaccination rates 
3.15.1 Audit and feedback to improve vaccination rates  
There were two systematic reviews of the effect of audit and feedback on vaccination 
(Briss et al. 2000; Bordley et al. 2000). Interestingly both reviews found evidence to 
support audit and feedback alone, or as part of a multifaceted intervention to increase 
immunisation levels. This was in contrast to the lack of evidence for audit and feedback 
in improving professional performance in general (see 3.10.5). There were two possible 
reasons for this. The process of audit and feedback might have changed the behaviour of 
doctors and nurses to vaccinate more patients per se; it may also have encouraged them to 
implement system or process changes, such as reminder systems, to improve vaccination 
rates. Whatever the reason, it seems self-evident that any quality improvement process for 
increasing influenza and pneumococcal vaccination rates in high-risk patients requires 
measurement of vaccination rates as a prerequisite. In the review by Bordley et al. (2000), 
twelve of the fifteen studies that met the quality criteria showed improvements in 
vaccination performance using audit and feedback alone or with other interventions. The 
increase in vaccination rate using audit and feedback alone was sixteen per cent (9 to 
41%) (Briss et al. 2000). A variety of methods may be used to provide feedback in audit 
studies, including tabular, graphical or verbal feedback, the latter as part of an educational 
outreach visit. An attractive method was the use of a practice poster showing weekly 
cumulative influenza vaccination rates which led to a thirty per cent increase in 
vaccination rates, over and above those in control practices in one study (Buffington et al. 
1991).  
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3.15.2 Education for healthcare staff 
Although education was effective at increasing knowledge about influenza, 
pneumococcal and other vaccinations (Zimmerman et al. 1997) there was very limited 
evidence for the effectiveness of education alone in improving vaccination rates (Briss et 
al. 2000). This was due to the dearth of studies rather than a failure to address the 
competence-performance gap. One Australian study showed no evidence of change in 
influenza vaccination rates in elderly patients over 65 years, although there were 
improvements in some healthy behaviours and quality of life (Kerse et al. 1999). The 
educational intervention in this study was to general practitioners alone and focused on 
prevention care in general rather than solely on vaccination. Education to providers (and, 
or) patients as part of a multifaceted intervention was studied much more often and 
shown to be effective (Briss et al. 2000). 
3.15.3 Financial incentives for providers 
Financial incentives for providers had variable effects. Some studies showed small 
positive effects. For example, one study of financial incentives to practitioners showed an 
increase in influenza immunisation rate of seven per cent above controls (Kouides et al. 
1998). Another cross-sectional study showed no association between the receipt of 
additional funding and influenza vaccination (Wee et al. 2001). 
3.16 Systems mediated strategies to improve vaccination rates 
3.16.1 Vaccine guidelines 
Clinical guidelines and written support materials led to an increase in pneumococcal 
vaccination in one before and after study (McDonald et al. 1997a). Pneumococcal 
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vaccination rates increased from three per cent to thirty three per cent during the six 
months of the study. However, this was not a controlled study and no comparison group 
was available to show secular trends or account for confounding factors.  
3.16.2 Standing orders for vaccination 
Standing orders for vaccination are widely used in North America and have been adopted 
in the United Kingdom as patient group directions. They are designed to increase the 
flexibility and professional autonomy of nursing staff to administer influenza and 
pneumococcal vaccinations to high-risk individuals. They have been shown to be 
effective both alone and in conjunction with other interventions. Increases in vaccination 
rates of fifty per cent (31-81%) were found with standing orders alone (Briss et al. 2000). 
To be effective they required good interprofessional working, adequate nursing capacity, 
and doctors and nurses to be willing to give and take responsibility for decision-making 
respectively.  
3.16.3 Registers 
Age-sex and disease registers for high-risk patients were essential for audit, feedback, 
patient and practitioner reminders and often as a component of education for providers. 
General practice in the United Kingdom has benefited from the lifelong patient record, 
the integrity of this system having considerable advantages for the development and 
maintenance of registers. This is in stark contrast to the fragmentation of patient 
information in other health systems (Stokley et al. 2001). Historical problems with data 
consistency in the National Health Service (Scobie et al. 1995) are slowly being 
addressed through additional funding for computer hardware, developments in software, 
 118
data collection and analysis. Despite these improvements and the move towards paperless 
systems, in line with the trajectory towards the electronic patient record, further 
improvements need to be made (McColl et al. 2000). 
3.16.4 Provider prompts to vaccinate  
Case-control studies suggested that recommendation from a doctor or nurse was strongly 
associated with higher influenza and pneumococcal vaccination rates (Kyaw et al. 1999). 
Because practitioners frequently forgot to vaccinate patients during busy surgeries, 
prompts were a good method of reminding doctors and nurses to recommend and 
administer vaccination. 
 
Manual prompts were effective and cheap (Wyatt 2002) but were unwieldy in an 
increasingly computerised primary care system, particularly when considering the 
administrative burden of implementing an influenza and pneumococcal vaccination 
programme. One study using a written checklist for junior hospital staff increased 
influenza and pneumococcal vaccination rates in outpatients from two to forty per cent 
(Cohen et al. 1982). Computerised prompts require good systems and data on age and 
diseases to be useful but have been shown to be effective (Gill and Saldarriaga 2000; Hak 
et al. 1998c; Hutchison 1989). Practitioners, like patients, were also been found to 
become dependent on reminders, and prompts are therefore most effective when available 
at every visit (Chambers et al. 1991). 
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3.16.5 Improved access 
Access to influenza and pneumococcal vaccinations can be improved in existing 
healthcare settings, by using alternative locations or by providing home visits to vaccinate 
the housebound. Possibilities for improving access in existing settings include extra 
clinics at additional times, such as lunchtimes, evenings or weekends and by providing 
drop-in or ‘quick-fire’ express clinics. Alternative settings include vaccinating in 
residential or nursing homes, satellite clinics or branch surgeries nearer the patients’ 
homes. Opportunistic vaccination during disease management clinics is another option. In 
the United States, vaccination has been contracted out to health care providers other than 
the family doctor, including public health or emergency departments, outpatient clinics 
and even nurses employed in pharmacists, grocers or supermarket chains. Problems with 
alternative settings or providers include difficulties accessing health records, 
fragmentation of health information and patients’ difficulties remembering vaccination 
status or eligibility. Alternative providers have not been used in the United Kingdom 
because of these problems. Vaccination during home visiting by district nurses and health 
visitor is carried out, although staff may have some concerns over resuscitation in case of 
vaccine reactions and home injections are more costly than vaccination at the surgery or 
clinic. Improved access was undoubtedly an effective way of improving vaccine uptake 
(Briss et al. 2000). 
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3.17 General findings and concepts 
3.17.1 Ceiling effect 
Analysis of pooled vaccination rates showed that improvement in vaccination uptake 
when baseline vaccination rates were high (over 50 per cent) was less compared to when 
they were low (less than 20 per cent) (Gyorkos et al. 1994). This ceiling effect (Table 11) 
may have been due to a number of factors. It could simply have been due to the greater 
capacity for improvement resulting from low initial vaccine coverage rates. It could have 
been partly due to selection bias where practitioners or organisations that took part in 
vaccine studies were more predisposed to improving vaccination rates and had already 
implemented immunisation strategies, thereby reducing their capacity to benefit from 
additional interventions. It would be important to consider this effect when designing 
experimental studies for improving vaccination rates.  
 
Table 11 Variation in improvement in influenza immunisation according to baseline 
vaccination rate (adapted from Gyorkos et al. 1994) 
Baseline 
immunisation rate  
Number of 
comparisons
Pooled effect 
(%) 
95% Confidence 
interval 
    
<20% 17 20.5 19.0, 21.9 
20%-50% 15 19.3 17.5, 21.2 
>50% 4 14.8 12.3, 17.3 
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3.17.2 Relative success of interventions 
It can be seen that certain interventions seemed to be better than others and some 
combinations were synergistic rather than additive, leading to a greater improvement than 
would have been expected from using each intervention separately. An early review 
found that feedback, education and reminders were most effective as single interventions 
and education and feedback with or without other strategies was the most effective 
combined approach (Wensing and Grol 1994).  
 
However, most studies employed a variety of techniques rather than a single approach to 
improve vaccination rates. It was also apparent that some interventions, such as 
education, would have naturally led to others, such as reminder systems. It was difficult 
for many researchers and reviewers to dissect the effect of individual interventions from 
these studies of multifaceted interventions. Stone at al. (2002) used a specialised 
statistical technique of meta-analysis, called meta-regression to measure the effect of 
individual interventions in studies using combinations of techniques (Table 12).  
 
Using this technique Stone found that the most effective interventions for improving 
immunisation rates were those that involved organisational change. Organisational 
change was defined as a change in work processes to improve vaccination rates and 
included job redesign, altering clinical procedures or modifying facilities or 
infrastructure. Examples of this may have been allocating additional staff such as district 
nurses or health visitors to administer vaccines, putting on additional clinics or 
implementing vaccination at home for housebound elderly. 
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 Reminders for patients and providers, provider education and financial incentives for 
patients (in fee paying health systems) were moderately effective across the range of 
studies. Patient education, provider feedback and financial incentives to providers showed 
weak effects. The reviewers also found evidence to support the hypothesis that combining 
effective interventions was synergistic, mixing effective with weak interventions was 
usually positive, whereas adding weak interventions together often did not produce 
additional benefits to using each separately.  
 
Table 12 Effectiveness of individual interventions within 29 single method and 
multifaceted studies to improve immunisation rates (adapted from Stone et al. 2000) 
Intervention component Adjusted odds 
ratio 
95% Confidence 
interval 
   
Organisational change 16.0 11.2, 22.8 
Provider reminder 3.80 3.31, 4.37 
Patient financial incentive* 3.42 2.89, 4.06 
Provider education 3.21 2.24, 4.61 
Patient reminder 2.52 2.24, 2.82 
Patient education 1.29 1.14, 1.45 
Provider financial incentive 1.26 0.83, 1.90 
Provider feedback 1.23 0.96, 1.58 
*This refers to reduction or waiving fees in healthcare systems which charge for services and so is not 
directly applicable to the United Kingdom. 
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In addition, when similar statistical techniques were applied to the key features of these 
interventions they were also found to have differential effects. The most effective 
intervention feature for improving immunisation rates was that involving collaboration 
and teamwork between all those involved in administering and delivering the vaccination 
programme including doctors, nurses and administrative staff. This conclusion 
emphasised the importance of teamwork to a successful immunisation programme (Table 
13).  
 
These findings whilst elegant may only apply to preventive care and may not be the 
complete picture because of the heterogeneity of the studies, the larger number of 
multifaceted interventions and effect of publication bias. 
 
Table 13 Effectiveness of individual intervention features in single method and 
multifaceted studies to improve immunisation rates (adapted from Stone et al. 2000) 
Intervention component Adjusted odds 
ratio 
95% Confidence 
interval 
   
Collaboration and teamwork 17.9 10.4, 30.9 
High visual appeal and clarity 3.25 2.09, 5.06 
Designed to address barriers and 
incentives 
1.61 1.52, 1.71 
Social influence 1.35 0.78, 2.34 
Active learning strategies 1.29 0.68, 2.42 
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3.17.3 Economic considerations 
Before considering economic analysis of interventions to improve influenza and 
pneumococcal vaccination rates, it was important to determine that the vaccines 
themselves had also been shown to be cost-effective (Sculpher 2000) (see 2.17). Very 
few of the intervention studies described above included an economic analysis. The few 
studies that did include an economic evaluation were mostly from North America (Briss 
et al. 2000). Many of these studies were inadequate or had important gaps in analysis 
(Carande-Kulis et al. 2000). A robust health economic analysis would have contained 
detailed information on costs (and how these had been obtained) of the intervention (such 
as the educational programs, reminder systems, postage etc.), additional professional time 
(e.g. to attend courses, give vaccination advice or administer vaccines to patients etc.), 
and additional costs of the extra vaccines given as well as costs to the patient. The 
benefits in terms of adverse outcomes prevented or a measure of utility such as quality 
adjusted life years would have been needed (Kernick 1998). In a cost effectiveness 
analysis additional data on vaccine effectiveness in terms of adverse outcomes prevented 
would have been included. In a cost-utility analysis a measurement of utility such as 
quality of life would have been compared with the costs. Cost-benefit analysis would 
require costs and benefits in monetary costs (Palmer et al. 1999). Barriers to health 
economic analysis may have included a scarcity of health economists, problems with 
funding studies that required economic evaluations and a failure of healthcare researchers 
to understand the importance of an economic evaluation as an integral part of their 
research and have had appropriate training to address this (Brown et al. 2002). 
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3.18 Conclusion 
This review of the literature around improving professional performance and vaccination 
rates formed the basis for a series of field studies into improving influenza and 
pneumococcal vaccination rates in the setting of British general practice. These 
investigations took into account the ideas and lessons from previous studies of complex 
organisational interventions (Rogers et al. 2000) by using multiple approaches to effect 
change, tailored specifically to improving influenza and pneumococcal vaccination rates, 
within a primary care setting. 
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CHAPTER 4 METHODOLOGY 
4.1 Introduction 
This chapter describes the series of experimental studies that were undertaken to 
investigate implementation of a systematic influenza and pneumococcal vaccination 
programme in primary care. A variety of settings and methods were used to increase the 
validity and generalisability of the results and these are described below.  
 
The initial pilot study employed an action research methodology (Hampshire 2000), with 
a cross sectional survey and an uncontrolled before and after experimental study carried 
out in one practice to promote and explore change. The main findings and experience 
gained from the pilot phase were applied to two further uncontrolled before and after 
studies. The first of these was a multipractice audit conducted in volunteer Lincolnshire 
practices as part of a countywide initiative. The same methodology was subsequently 
refined and applied to a multipractice audit, which formed part of a clinical governance 
programme in West Lincolnshire Primary Care Trust, one of the new primary care 
organisations. Finally, a cluster randomised study was carried out in volunteer practices 
from West Lincolnshire Primary Care Trust (who participated in the primary care trust 
audit) and also from the Trent Focus Collaborative Research Network to investigate the 
effects on vaccination rates of an educational outreach visits to primary healthcare teams. 
 
This series of studies broadly followed the Medical Research Council framework for the 
design and evaluation of complex interventions as its basis (Medical Research Council 
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2000; Campbell et al. 2000a). This consisted of a phased approach, which involved 
preclinical (theoretical), modelling (Phase I), exploratory (Phase II) and definitive (Phase 
III) phases. It was beyond the remit of the study to undertake the final long-term 
implementation phase (Phase IV) described in the framework. In the preclinical phase, 
evidence was obtained from the literature review that the proposed interventions might be 
effective. The pilot study formed the modelling phase, which through an action research 
methodology sought to establish the components of the intervention, how they would 
work, and potential or actual barriers to change. The exploratory phase was conducted 
through two multipractice audits, which using an uncontrolled before and after design, 
investigated the feasibility of improving influenza and pneumococcal vaccination rates 
across a range of general practices, tested outcome measures, helped to define the control 
intervention and enabled an estimate of effect size which was subsequently used for the 
power calculation in the randomised controlled study. The final definitive study 
conducted as part of this thesis was a cluster randomised study, which used the 
experience of the previous studies and extended this to a complex intervention involving 
an educational outreach intervention for primary healthcare care teams to use multiple 
methods to improve influenza and pneumococcal vaccination.  
4.2 Pilot study: Feasibility study targeting influenza and pneumococcal 
vaccination to high-risk groups in a single general practice 
4.2.1 Introduction 
The first step in this research after undertaking a literature review was to undertake a pilot 
study. The broad aims of this pilot phase were to implement an influenza and 
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pneumococcal vaccination programme in an existing practice and to observe, investigate 
and document the problems, barriers, effects and consequences of this change. The pilot 
used an action research method that actively involved practitioners in the research 
process, integrated education into the research process, focused on change to increase 
vaccination rates and used audit to feedback and to generate knowledge (Elliott 1991; 
Hart and Bond 1995). 
4.2.2 Setting 
The pilot study was conducted in my own practice. This practice was chosen because of 
convenience of access, to minimise disruption to patients and staff, facilitate feedback 
and enable closer observation of the process elements of the pilot. The practice was in 
many respects a typical general (family) practice with four partners (three and three 
quarter whole time equivalents), three practice nurses and a variety of employed and 
ancillary (attached to the practice but employed by the local community trust) staff 
including district nurses, health visitor and nursing assistants. The practice was engaged 
in training general practitioners. Training practices, which comprised about a quarter of 
practices in Lincolnshire, were linked in previous studies to greater levels of 
organisational development (Baker 1992). The practice had approximately seven 
thousand five hundred patients giving a list size of two thousand patients per partner. This 
was slightly above the average for general practices in England and Wales at the time of 
the study. Because this was a single practice the results were not generalisable. However, 
as this was a pilot study and because it was the process of change and its implementation 
that was the subject of study the choice of a single practice was appropriate for the 
purposes of the investigation.  
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4.2.3 Background 
We had already been conducting an annual influenza vaccination programme for several 
years in line with many other practices but had not previously instigated a pneumococcal 
vaccination programme. The existing practice influenza vaccination programme was 
targeted at high-risk groups as defined by the Department of Health (Begg and Salisbury 
1996) at that time. This pilot study was conducted between 1996 and 1997 before the 
Department of Health guidance to vaccinate patients over 75 years against influenza 
introduced in August 1998 (Department of Health 1998c) and for those over 65 years in 
May 2000 (Department of Health 2000c). However, as part of our practice policy, 
patients specifically requesting influenza vaccination, usually aged sixty-five years or 
over, who were not in a disease risk group were not refused influenza vaccination. As a 
result, we were also uncertain of the effectiveness of our current influenza vaccination 
campaign in reaching high-risk groups. 
4.2.4 Introducing change 
Prior to the pilot study a programme for pneumococcal vaccination had not been 
considered at the practice except for a small number of asplenic patients, i.e. those 
patients with an absent spleen, through surgery or disease. These individuals were at 
particular risk of contracting overwhelming septicaemia or overwhelming post-
splenectomy infection (Waghorn and Mayon-White 1997) (see also 2.13). Expert 
guidelines recommended measures to reduce this complication including pneumococcal 
vaccination (Working Party of the British Committee for Standards in Haematology 
Clinical Haematology Task Force 1996) and these guidelines had been largely accepted 
because of fear of litigation.  
 130
After a preliminary discussion it became clear that the main reason for the failure to 
consider a more general pneumococcal vaccination programme at the practice was 
because of lack of knowledge about the vaccine amongst doctors and nurses and a lack of 
awareness of the current guidelines. A preliminary review of the literature on 
pneumococcal vaccination was undertaken and the findings presented at a primary 
healthcare team meeting involving doctors, nurses and practice manager. A practice 
policy of vaccinating high-risk groups with pneumococcal vaccine was formulated and 
agreed in midyear 1996 after reviewing the evidence and a discussion within the primary 
healthcare team. This policy was endorsed by the Chief Medical Officer’s update on 
influenza and pneumococcal vaccination prior to our programme which was introduced in 
the Autumn of 1997 (Department of Health 1977).  
 
The recommendations for influenza and pneumococcal vaccination were discussed again 
with doctors, nurses, health visitor and practice manager at a monthly primary healthcare 
team meeting in August 1996. The group considered how the existing influenza 
vaccination programme might be improved and how a pneumococcal vaccination 
programme could be implemented. We recognised the possibility and advantages of 
linking the two vaccination programmes because of the overlap between patient groups 
recommended for the vaccines, the possibility of additive effects and the evidence that 
they were effective and safe when administered together. It was thought likely that many 
patients given influenza vaccination would also be eligible for pneumococcal vaccination 
because of the similarities between at-risk groups so we discussed the possibility of 
administering pneumococcal vaccine to those patients receiving influenza vaccination. 
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The largest group of patients who were eligible for influenza but not pneumococcal 
vaccine in the United Kingdom were nursing home or institutionalised patients so it was 
important that we avoided giving pneumococcal vaccination to this group unless they had 
an additional reason for receiving it. 
4.2.5 Unanswered questions  
It became clear that there were a number of other issues that needed to be clarified before 
undertaking a combined vaccination programme. To what extent were patients aware of 
pneumococcal vaccination? Were patients fully informed about the benefits and risks of 
vaccination? Did patients know of the high-risk groups eligible for vaccination and 
whether they fell into one of these groups? Even if patients were aware of the vaccine and 
eligible risk groups, would they accept vaccination as part of a preventive programme? 
How positive were patients to influenza and pneumococcal vaccine and how positive 
were they to vaccination in general? What factors influenced whether patients would 
agree to be vaccinated? Were we correct in assuming that the right patients were being 
vaccinated against influenza? These questions can be summarised as patient knowledge, 
attitudes, current behaviour and intended behaviour in relation to influenza and 
pneumococcal vaccination. 
 
It was important to find the answers to these questions in order to gauge the likelihood of 
success of improving the existing (influenza) vaccination programme, introducing an 
additional vaccination (pneumococcal vaccine), and also from a purely logistical point of 
view, for example to determine how much vaccine was needed so that we could prepare 
appropriately for vaccine storage and stock control.                                                                                      
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Alternative ways of answering these questions in relation to our practice population were 
considered. Possible solutions included exploring the existing literature; using qualitative 
methods such as individual interviews or focus groups; or using a self-completed patient 
questionnaire. A patient questionnaire would also enable a quantitative estimate of 
patients’ intention to be vaccinated. Although there had been some reference in the 
literature to patient attitudes to influenza and pneumococcal vaccination this was mainly 
derived from studies in North America, where there had been greater private provision of 
healthcare, so the results may not have been generalisable to the general practice setting 
in the United Kingdom. There were limited resources, time and expertise to conduct 
interviews or focus groups. It was decided the most appropriate method to achieve the 
aims of this study was to develop a questionnaire for self-completion and administer this 
to a suitable sample of patients.  
4.2.6 Questionnaire development and sampling frame 
There were a number of issues that needed to be considered in adopting this approach. 
These included defining the purpose of the questionnaire, developing a valid and reliable 
questionnaire instrument for assessing attitudes, refining, piloting and testing the 
questionnaire, gaining a valid and representative sample, ensuring adequate response 
rates and assessing non-responders. 
 
The purpose of the questionnaire was to assess patient awareness of pneumococcal 
vaccine, to ascertain whether patients were able to identify whether they fell into a risk 
group and which risk groups these were, to gauge attitudes to vaccination in general and 
pneumococcal vaccination in particular, and to determine the acceptability of 
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pneumococcal vaccination amongst those patients already attending for influenza 
vaccination.  
 
A self-administered questionnaire was used as the instrument for measuring attitudes and 
gathering other data for this study. A suitable questionnaire was devised after searching 
the literature on questionnaire design and pneumococcal vaccination. The questionnaire 
was modified after a small pilot study to a sample of twelve patients. There was 
accompanying explanation included at the beginning outlining the purpose of the 
questionnaire with information at the beginning on pneumococcal vaccination and at the 
end for patients who wished to have the vaccination (Appendix 1).  
 
The questionnaire was devised using published guidelines and considering the various 
stages of questionnaire design including data content, question selection and wording, 
coding, presentation and layout (Stone 1993; Lydeard 1991). It included an initial section 
outlining the reasons and indications for pneumococcal vaccination and possible side 
effects. Information about the benefits and side effects of pneumococcal vaccine was 
included so that the questionnaire itself served as a method of raising awareness in the 
target group. Patients were asked to complete questions on general attributes such as age 
and sex as well as beliefs such as whether they thought they were in a risk group, prior 
knowledge of pneumococcal vaccine and the source of this information.  
 
The second part of the questionnaire consisted of a series of statements reflecting 
attitudes about vaccination in general and pneumococcal vaccination in particular. These 
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attitudinal statements were derived from five dimensions or areas of concern identified 
from the literature review. The attitude statements, which included underlying beliefs 
(cognition), feelings (emotion) and what patients reported that they would do as a result 
of their beliefs and feelings, sometimes termed resultant behaviour or action tendency, 
were developed using recognised techniques (Oppenheim 1966). These techniques 
included assembling a pool of relevant items, constructing a questionnaire instrument 
from these, applying this to an appropriate sample, developing the instrument based on 
the response to questions and item analysis, assessing reliability and validity and 
modifying the instrument on the basis of this if necessary (Proctor 1993).  
 
Because respondents were more likely to reply in the affirmative leading to acquiescent 
bias (Martin 1964), paired statements were employed expressing opposite attitudes, i.e. a 
'balanced' questionnaire. Some of the statements were simply reversed in wording to 
produce their negative counterpart whereas others used recognised negative concepts 
identified from the preliminary exploration (Figure 2). This technique had been used 
previously in general practice (Pringle et al. 1984) to counter bias due to ‘response 
acquiescence’. The five pairs of statements were ordered to avoid paired questions 
occurring together giving an item pool of ten questions in all. A Likert-type (Likert 1932) 
format with five response codes numbered one to five, ranging from “strongly agree” to 
“strongly disagree” with a central “not sure” numbered three was used for each statement. 
Care was taken to avoid ambiguous statements, double questions and loaded questions 
and the questionnaire was developed with awareness of the various types of respondent 
bias that could operate in this type of questionnaire including acquiescence (central 
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tendency), skewed responses and social desirability bias (Lydeard 1991) whilst 
acknowledging that some of these could only be detected at the analysis stage. A suitable 
coding frame was developed for the questionnaire responses so that the data could easily 
be entered onto a database for analysis. 
 
The sample that was selected was patients attending, or being visited for, influenza 
vaccination. This included vaccinations administered by practice and district nurses or 
doctors during a single influenza vaccination season. This set of patients was chosen 
because of the overlap between risk groups for the two vaccines, because those attending 
for influenza vaccine would be generally positive to vaccination and because it was felt 
that targeting them would lead to the greatest rise in coverage for pneumococcal vaccine. 
An alternative would have been to select a random sample from all patients in the 
practice or those above a certain age or those in particular risk categories. An advantage 
of this approach would have been that it targeted a wider, more representative group of 
patients who might have been eligible for influenza and pneumococcal vaccination. The 
disadvantages would have included the additional costs of postage and the risk of a low 
response rate that often occurs with postal questionnaires. 
 
Nursing and residential homes or similar institutions were excluded because patients 
within these establishments did not fall within the recommendations for pneumococcal 
vaccination per se but also because it was known that a proportion of nursing home 
patients were unable to complete the questionnaire because of illness or disability, for 
example dementia.  
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Although this sampling strategy might have led to selection bias, i.e. excluding patients 
who did not attend for influenza vaccine for whatever reason, this was felt to be a 
legitimate pragmatic approach for the purposes of this study as it was the patients who 
were sampled who would subsequently be targeted for pneumococcal vaccination. 
 
A small initial sample of twelve patients attending the practice diabetic clinic was chosen 
to pilot the questionnaire. Patients attending this clinic were handed the questionnaire 
before their appointment and had an opportunity to complete and return the questionnaire 
before leaving. This allowed the investigator to check whether questions were understood 
and that the format, layout, wording and responses were adequately accounted for by 
directly checking with each patient. 
 
After minor modifications the questionnaire was distributed to patients attending or being 
visited for influenza immunisation by receptionists and district nurses. The questionnaire 
was not strictly anonymised. Patients who were interested in receiving pneumococcal 
vaccination in addition to influenza vaccination, after receiving the patient information, 
were given an opportunity to record their name on the questionnaire so that they could be 
contacted at a later date when the vaccination programme had begun. Those patients who 
did not wish to have the additional vaccine or preferred not to give their name could 
return the form anonymously. 
4.2.7 Ethical issues 
It was also important to consider the ethical issues arising from this project. After seeking 
informal advice from the local research ethics committee at the time of the pilot it was 
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felt that this was primarily an audit rather than a research study. The patient questionnaire 
also informed patients about the vaccine and its side effects and provided an invitation for 
patients to seek vaccination when this became available. The subsequent additional 
medical intervention of pneumococcal vaccination was an existing health technology that 
was advocated by national guidelines. Patients were informed as to the purpose of the 
questionnaire by the receptionist or nurse and also in the preliminary information. They 
were not under any obligation to complete the questionnaire and it was returned after 
completion to a box in the reception area. On the balance of this advice formal ethical 
approval was not sought. 
4.2.8 Data collection and analysis of patient questionnaire 
Questionnaires were distributed to patients attending for influenza vaccine during the first 
available vaccination season between September and December 1996. Practice 
receptionists collected the collected completed questionnaires. Data from the 
questionnaires was coded and entered onto Microsoft Excel version 5 by a practice 
receptionist trained in data entry. Analysis was performed using EPI INFO version 6 (EPI 
INFO version 6 DOS. 1996) and SPSSPC version 10 (Norusis 1990). SPSS was used to 
generate correlation coefficients, item and scale statistics and the reliability coefficient 
(Cronbach’s alpha) for the attitudinal statements. Questionnaire reliability and validity 
were evaluated using techniques described in the methods section. Subgroups 
differentiated according to age, sex, previous vaccination behaviour and risk groups, were 
compared using the chi square test for nominal data and the Kruskal-Wallis test for total 
attitude scores (Brown and Beck 1990) since the data were non-parametric. 
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4.2.9 Changes introduced 
As a direct result of analysing the questionnaire it was possible to estimate and purchase 
sufficient vaccines for the subsequent vaccination programme. A number of measures 
were undertaken to improve the logistics of the vaccination programme, based on the 
literature review, in order to increase uptake of both influenza and pneumococcal 
vaccines to high-risk groups. 
 
In order to comply with recommendations for storage an additional dedicated vaccine 
refrigerator with an inbuilt thermometer was purchased. Practice protocols were devised 
for practice nurses, district nurses and doctors. These were discussed and agreed at a 
primary healthcare meeting. Agreement of shared protocols was considered important in 
order to raise awareness amongst healthcare staff and to ensure that vaccine was being 
correctly delivered to target groups (Figure 3 and 4). Practice and district nurses ensured 
that they had access to a ‘shock box’ and that this was stocked with emergency drugs, 
including adrenaline, in case of allergic reactions to the vaccine. The ‘shock box’ was a 
box containing the necessary equipment required in case of a potentially fatal severe 
allergic reaction to the vaccine. The box contained an airway to help the patient breathe 
and drugs such as adrenaline and hydrocortisone that if correctly used can treat this 
condition, which is also known as anaphylactic shock. Patients were informed about the 
pneumococcal vaccine through poster displays in the surgery and about both influenza 
and pneumococcal vaccines during the annual influenza vaccination round. Automated 
prescription messages were printed onto prescriptions informing patients about the two 
vaccines and risk groups. 
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Figure 2 Attitude statements: values and beliefs about vaccination 
Safety 
1. I think that vaccinations are generally safe 
2. I am worried about the side effects of vaccination    
 
Prevention 
3. Prevention is better than cure       
4. I do not believe in prevention  
 
Susceptibility to infection   
5. I never get colds or chest infections     
6. I am worried about getting chest infections  
 
General health   
7. I believe that I am a healthy person  
8. I would say overall that I am unwell   
 
Pneumococcal vaccination 
9. I feel that I would like pneumococcal vaccination   
10.I don’t think that I need pneumococcal vaccination   
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Pneumococcal vaccine was administered to high-risk patients between January and 
December 1997 opportunistically by general practitioners and practice nurses during 
routine surgery attendances, attendance at specialised clinics (e.g. diabetic and asthma 
clinics), district nurse visits to the housebound elderly, after discharge from hospital and 
most importantly during the subsequent influenza vaccination programme. The influenza 
vaccination programme was conducted between September and December 1997. Special 
nurse clinics were set up during this time for influenza and combined influenza and 
pneumococcal vaccination.  
4.2.10 Completing the cycle 
The effect of the vaccination programme was evaluated after one year by conducting a 
complete audit cycle of vaccine uptake in risk groups. Five tracer conditions (Kessner et 
al. 1973), ischaemic heart disease, diabetes, splenectomy, chronic obstructive airways 
disease (including asthma) and chronic renal failure were chosen to measure vaccine 
uptake. As well as being high-risk groups for both influenza and pneumococcal 
vaccination, these were the most accurately recorded of the high-risk conditions on the 
practice disease register and were conditions that were relatively clearly defined. Asthma 
and chronic obstructive pulmonary disease (COPD) were grouped together because of 
difficulties with classification. Many older patients on inhalers, particular smokers, were 
wrongly classified as having asthma rather than COPD. Although chronic heart disease 
was stated as a risk group for pneumococcal vaccination, most patients with heart failure 
(which was usually taken to mean chronic heart disease) had coronary disease. It was 
known that heart failure registers were unreliable in general practice at that time because 
of misdiagnosis, either false positives (Remes et al. 1991) or under diagnosis (Sutton and 
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Poole-Wilson 1996; Morgan et al. 1999) and so coronary heart disease rather than heart 
failure was used as a tracer for this audit.  
4.2.11 Final data collection and analysis 
The rate of influenza and pneumococcal vaccination in each target group was calculated 
using the reporting function of the general practice computing system. Patients who fell 
into more than one target group were treated separately for each part of the audit. The rate 
of vaccine delivery to high-risk groups was calculated by searching the patients who had 
received influenza and pneumococcal vaccine for each of these risk groups. The results of 
the pilot are presented below (see 5.1). 
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Figure 3 Protocol for influenza vaccination  
TARGET GROUPS 
 
1. Asplenia or severe splenic dysfunction including sickle cell disease. 
2. Chronic lung disease and asthma: COAD, bronchiectasis. 
3. Chronic heart disease: coronary disease, heart failure. 
4. Diabetes mellitus. 
5. Chronic renal disease: chronic renal failure, nephrotic syndrome, dialysis or transplant. 
6. Chronic liver disease. 
7. Immunodeficiency or immunosuppression: HIV, drugs, lymphoma, myeloma. 
8. Patients in residential or nursing homes. 
 
Contraindications 
1. Pregnancy (unless there is a specific indication). 
2. Anaphylactic hypersensitivity to hens’ egg products. 
 
Clinical Responsibility 
6. Ultimate responsibility rests with GP. 
7. Can be delegated to suitably trained nurses. 
8. Practice nurse must adhere to practice guideline. 
9. Advise patient of purpose and possible side effects of vaccination. 
10.Method of administration: IM or SC 0.5 ml into deltoid (adult) or lateral aspect of mid 
thigh (children); 0.5 ml for children 4 to 12 years repeated 4-6 weeks later if receiving 
vaccine for the first time; 0.25 ml for children 3 months to 6 years repeated 4-6 weeks 
later if receiving vaccine for the first time. NOT intradermal or iv. Separate site if 
given at the same time as pneumococcal vaccine. 
11.Record site, lot number, expiry date in notes. 
12.Flag computer record. 
13.Emergency drugs and equipment available for anaphylaxis. 
 
Outcome 
All patients who fall into ‘risk categories’ will have been offered and given influenza 
vaccine if appropriate. 
 
Reference 
Department of Health, Welsh Office, Scottish Home and Health Department, Department 
of Health and Social Services Northern Ireland. Immunisation against infectious disease. 
London: HMS0,1996: 167-72. 
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Figure 4 Protocol for pneumococcal vaccination  
TARGET GROUPS 
 
Age 2 years and over with the following conditions: 
1. Asplenia or severe splenic dysfunction including sickle cell disease. 
2. Chronic lung disease: COAD, bronchiectasis, chronic asthma. 
3. Chronic heart disease: coronary disease, heart failure. 
4. Diabetes mellitus. 
5. Chronic renal disease: chronic renal failure, nephrotic syndrome, dialysis or transplant. 
6. Chronic liver disease. 
7. Immunodeficiency or immunosuppression: HIV, drugs, lymphoma, myeloma. 
 
Contraindications 
1. Previous pneumococcal vaccine (within 5-10 years) - consult doctor if unsure. 
2. Previous severe reaction to vaccine. 
3. Pregnancy, breast feeding. 
4. Children under 2 years (vaccine ineffective). 
5. High dose steroids. 
 
Clinical responsibility 
6. Ultimate responsibility rests with GP. 
7. Can be delegated to suitably trained nurses. 
8. Practice nurse must adhere to practice guideline. 
9. Advise patient of purpose and possible side effects of vaccination. 
10.Method of administration: IM or SC 0.5 ml into deltoid or lateral aspect of mid thigh. 
NOT intradermal or iv. Separate site if given at the same time as influenza vaccine. 
11.Record site, lot number, expiry date in notes. 
12.Flag computer record. 
13.Emergency drugs and equipment available for anaphylaxis. 
 
Outcome 
All patients who fall into ‘risk categories’ will have been offered and given 
pneumococcal vaccine if appropriate. 
 
Reference 
Department of Health, Welsh Office, Scottish Home and Health Department, Department 
of Health and Social Services Northern Ireland. Immunisation against infectious disease. 
London: HMS0,1996: 167-72. 
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4.3 Lincolnshire-wide multipractice study: multipractice audit to assess 
influenza and pneumococcal vaccination uptake in high-risk groups 
4.3.1 Background and aims 
The next step was to apply the findings of the pilot study more widely by conducting a 
quality improvement study across a number of general practices in Lincolnshire. The aim 
of this study was to compare vaccination coverage between practices, assess practices’ 
ability to target vaccination to high-risk groups and to improve vaccination of these risk 
groups. As well as exploring the feasibility of improving influenza and pneumococcal 
vaccination rates across a range of general practices, it helped to define the control 
intervention and enabled a power calculation in the randomised controlled study. 
4.3.2 Outline of problem 
Lincolnshire is a large rural county. Primary healthcare teams were responsible for 
delivery of influenza and pneumococcal vaccinations to high-risk groups. At the time of 
the study there had been little support for practices to improve influenza and 
pneumococcal vaccination rates. Improving the uptake of these vaccines was becoming 
increasingly important as evidence on efficacy, reduced mortality, morbidity and hospital 
admission, and the prospect that they may help to reduce winter pressures, was growing. 
This was undertaken as part of a Primary Care Audit Group (PCAG) initiative. 
Lincolnshire PCAG was the successor to the Medical Audit Advisory Group and a key 
organisation responsible for organising audit and achieving quality improvement in the 
county and took an initiative to improve rates of these adult vaccinations. Membership of 
this group helped considerably in providing access to practices for this project.  
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The aims of this study were to compare vaccination coverage between practices, assess 
practices’ ability to target vaccination to high-risk groups and to improve vaccination 
rates in risk groups by advising on interventions that addressed these barriers and to see 
how practices changed their vaccine delivery and performance as a result. 
4.3.3 Key measures for improvement 
The objective was to increase influenza and pneumococcal vaccination rates in high-risk 
groups. We chose patients with coronary heart disease, diabetes and splenectomy to 
reflect these groups. These ‘tracer’ conditions (Kessner et al. 1973) were chosen because 
they were the most accurately recorded of the high-risk conditions on practice disease 
registers.  
 
There were six audit criteria. In summary these were that patients with coronary heart 
disease, diabetes or splenectomy should receive annual influenza vaccination and have 
received pneumococcal vaccination at least once previously. 
4.3.4 Gathering information and strategies for change 
In July 1998, all practices in the county of Lincolnshire (n=105) were invited by letter to 
participate in a multipractice audit of influenza and pneumococcal vaccination in high-
risk groups (Appendix 2). A core group comprising a general practitioner, nurse and audit 
staff from the PCAG developed the audit package. This was further refined by the wider 
membership of the PCAG comprising several general practitioners including 
educationalists (general practice trainers), practice and district nurses, a consultant 
physician, public health physician and audit managers and staff. It was also piloted by 
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two practices before being disseminated. The baseline data collection was carried out in 
September to November 1998. Practices were asked to collect vaccination data for 
patients with coronary heart disease, diabetes and splenectomy. These three conditions 
were chosen because they were more likely to be accurately recorded on disease registers 
than asthma and chronic obstructive pulmonary disease or chronic renal failure, which 
were included in the single practice study. There was also some controversy as to whether 
asthmatic patients should receive pneumococcal vaccination (Siriwardena 1997). Patients 
over 65 years were not included in this countywide audit as this was not national policy at 
that time. Reducing the number of conditions also simplified the data collection process 
although this was not a primary consideration. For each condition, practices recorded if 
patients had received influenza vaccine in the previous year or pneumococcal vaccination 
ever. Practice receptionists or nurses collected data on structured data collection forms 
and sent these together with their target standards to the Primary Care Audit Group 
(PCAG) office for analysis. To ensure patient confidentiality practices completed these 
data collection forms using patient identification numbers only and held the patient 
reference sheet with names of patients against those numbers. There was some potential 
for bias in this process with the potential for staff to generate inaccurate lists of high-risk 
patients or those that had been vaccinated. This was minimised by giving clear 
instructions on how to produce these lists or to generate computer reports of the relevant 
data.  
4.3.5 Data analysis and feedback 
Data were analysed to produce summary data, graphs and results for feedback to 
practices. We returned anonymised graphical feedback of performance in January 1999 
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(Appendix 4). The feedback of practice results was done in graphical form as a bar chart 
(Figure 5). Each bar represented a single practice’s individual vaccine uptake for a single 
high-risk group compared with other practices, mean uptake and standard set. The 
feedback was anonymised so that practices were given their own results and could 
compare this with those of other practices without having knowledge of other practices’ 
individual performance. We also distributed information on good practice (Figure 6), 
example protocols for influenza (Figure 3) and pneumococcal vaccination (Figure 4), an 
explanation of how to undertake computer searches, and claim reimbursement for 
vaccines dispensed. Practices were encouraged to disseminate their results within their 
primary healthcare teams and discuss how they could increase vaccination rates in their 
high-risk patients.  
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Figure 5 Example of feedback to practices: Percentage of diabetic patients who 
received influenza vaccination 
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Figure 6 Advice given to practices after the first audit 
 
Initiating, updating and maintaining chronic disease registers are essential if practices 
wish to improve targeting of high-risk groups. 
 
Use and implement written protocols for adult vaccination. 
 
Ensure adequate vaccine supplies and stock control, especially pneumococcal vaccine; 
sufficient refrigerator space and maintenance of the cold chain are important. 
 
When presenting for flu jabs, check pneumococcal status in at-risk patients and advise 
vaccination if appropriate. Simultaneous vaccination is a good way of increasing 
coverage of high-risk groups. 
 
A co-ordinated approach, agreed on by all personnel in the practice, including doctors, 
practice and district nurses, receptionists and practice manager works best. 
 
A poster campaign and advice printed on repeat prescriptions each winter will help raise 
patient awareness. 
 
Recommendation by a health professional and a consistent message has been shown 
consistently to improve vaccination rates. 
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Figure 7 Flow of practices through Lincolnshire-wide multipractice study 
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4.3.6 Measuring change 
The audit was repeated in January 2000, just a year after the initial data collection was 
completed and feedback sent to practices. This allowed just a year for practices to assess 
and compare their vaccination rates, discuss and implement change, conduct a 
pneumococcal vaccination programme and complete a further winter vaccination 
programme for influenza. Twenty-one practices took part in both phases for diabetes and 
fourteen of these for coronary heart disease and splenectomy. All the practices that 
undertook the baseline assessment completed both phases but a number of practices 
joined for the second phase. Figure 7 shows the flow of practices through the audit. 
 
Data were analysed using SPSSPC version 10 (Norusis 1990). Mean values for 
vaccination uptake were calculated between the two phases of the audit for practices that 
completed the audit cycle. Performance was compared with standards that practices set 
themselves (expressed as a median standard). The data were approximately normally 
distributed so a paired t-test was used to assess improvement in performance. A 
Wilcoxon rank sum test showed similar results. Although a number of practices joined 
the audit at the re-evaluation phase these were not included in the analysis.  
 
A postal questionnaire was used at baseline (Appendix 3) and a semistructured postal 
questionnaire after the first phase of the audit (Appendix 5) to survey organisational 
changes that occurred in practices as a result of the audit.  
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4.4 West Lincolnshire Primary Care Trust study: multipractice audit to 
assess influenza and pneumococcal vaccination uptake in high-risk 
groups 
4.4.1 Aim and setting 
Following the multipractice study a similar study was conducted to assess the effect of 
audit and feedback on vaccination performance within two Primary Care Groups that 
amalgamated in April 2001 to form a Primary Care Trust. This study coincided with the 
new recommendation to vaccinate patients aged over 65 years as well as those in high-
risk groups. In addition the Department of Health set health communities a target of 
achieving a minimum 60% uptake of vaccination in these groups in the year 2000 and 
advised them to monitor the immunisation programme and provide data for national 
monitoring. As part of this study practices were approached to participate in a randomised 
controlled study of an educational intervention for primary care teams aimed at 
improving influenza and pneumococcal vaccination rates (see 4.5 below). 
 
In July 2000 all practices from both North West Lincoln and South Lincoln Primary Care 
Groups (PCGs), subsequently West Lincolnshire Primary Care Trust, were invited to 
participate in an audit of influenza and pneumococcal vaccination (Appendix 6). The aim 
of the audit was to improve the uptake of influenza and pneumococcal vaccination in 
patients aged 65 years and over and those in high-risk disease groups. Patients aged over 
65 years were included in this audit following the Chief Medical Officer’s guidance 
(Department of Health 2000b) and subsequent letter (Department of Health 2000c). 
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Twenty-seven practices took part in this initial audit, sixteen from North West 
Lincolnshire PCG and eleven from South Lincoln PCG. Twenty of these practices also 
consented to participate in the randomised controlled study by returning the signed 
consent (Appendix 6). 
 
The audit pack was adapted from that used for the countywide audit and remained 
consistent from the initial audit undertaken in July 2000 to the re-audit in April 2001. To 
facilitate comparison between the two data collection phases, practices were required to 
collect data for the same target group of patients, i.e. over 65s and the three tracer 
conditions, coronary heart disease, diabetes and splenectomy. The practices were not 
required to use exactly the same patients for both of the audit phases, as any changes 
implemented following the initial audit would affect the entire target population. Again, it 
was recommended to the practices that their entire target population were audited. 
However, information was included in the audit pack on how to select a representative 
audit sample.  
4.4.2 Data analysis and feedback 
Data were analysed to produce summary data, graphs and results for feedback to 
practices. As a result of the audit we distributed information on good practice, example 
protocols for influenza and pneumococcal vaccination and feedback of audit results after 
the first cycle as for the Lincolnshire-wide audit. 
 
Practices from both PCGs were invited to re-audit their influenza and pneumococcal 
vaccination rates in April 2001 to complete the audit cycle and evaluate whether the 
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changes implemented as a result of the initial audit had been effective. Twenty-four of the 
original twenty-seven practices took part in the re-audit, with an additional eight practices 
taking part in the audit for the first time. In total thirty-two practices took part in the re-
audit (fourteen from South Lincoln PCG and eighteen practices from North West Lincoln 
PCG). It was recommended to the practices that the standards that they had set in the 
initial audit should remain the same in the re-audit, unless they had achieved the initial 
standard and wished to aim higher. 
 
Once the practices had completed the data collection they were instructed to return their 
data to the primary care audit group (PCAG) office. As in previous PCAG audits, for 
patient confidentiality purposes, practices completed data collection forms using patient 
ID numbers only and held their own patient reference sheet with the names of the patients 
audited against those numbers. Those practices that were able to access the audit data 
from their practice computer systems were encouraged to return computerised data 
collection forms, which were also designed to protect patient confidentiality. 
 
Data analysis was performed using SPSSPC version 10 (Norusis 1990). Mean values for 
vaccination uptake were calculated between the two phases of the audit for the twenty 
practices that undertook two phases of the audit cycle. A paired t-test was then used to 
assess improvement in performance between the two phases of the audit because the data 
were approximately normally distributed. A non-parametric tests (Wilcoxon rank sum) 
showed similar results suggesting that the t-test was robust for this data. 
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Figure 8 Flow of practices through Primary Care Trust multipractice study 
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4.5 Trent Influenza and Pneumococcal study: cluster randomised 
controlled trial of the effect of an educational intervention directed at 
primary healthcare teams to improve influenza and pneumococcal 
vaccination uptake in high-risk groups 
4.5.1 Introduction 
Although the countywide audit and Primary Care Trust audit could demonstrate 
improvements in vaccination rates the uncontrolled nature of these studies could not 
account for secular trends. By secular trends is meant changes that occur naturally over 
time in the process of healthcare. Such changes can occur because of increased awareness 
of new processes, local and national influences for change, demographic changes or non-
specific temporal effects. Pneumococcal vaccination rates would be expected to gradually 
increase with time because of these factors. The mere fact of being observed during an 
audit study would also tend to alter the behaviour under observation due to awareness of 
being observed, the so-called “Hawthorne effect” (Holden 2001). 
 
One way of accounting for secular trends would have been to have a non-randomised 
comparison group for the multipractice studies where feedback of audit results and 
written advice was withheld. This was not possible because of resource and ethical 
constraints. There was not a suitable county to act as a comparison as in the United States 
demonstration projects (Barker et al. 1999) because of lack of funding and the absence of 
an interested partner. It may have been unethical to use a control group of practices in a 
multipractice audit since the purpose of such an audit would be to improve current 
practice according to predetermined criteria and standards rather than for research 
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purposes. There may also have been problems of bias and contamination, depending on 
how practices were chosen for intervention or comparison groups and whether they were 
in sufficient proximity to share information on what was being done in intervention 
practices. Since each practice would also collect their own audit data it would have been 
relatively simple for them to analyse their own performance and act on it accordingly. 
 
Another way of accounting for secular trends would have been to use an interrupted time 
series design, taking data at several points in time before and after the intervention and 
analysing the data to see if there was significant increase in immunisation rate following 
the intervention. This would have necessitated multiple data points and with many more 
sets of data to be collected was not feasible in this type of unfunded study, for pragmatic 
reasons. 
 
A key finding from the literature review was that audit and feedback by itself was of 
limited benefit in improving practitioner performance or patient outcomes but that in 
combination with other, particularly educational, techniques it could lead to greater 
improvements in performance, particularly in relation to vaccination rates. Methods that 
were used in the multipractice audits and had been shown to be effective in systematic 
reviews included the use of protocols or clinical guidelines.  
 
A more effective way of improving performance included educational outreach with 
education being delivered to practitioners at or close to their place of work. Previous 
studies of educational outreach had been directed at single professional groups, usually 
 158
general practitioners, rather than multidisciplinary practice teams. An influential report on 
the future of continuing professional development in primary care suggested that greater 
emphasis should be placed on multidisciplinary practice-based learning (Department of 
Health 1998b) in order to stimulate change in practice and real improvements in patients 
care. Despite this and theoretical support from adult learning theory (Knowles 1990) that 
small group learning, relevant to practice and delivered at the workplace could improve 
the performance of primary healthcare teams there had been little research undertaken on 
the effectiveness of multidisciplinary education for primary healthcare teams the United 
Kingdom.  
 
It was therefore decided to undertake a study that sought to combine these concepts by 
using an educational outreach intervention directed at primary care teams. The purpose of 
the educational intervention was to identify barriers to vaccination and implement 
evidence based methods for improving vaccine uptake. The methods used were based on 
information and experience from the literature search, pilot and interpractice studies but 
were tailored according to the needs of practices. A randomised controlled trial was 
conducted to assess the effect of an educational outreach visit to primary healthcare teams 
on influenza and pneumococcal vaccination rates. 
4.5.2 Design  
The study used a cluster randomised controlled design. The study was partly nested 
within the primary care trust audit (see 4.5.3). The aim of the study was to measure the 
effect of an educational intervention on influenza and pneumococcal vaccination uptake 
in high-risk groups (patients aged 65 years and over and those with coronary heart 
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disease, diabetes or splenectomy). Intervention and control practices also received audit 
feedback and written guidance. The hypothesis being tested was that volunteer practices 
undergoing a primary care team based educational outreach session would have greater 
influenza and pneumococcal vaccination rates as a result. The null hypothesis was that an 
educational outreach visit to volunteer primary healthcare teams would have no effect on 
increasing influenza and pneumococcal vaccination rates in high-risk groups. A 
randomised controlled design was chosen to reduce the effect of confounding factors and 
to account for secular trends. Baseline imbalance in the intervention and control practices 
was corrected for by stratifying according to baseline vaccination rate. 
 
The use of clusters was an important feature of the design. Cluster randomised designs 
are those where social units rather than individuals are randomly allocated to two or more 
intervention strategies. This type of design, where in this case the general practice was the 
preferred cluster, was chosen for several reasons (Bland and Kerry 1997). Firstly, the 
general practice team was the target of the educational intervention. Because the 
intervention was directed at practices rather than individual patients and because the 
primary outcome was the influenza or pneumococcal vaccination rate in the high-risk 
population from each practice, a cluster design, using clusters of high-risk patients from 
individual practices, was most appropriate for this study (Grimshaw et al. 2000). 
Secondly, it would not have been possible to randomise patients within a practice to the 
organisational changes that would affect the whole practice and its primary care team, 
because the changes were likely to have affected all individuals including staff and 
patients belonging to the organisation. Thirdly, outcomes in each cluster would tend to be 
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correlated because of similarities between patients (registering with each practice), other 
influences exerting effects on vaccination rate across the whole practice population (such 
as local media campaigns), and interaction between patients in each practice (for 
example, personal recommendation from friends and relatives to have vaccination) 
(Ukoumunne et al. 1999b). Finally, data was collected at practice level, the same level as 
the intervention, and therefore the general practice was naturally the correct unit of 
analysis (Altman and Bland 1997).  
 
Cluster randomisation was also chosen to reduce contamination (Torgerson 2001). 
Contamination is said to occur when subjects, either patients or in this case healthcare 
staff, randomised to a control group are inadvertently subject to the intervention. This is 
most likely to occur when patients in the same practice are allocated to both intervention 
and control groups. Cluster randomisation would reduce this possibility, unless it could 
be shown that practices in the control group were able to implement the intervention 
themselves, or had learnt the lessons of the educational intervention from nearby 
intervention practices through informal communication. However, the control practices in 
this study did not receive a practice based educational session on methods of improving 
influenza and pneumococcal vaccination rates during the period of the study. 
Contamination may have inadvertently occurred in neighbouring practices. This would 
have tended to reduce the effect of the intervention. 
 
A number of other potential sources of bias and possible problems with the internal 
validity of this type of design were recognised at this stage. These included the possibility 
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of selection bias in which practices or patients with different characteristics might be 
allocated to intervention or control groups, external events affecting changes in 
vaccination rate between baseline and follow-up (termed “history”), changes in practice 
clusters independent of the intervention perhaps due to staff changes (“maturation”), 
effect of baseline measurements alone on behaviour as an example of the Hawthorne 
effect (“testing”), loss of clusters from the study related to the intervention (“attrition”) 
and the tendency of high or low vaccination rates to exhibit regression to the mean 
(Ukoumunne et al. 1999b). The design and analysis took into account many of these 
problems. 
 
This type of complex design had important implications for the sample size calculation, 
randomisation, stratification and subsequent analysis of the study. There were also 
important ethical considerations (see 4.5.11). Expert statistical advice was therefore 
sought and gained at all stages of the study. The study also complied with internationally 
accepted conventions on the design and reporting of randomised controlled trials (Begg et 
al. 1996) and cluster randomised controlled studies (Elbourne and Campbell 2001).  
4.5.3 Recruitment of practices 
All practices in West Lincolnshire Primary Care Trust (n=39) and Trent Focus 
Collaborative Research Network (n=50) were invited to participate in the study in June 
2000. There were no explicit exclusion criteria but an agreement to provide baseline and 
follow-up data was a prerequisite of recruitment. Practices from the primary care trust 
who were already participating in the trust wide multipractice audit were approached by 
letter for consent to the study (Appendix 6) and provided with a practice briefing and 
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consent to participate (Appendix 7). Practices from the collaborative research network 
were also approached by letter through the Trent Focus research network office with an 
outline of the study (Appendix 8) and consent to participate. Following this invitation, 
twenty practices from the primary care trust and ten practices from the research network 
agreed to participate. The first thirty practices to volunteer for the study were selected to 
participate and written to (Appendices 9 and 10). All subsequently undertook the study. 
Practices who expressed an interest after the recruitment process were informed that the 
study was closed to further selection (Appendix 11). The involvement of practices in the 
trial is summarised in Figure 9. Demographic data for non-participating practices were 
obtained from the respective organisations. 
 
Practices were selected on a pragmatic basis. There were a number of issues around 
recruitment, which may have affected the external validity or generalisability of this 
study. Some of the Lincolnshire practices (n=5) that participated were known have taken 
part in previous multipractice audits. They were likely to have already implemented some 
changes to improve vaccination rates. The research network practices may have been 
different from the Lincolnshire practices in terms of organisational or patient 
characteristics (like training status, deprivation etc.) or other factors that might have 
affected vaccination rates. The research practices in this study were known to be more 
likely to be involved in training, tended to be larger and to have a female partner but with 
fewer single-handed and younger doctors compared to other practices in the Trent region. 
However their patient populations were similar in hospital admission, morbidity and 
mortality compared with other practices in Trent (Hammersley et al. 2002). All these 
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factors, whether organisational or patient related were important in that they may have 
affected a general practice’s baseline vaccination rate or its ability to increase vaccination 
rate, and therefore it was important to include some means of accounting for this in the 
randomisation process. This was achieved as shown below by using stratification based 
on baseline vaccination rate prior to randomisation. Since other organisational factors 
such as training status or patient factors such as deprivation were important because of 
their potential effect on the outcome of interest it could be postulated that selection bias, 
although present, could be partly offset by including practices with a broad range of 
organisational characteristics and baseline vaccination rates. 
4.5.4 Baseline data collection 
The initial baseline data collection was carried out in August 2000 with thirty volunteer 
practices. Practices were sent a letter outlining the purpose of the study (Appendices 9 
and 10). A detailed audit protocol was sent to all practices (Appendix 12). Practices were 
asked to complete their baseline data together with a questionnaire of vaccination practice 
(Appendix 3). The data collection method had been previously piloted in both the single 
practice and countywide study. The data collection was carried out by Lincolnshire 
Primary Care Audit Group (PCAG) on behalf of the Primary Care Trust (PCT) as part of 
a multipractice audit and additionally (by the researcher) for the Collaborative Research 
Network practices. Practices were asked to collect vaccination data for those aged 65 
years and over and patients with coronary heart disease, diabetes or a previous 
splenectomy using Read codes onto a standardised data collection sheet (Appendix 13). 
Coronary heart disease, diabetes and splenectomy were again selected as so-called tracer 
conditions.  
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Figure 9 Flow chart summarising involvement of practices in randomised controlled 
trial 
 
 
 
 
 
30 volunteer practices from West 
Lincolnshire Primary Care Trust and 
Trent Focus Collaborative Research Network 
agreed to take part
Baseline influenza and pneumococcal 
vaccination rates in disease groups and 
influenza vaccination in age 65 years and 
over measured and fed back to practices
Randomisation of practices (stratified 
according to baseline influenza vaccination 
rates for diabetics) 
 
 
Control group 
15 practices 
 
Intervention gr
15 practices 
 
oup 
Primary outcomes measured 6 months after 
educational intervention  
(Repeat data collection 8 months after 
baseline data collection) 
39 practices from West Lincolnshire Primary 
Care Trust and 50 practices from Trent Focus 
Collaborative Research Network invited to 
take part in study
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For patients aged sixty-five years and over and for each disease group participating 
practices recorded if patients had received influenza vaccination in the previous year, or 
for the disease groups only, pneumococcal vaccination ever. In order to ensure patient 
confidentiality practices completed these data collection forms using patient identification 
numbers only and held the patient reference sheet with names of patients against those 
numbers.  
 
Practices used their own staff to collect data on pre-printed forms, with clear instructions 
for on how this should be done, and sent these to the PCAG for analysis. Alternatively, 
practices sent details of number vaccinated and denominators for each target group 
obtained from searching the practice computer database. Practices were sent one reminder 
letter (Appendix 14). Data were analysed to produce summary data, graphs and results for 
initial feedback to practices.  
4.5.5 Randomisation 
Randomisation was carried out in September 2000 with the general practice as the unit of 
randomisation. Because of the possibility of ceiling effects (see 3.17.1), stratified 
randomisation was used, based on initial rate, so that intervention and control practices 
would have similar baseline vaccination rates. Baseline influenza vaccination rate for 
diabetes was chosen as the stratifying variable since all the rates were correlated. Within 
strata, practices were randomly allocated to intervention or control. This was carried out 
by listing all thirty practices in order of vaccination rate (for diabetes) and allocating each 
to odd or even and tossing a coin to decide which group they should be in. No method of 
allocation concealment was employed and this was a weakness in the design of this study. 
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Failure to conceal allocation, despite the randomisation process being explicit would have 
inflated effect sizes.  
 
Intervention and control practices were written to, informing them whether they had been 
randomised to intervention or control groups. Intervention practices were told that they 
would receive an educational outreach visit to discuss their influenza and pneumococcal 
immunisation programmes, focusing on methods of increasing vaccination rates based on 
the research evidence. Intervention practices were asked to arrange to have at least one 
doctor, one nurse and the practice manager at this meeting and any other key members of 
staff that they felt appropriate (Appendix 15). Control practices were asked to continue 
their immunisation programme as planned and informed about a short semistructured 
questionnaire which they would be asked to complete at the end of their campaign 
(Appendix 16). 
4.5.6 Intervention 
The intervention was an educational outreach visit by the researcher to practice teams 
based on the principles of academic detailing (Thomson O'Brien et al. 2000c; Soumerai 
and Avorn 1990). The visit took place at the practice, lasted no longer than one hour and 
usually took place during a primary healthcare team meeting at which at least one general 
practitioner, practice nurse and practice manager but often the majority of the primary 
care team were present. The researcher acted as facilitator for the meeting, stating the 
ground rules, which included timing and confidentiality, and outlining the purpose and 
task of the meeting. The educational elements of this method were an initial assessment 
of the issues that were of interest to or difficulty for the practice team by generating a 
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dialogue around perceived barriers to vaccination within the organisation. Feedback of 
practice vaccination rates and comparison with other practices in the study and national 
targets was then provided. Following this there was a discussion about practice policy 
and methods for delivering the vaccination programme. A discussion around techniques 
employed to improve adult vaccination rates ensued with a summary of the evidence of 
effective interventions emphasising patient reminders and recall (Szilagyi et al. 2000), 
professional recommendation (Kyaw et al. 1999), reminder systems for practitioners 
(Austin et al. 1994), audit and feedback (Thomson O'Brien et al. 2000b) and emphasis on 
teamwork and a multifaceted approach. The aim was to provide reliable and unbiased 
information, presenting both sides of controversial issues, encouraging active learning, 
using simple overheads and graphs and emphasising the essential messages from the 
evidence on how to address specific barriers to improving immunisation rates. The 
educational session, whilst following academic detailing principles described above, 
sought to enable teams to identify barriers to change and begin to try and address these 
within their own practice. The role of the educational outreach was to try and facilitate 
this rather than to standardise the dialogue or impose an external set of solutions. There 
was ample opportunity for group discussion and interaction allowing the practice team to 
begin to think about how they might improve their immunisation programme. Both 
intervention and control practices also received written feedback of audit results 
comparing their performance with other participating practices together with written 
guidance for vaccination and recommendations for improvement. 
4.5.7 Repeat data collection 
The repeat data collection was carried out eight months after the baseline data collection 
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and six months after the educational outreach visit. Letters were sent to practices asking 
then to repeat the data collection (Appendices 17 and 18) and also asking them to provide 
data on what repeat or additional interventions had been used during their recent 
influenza and pneumococcal vaccination campaigns using a semistructured questionnaire 
format (Appendix 19). A single reminder letter was sufficient to collect data from all the 
participating practices (Appendix 20).  
4.5.8 Study outcomes 
The study outcomes were increase in vaccination rate by practice for those aged sixty-
five years and over, patients with coronary heart disease, diabetes and splenectomy, six 
months after the educational outreach visit. The groups were treated separately for the 
analysis although they were overlapping. Practices were also surveyed using a 
semistructured questionnaire to find out what existing and new strategies had been used 
to improve vaccination rates. 
4.5.9 Sample size 
Sample size was calculated with vaccination rate per practice as the primary outcome. 
Using preliminary data from the countywide multipractice audit of vaccination uptake 
conducted by Lincolnshire PCAG in 1998 control rates and standard deviations of these 
rates were estimated. In the audit, practices achieved an increase in uptake of 10% for 
influenza vaccination and over 20% for pneumococcal vaccination from a baseline of 
40%, in patients with coronary heart disease and diabetes with audit and feedback. An 
increase in vaccination uptake of 20% would move vaccination rates towards or above 
the government target of 60% from a baseline rate of 40%. To detect a difference 
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between control rates and the desired targets of at least one standard deviation using 
Student's t test with 80% power and 5% significance level would have required seventeen 
practices per group. With most of the comparisons being effects of at least 1.5 standard 
deviations would have required nine practices per group to detect differences between 
intervention and control groups with the same power.  
 
An alternative method would have been to calculate the power for a patient randomised 
controlled trial and adjust for clustering. This was because patients in clusters do not 
behave independently of one another. They tend to behave similarly owing to practice 
characteristics, some of which could be accounted for such as age-sex distribution or 
deprivation, but others which are less quantifiable such as the physical qualities of the 
practice (e.g. adequate car parking and access), type of healthcare workers employed (e.g. 
age, sex, training or skill-mix), or the type of patient attracted to the list (e.g. student 
populations for practices close to further education institutions) (Underwood et al. 1998). 
 
This method gave similar results to that of inflating the sample size for individual patients 
using an intracluster correlation coefficient. The intracluster coefficient was estimated at 
0.05 using data from a similar study and practice population (Yudkin and Moher 2001). 
Assuming an average cluster size of one hundred (diabetic patients per practice), baseline 
pneumococcal vaccination rate of 40%, effect size in the intervention group of 20% and 
an estimated intracluster correlation coefficient of 0.05 would give a sample size of 1200 
patients in 12 practices (Campbell et al. 2000b).  
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Fifteen practices for each of the intervention and control groups, i.e. thirty practices in 
total, were chosen as sufficient to achieve statistical power and to allow for dropouts. 
4.5.10 Statistical methods 
Data analysis was carried out using Egret and SPSS version 10 (Norusis 1990). Analysis 
was carried out at practice (cluster) level with outcomes expressed as proportions of 
patients in each risk group vaccinated before and after the intervention, mean 
improvement in vaccination rate and 95% confidence intervals for mean improvement. 
Analysis was also carried out at individual patient level using regression to account for 
clustering, baseline rates and stratification (Campbell et al. 2000c). Poisson regression 
was used to detect significant differences between intervention and control groups in 
vaccination rate change using population at risk as an offset and taking account of the 
stratification. Strata were included as fixed effects rather than as a random effect. 
Baseline rates were included as a covariate. Rates were expressed as mean vaccination 
rates, risk ratios and confidence intervals. The regression analysis was carried out with 
the help of an expert in statistics (Dr Michael Dewey, Senior Lecturer, Nottingham 
University and Deputy Director, Trent Institute).  
4.5.11 Ethical issues 
A number of ethical issues were considered in relation to the study design (Hutton 2001). 
Approval was required both from the University ethics committee and through the 
Multicentre Research Ethics Committees, the latter since it was anticipated that the study 
might involve practices in more than two counties. Consent was also required from 
general practitioners before enlisting their practice on the study. General practitioners 
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consented on behalf of their practice teams and patients for collection of anonymised 
routine vaccination and morbidity data, exposure to the educational intervention and 
additional data on how the practice changed as a result of the educational intervention. 
There was a small but definite risk of harm to patients in the intervention group from 
vaccine side effects due to increased influenza or pneumococcal vaccination rates. 
However, the vaccines and the risk groups targeted were those that were nationally 
recommended and patients were asked and able to give individual informed consent to 
vaccination. Practices who were randomised to the control group were not disadvantaged 
and were allowed to organise their vaccination programmes in whichever way they chose. 
They also had the benefit of national guidance, information sent with the study pack and 
feedback of anonymised data. Individual informed patient consent was explicitly stated as 
a prerequisite for vaccination but not for the study itself since this would not have 
affected care, except possibly in the case of intervention practices to improve the delivery 
of routine care. However this would have been in line with accepted medical practice and 
national guidelines. Patients were informed about the study using a poster in the waiting 
room. 
 
 Ethical approval was obtained for the study from Trent Multicentre Research Ethics 
Committee and De Montfort University School of Nursing and Midwifery Human 
Research Ethics Sub-Committee. Trent Focus Collaborative Research Network also 
approved the study. Consent from gained from the clinical governance leads, chief 
executives and chairs of both primary care groups and from individual general practices. 
The advice of an expert in statistics and research methodology was sought throughout the 
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study.  
4.6 Conclusion 
The studies described here broadly followed the framework of Campbell (Campbell et al. 
2000a). The stages described by Campbell included a preclinical or theoretical stage 
(literature review to develop a theoretical framework), a modelling phase (case studies, 
qualitative, descriptive, or survey studies), an exploratory trial (to define and develop the 
interventions and outcomes of interest) followed by a definitive randomised controlled 
study (to compare the intervention with a valid control group in an appropriately powered 
study).  
 
The methods used in the pilot study and the multipractice audits were more sensitive to 
individual practices preferences for how they might go about improving their vaccination 
rates compared to the use of an externally imposed educational intervention as in the 
randomised study. No account was taken of differences in practice preference to the 
educational outreach in the randomised study although it was assumed that practices, by 
consenting to participate, were by definition those that were more likely to accept this 
type of intervention. The effect of including practices that were less predisposed to this 
type of educational intervention, although such practices would have been randomly 
distributed in both the intervention and control arms, would have been to underestimate 
the benefits of the intervention (Black 1996). 
 
Issues of randomisation and confounding were addressed by the randomised controlled 
trial. The randomised study compared a control group (provided with audit and feedback) 
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with an intervention group given an educational intervention (which included audit and 
feedback) so that genuine uncertainty or equipoise existed in the study. The process of 
randomisation, after baseline stratification, allowed comparison between these groups 
with confounding factors likely to be equally distributed between the intervention and 
control group. However, Hawthorne effects may have operated to a greater extent in the 
intervention practices, since it was not possible for practices to be blinded (Prideaux 
2002a). Despite the debate around which methods are most appropriate designs for 
evaluating educational interventions the benefits of randomisation were that the 
hypothesis could be properly tested (Fitz-Gibbon 2002), minimising confounders, 
reducing the effect of secular trends (Torgerson 2002) and providing an estimate of the 
true effect of the educational intervention. 
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CHAPTER 5 RESULTS 
5.1 Pilot study: Feasibility study targeting influenza and pneumococcal 
vaccination to high-risk groups in a single general practice 
5.1.1 Questionnaire respondents 
551/747 (73.8%) patients who attended for influenza vaccination between September and 
the end of December 1996 (excluding nursing or residential home patients) returned 
completed questionnaires. This was a high response rate for patient surveys. 58.5% 
(321/549, data missing for 2 patients) of these were female. Most respondents, 67% 
(392/509, data missing for 42), were aged 65 or over. Most 90.6% (461/509, data missing 
for 42) were receiving repeat influenza vaccination. Only 4.5% of respondents (20/442, 
data missing for 10) stated that they had received pneumococcal vaccine previously. 
5.1.2 Risk groups 
Less than half the respondents (44.1%, 243/551) considered themselves to be in a high-
risk group. Table 14 shows the risk groups that vaccinees identified. 7% (38/551) 
considered themselves to be in two risk groups and 1% (6/551) identified themselves to 
be in three risk groups. An analysis of patient records of a randomly selected sample of 
respondents showed that more patients (50.9%, 55/108) were actually in a risk group than 
identified themselves as so in the questionnaire (46.3%, 50/108). Most patients, 71% 
(39/55), who were at risk were correct in identifying themselves to be in a risk group 
(Table 15). 
 175
Table 14 Risk groups identified by questionnaire respondents*
 
 
Risk group  
 
 
Number of 
patients 
n=551 
 
(%) 
   
Chronic lung disease 
 
106 (19.2) 
Angina/heart disease 
 
107 (19.4) 
Kidney disease 
 
8 (1.5) 
Liver disease 
 
0 (0) 
Diabetes 
 
45 (8.2) 
Spleen removed 
 
0 (0) 
Drugs that lower immunity 
 
21 (3.8) 
Chemotherapy/radiotherapy 
 
6 (1.1) 
 
 
 
* 44 patients identified more than one risk group and of these 6 patients ticked three risk groups. 
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Table 15 Patients perceptions of risk versus actual situation using a random sample 
of 108 patients taken from the questionnaire respondents 
  
 True risk (%): n = 108 
 Not at risk At risk 
 
Perceived risk: 
  
Not at risk  
 
50 §§§ 14 ***
3 ( ††† 41 ‡‡‡
 (46.3)§§§§§ (13.0)******
At risk 
 
2.8)†††††† (38.0)‡‡‡‡‡‡
 
 
roup 
gory 
were 
up (n=2) 
§§§§§§§§ Patient correctly identified themselves as not being in a risk g
********* Patient in a risk group but unaware that they were or did not tick a cate
††††††††† Patient not in a risk group but thought they 
‡‡‡‡‡‡‡‡‡ Patient correctly identified themselves to be in a risk group (n=39) or patient in a risk group but 
chose the incorrect gro
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Table 16 Sources of information stated by those who had heard about pneumococcal 
vaccine§§§§§§§§§
 
Source 
 
 
Number of 
patients 
n=133 
 
 
(%) 
   
General practitioner 
 
34 (26) 
Practice nurse 
 
14 (10) 
Hospital doctor 
 
1 (1) 
Relative 
 
14 (10) 
Friend 
 
21 (16) 
Newspaper/magazine 
 
30 (22) 
Television 
 
3 (2) 
Other 
 
9 (7) 
Not stated 
 
8 (6) 
 
er of §§§§§§§§§ This question allowed multiple responses, therefore the number of responses exceeds the numb
patients 
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5.1.3 Sources of information 
26.1% of respondents (133/509, data missing for 42) stated that they had heard of 
pneumococcal vaccine. Table 16 shows the sources that they had heard about it from. 
Thirteen patients had heard about it from two sources and three patients stated three 
sources. Most who had heard about the vaccine did so from a health professional, either 
their general practitioner or practice nurse (36%) but a significant proportion had heard 
about the vaccine from the media (24%) or a relative (10%).  
5.1.4 Questionnaire reliability 
By reliability is meant the degree to which patients responded in a consistent way to the 
attitude questionnaire. It was important to test whether the attitude questions were 
measuring broadly the same attitude, i.e. whether patients were positive (or negative) 
towards vaccines in general and pneumococcal vaccines in particular. 
 
The ten attitude statements consisted of five positive and five negative statements with 
responses ranging from “strongly agree” to “strongly disagree” in a five-point Likert type 
scale, giving 1 (strongly agree), 2 (agree) and so on up to 5 (strongly disagree), with 0 for 
no response. Scoring was reversed for positive statements so that a high score always 
meant a positive attitude to guidelines with one indicating a negative attitude and five a 
positive attitude. Mean scores showing the overall attitude among respondents towards 
guidelines for each statement were calculated (see Table 17).  
 
Reliability analysis was completed using SPSSPC version 10 (Norusis 1990). Even 
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though scores were derived from ordinal scales and distributions were not normal 
parametric tests are routinely applied to such data (Bryman and Cramer 1999). Pearson 
product moment correlation coefficients between items are shown (see Table 18). Most of 
the correlations were very low (up to 0.19) or low (0.2 to 0.39) with the strongest being 
only modest (0.4 to 0.69) at 0.57 and none high (0.70 to 0.89) or very high (0.9 to 1.0) 
(Cohen and Holliday 1982). 
 
The items with the smallest correlation compared with other items were Q8, “I am 
worried about the side effects of vaccination”, with correlation coefficients less than 0.1 
for 7 items and including 4 negative correlations, Q5, “I would say overall that I am 
unwell”, with correlation coefficients less than 0.1 for 6 items and including 4 negative 
correlations and Q2, “I do not believe in prevention”, with correlation coefficients less 
than 0.1 for 5 items and including 2 negative correlations.  
 
The covariance matrix (see Table 19) showed how individual items tended to move or 
vary with each other and confirmed a similar pattern of association between responses to 
the correlation matrix.  
 
The relationship between attitude statements was further evaluated (see Table 20). The 
column labelled ‘Corrected item-total correlation’ shows the correlation between scores 
for individual items with the sum of the scores on all the other items, using the Pearson 
correlation coefficient. The items with the lowest correlations were Q2, “I do not believe 
in prevention,” (0.1350), Q5, “I would say overall that I am unwell,” (0.1202) and 
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particularly Q8, “I am worried about the side effects of vaccination,” (0.0009) confirming 
the poorer relationship between these and the other items. Conversely, Q3 (“I am worried 
about getting chest infections”), Q4 (“I feel that I would like pneumococcal vaccination”) 
and Q7 (“I don’t think that I need pneumococcal vaccination”) had the highest 
correlations of 0.3521, 0.4779 and 0.4718 respectively. It is important to reiterate that 
positive and negative statements were positively correlated because the scoring was 
reversed for positive statements. 
 
The internal consistency of attitude responses (again with positive statements recoded) 
was calculated. Cronbach’s alpha was 0.55. The standardised item alpha, which is the 
value of α when all items are standardised to have a variance of 1 was 0.56. The 
moderate degree of consistency between the elements showed a satisfactory but not high 
level of test-retest reliability for this questionnaire. This showed that the questionnaire 
may have been adequate for assessing attitudes in general but could not be used to clearly 
discriminate between respondent types, such as those who were positive or negative 
towards vaccination. 
 
Alpha if item deleted (see Table 20) showed little change in Cronbach’s alpha for the 
combined statements when any of the items was excluded indicating that omitting any of 
the statements would not appreciably alter the reliability of the attitude questionnaire as a 
whole. The slight increase in α when Q2, Q5 and Q8 were deleted reflected the poorer 
correlation of these statements with respondents’ attitudes towards guidelines. 
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Table 17 Coding system for attitude statements 
 
Code 
 
Attitude statement 
 
  
 Q1  SAFE I think that vaccinations are generally safe 
 Q2  EFFECTS I am worried about the side effects of vaccination 
 Q3  PREVENT Prevention is better than cure 
 Q4  BELIEVE I do not believe in prevention 
 Q5  NOCOLDS I never get colds or chest infections 
 Q6  CHESTINF I am worried about getting chest infections 
 Q7  HEALTHY I believe that I am a healthy person 
 Q8  UNWELL I would say overall that I am unwell 
 Q9  LIKEPN I feel that I would like pneumococcal vaccination 
 Q10 NONEED I don’t think that I need pneumococcal vaccination 
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Table 18 Correlation matrix for attitude statements**********
 
m 
 I need 
 
         SAFE  BELIEVE  CHESTINF LIKEPN  UNWELL 
 
SAFE       1.0000 
BELIEVE   .1214  1.0000 
CHESTINF  .1041  .0184   1.0000 
LIKEPN    .1386  .0861   .4823    1.0000 
UNWELL    .0357  -.2095  .2061    .1752     1.0000 
PREVENT   .1147  .1859   .0955    .1678     -.0853 
NONEED    .1706  .2900   .2482    .4670     -.0152 
EFFECTS   .1056  .0826   -.1492   -.0653    -.1259 
HEALTHY   .0754  -.0409  .1882    .1720     .5699 
NOCOLDS   .0545  .1213   .2411    .2427     -.0289 
 
 
         PREVENT  NONEED  EFFECTS  HEALTHY  NOCOLDS 
 
PREVENT    1.0000 
NONEED    .2859   1.0000 
EFFECTS   .1432   .0497    1.0000 
HEALTHY   .0291   .1467    .0491     1.0000 
NOCOLDS   -.0452  .2333    -.0215    .0420   1.0000 
 
 
 
********** Coding key: - SAFE: I think that vaccinations are generally safe; EFFECTS: I am worried about 
the side effects of vaccination; PREVENT: Prevention is better than cure; BELIEVE: I do not believe in 
prevention; NOCOLDS: I never get colds or chest infections; CHESTINF: I am worried about getting chest 
infections; HEALTHY: I believe that I am a healthy person; UNWELL: I would say overall that I a
unwell; LIKEPN: I feel that I would like pneumococcal vaccination; NONEED: I don’t think that
pneumococcal vaccination (from Table 17). 
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Table 19 Covariance matrix for responses to attitude statements††††††††††
 
m 
 I need 
 
      SAFE  BELIEVE  CHESTINF LIKEPN  UNWELL 
SAFE     .5182 
BELIEVE    .1215  1.9325 
CHESTINF    .0848  .0290   1.2817 
LIKEPN    .1020  .1224   .5585   1.0461 
UNWELL    .0292  -.3311  .2652   .2037    1.2919 
PREVENT    .0608  .1903   .0796   .1264    -.0714 
NONEED    .1369  .4497   .3134   .5327    -.0193 
EFFECTS    .0779  .1176   -.1730  -.0684   -.1466 
HEALTHY    .0599  -.0627  .2352  .1942     .7149 
NOCOLDS    .0415  .1783   .2885   .2625    -.0348 
 
 
      PREVENT  NONEED  EFFECTS  HEALTHY  NOCOLDS 
 
PREVENT     .5422 
NONEED    .2348   1.2439 
EFFECTS    .1080   .0567    1.0494 
HEALTHY    .0237   .1806    .0555   1.2178 
NOCOLDS    -.0352  .2751    -.0233   .0490   1.1178 
 
 
†††††††††† Coding key: - SAFE: I think that vaccinations are generally safe; EFFECTS: I am worried about 
the side effects of vaccination; PREVENT: Prevention is better than cure; BELIEVE: I do not believe in 
prevention; NOCOLDS: I never get colds or chest infections; CHESTINF: I am worried about getting chest 
infections; HEALTHY: I believe that I am a healthy person; UNWELL: I would say overall that I a
unwell; LIKEPN: I feel that I would like pneumococcal vaccination; NONEED: I don’t think that
pneumococcal vaccination (from Table 17). 
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Table 20 Item-total statistics for pilot study‡‡‡‡‡‡‡‡‡‡
 Scale mean 
if item 
deleted 
Scale 
variance if 
item 
deleted 
Corrected 
item-total 
correlation
Squared 
multiple 
correlation 
Alpha if 
item 
deleted 
      
Q1 SAFE    32.9957   20.4826   .2194    .0572    .5360 
Q2 BELIEVE  33.4026 18.8676   .1350    .1465 .5699 
Q3 CHESTINF 33.3853   17.7857   .3521    .2853    .4950 
Q4 LIKEPN   33.4329   17.3161   .4779    .3812    .4626 
Q5 UNWELL   34.6407   19.9182   .1202    .4045    .5630 
Q6 PREVENT  32.7403   20.4540   .2153    .1377    .5365 
Q7 NONEED   33.7706   16.8645   .4718    .3401    .4581 
Q8 EFFECTS  33.8961   21.3718   .0009    .0865    .5885 
Q9 HEALTHY  34.4848   18.3117   .3071    .3665    .5092 
Q10NOCOLDS  33.4459   19.3090   .2156    .1253    .5352 
 
 
 
 
m 
 I need 
‡‡‡‡‡‡‡‡‡‡ Coding key: - SAFE: I think that vaccinations are generally safe; EFFECTS: I am worried about 
the side effects of vaccination; PREVENT: Prevention is better than cure; BELIEVE: I do not believe in 
prevention; NOCOLDS: I never get colds or chest infections; CHESTINF: I am worried about getting chest 
infections; HEALTHY: I believe that I am a healthy person; UNWELL: I would say overall that I a
unwell; LIKEPN: I feel that I would like pneumococcal vaccination; NONEED: I don’t think that
pneumococcal vaccination (from Table 17). 
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5.1.5 Questionnaire validity  
By validity is meant the extent to which the questionnaire measured what it purported to. 
Responses to each attitude statement pair were tabulated (see Table 21). Mean scores 
showed the extent to which respondents were positive in their attitude towards guidelines, 
a score greater than three indicating a positive attitude overall. Responses were also 
represented graphically (Figures 10-12). The shape of the graphs and degree and direction 
of skewness showed the level of agreement with a particular statement. There was the 
expected inverse relationship for some question pairs (see Figures 10 and 11) but an 
equivocal pattern of response for others (see Figure 12). 
 
There was certainly a diversity of opinions expressed with the proportion of “strongly 
agree” and “strongly disagree” responses varying considerably. “Strongly agree” 
responses varied from 3 to 70 per cent and “strongly disagree” from 1 to 49 percent. 
Similarly the proportion of “neutral” responses varied from 4 to 42 per cent. It was 
inevitable with the number of questionnaires returned and the usual reluctance to use the 
extremes of the scale, sometimes referred to as central tendency or end-aversion, that 
some respondents would not always identify strongly with the statement or its opposite 
pair. 
 
Most patients responded to all the individual attitude statements implying that none of the 
statements were poorly understood and establishing the face validity of the questionnaire. 
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Table 21 Attitude score for patients responding to questionnaire 
  
Number (%) of patients responding 
N=551 
 
 
Attitude statement 
 
Agree or 
strongly 
agree 
 
Neutral 
 
Disagree or 
strongly 
disagree 
 
Mean 
score* 
 
1. I think that vaccinations 
are generally safe 
 
 
517 (93.8) 
 
 24 (4.8) 
 
 7 (1.3) 
 
4.4 
2. I do not believe in 
prevention 
 
 93 (16.9)  62 (11.3) 379 (68.8) 3.9 
3. I am worried about 
getting chest infections 
 
297 (53.9) 125 (22.7) 117 (21.2) 3.6 
4. I feel that I would like 
pneumococcal 
vaccination 
 
258 (46.8) 203 (36.8)  77 (14.0) 3.6 
5. I would say that overall I 
am unwell 
 
 94 (17.1) 113 (20.5) 334 (60.6) 2.4 
6. Prevention is better that 
cure 
 
503 (91.3)  25 (4.5)  18 (3.3) 4.6 
7. I don’t think that I need 
pneumococcal 
vaccination 
 
113 (20.5) 229 (41.6) 191 (34.7) 3.3 
8. I am worried about the 
side effects of 
vaccination 
 
 77 (14.0)  161 (29.2) 297 (53.9) 3.6 
9. I believe that I am a 
healthy person 
 
325 (59.0) 117 (21.2) 101 (18.3) 2.5 
10. I never get colds or chest 
infections 
 
 92 (16.7)  92 (16.7) 354 (64.2) 3.7 
*Positive statements i.e. those more likely to encourage vaccination were recoded so that a high score 
means a generally positive attitude towards vaccination, a score of three is neutral and a score less than 
three signifies an negative attitude overall 
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Figure 10 Graphs showing responses to attitude statement pairs on safety and 
prevention 
Safety 
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            Q8 I am worried about the side ef fects of  vaccination
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Figure 11 Graphs showing responses to attitude statement pairs on susceptibility to 
infection and general health 
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 Figure 12 Graph showing responses to attitude statement expressed preference for 
pneumococcal vaccination 
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There were very few amendments, deletions or additional comments quibbling with the 
statements demonstrating a good content validity. By measuring the correlation between 
n individual patients response and their expressed preference for pneumococcal vaccine 
it was possible to assess the construct validity of the questionnaire since patients who say 
they will accept the vaccine are more likely to do so.  
 
As there was no other validated instrument for measuring patient attitudes towards 
vaccination there was no way of comparing the results with another accepted measure or 
confirming the criterion validity of the attitude questionnaire. 
 
Attitudes to vaccination were generally positive. Positive statements, that is those more 
likely to encourage vaccination, were recoded so that a score greater than three meant a 
generally positive attitude, a score of three neutral and a score less than three signified an 
overall negative attitude towards vaccination. Responses to each attitude statement and 
ean scores were shown in Table 21. Patients who identified themselves to be in a risk 
roup were significantly more likely to have a positive attitude towards vaccinations than 
ose who did not recognise themselves to be in a risk group (total score 32.9 vs. 36.8; 
ruskal-Wallis H = 72.1, 1 degree of freedom (df), p<0.000). Patients who stated that 
ey had previously heard about pneumococcal vaccination were also more positive 
wards vaccination (total score 36.9 vs. 34.0; Kruskal-Wallis H = 28.2, 1 df, p = 
.000000). Patients who identified themselves to be in an at-risk group were significantly 
ore like to agree or strongly agree that they would like pneumococcal vaccine than 
ose who did not (145/238 [60.9%] versus 113/300 [37.7%]; χ2 = 46.1, 4 df, p = 0.000). 
a
m
g
th
K
th
to
0
m
th
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As one would expect patients who had already received pneumococcal vaccine were 
significantly more significantly more like to agree or strongly agree that they would 
accept pneumococcal vaccine than those who had not (16/19[84.2%] versus 198/418 
[47.4%]; χ2 = 12.1, 4 df, p = 0.017). 
 
A targeted vaccination campaign over one year resulted in the following proportions of 
patients in at risk groups being vaccinated with pneumococcal vaccine (Table 9): 
coronary disease 144/312 (46%), diabetes 79/132 (60%), splenectomy 2/2 (100%), 
hronic obstructive airways disease and asthma 135/700 (19%), chronic renal failure 5/9 c
(56%). Baseline rates for influenza vaccine were higher than for pneumococcal 
vaccination because of the existing annual influenza vaccination programme but these 
also increased in the first year of the pilot study.  
 
Most doses of pneumococcal vaccine 336/463 (73%) were delivered to patients in high-
risk groups. This figure increased to 365/463 (79%) when nursing home patients without 
other risk factors were included. 
 
Vaccination rates for pneumococcal and influenza vaccination continued to rise in 
subsequent years with the continued implementation of the systems that had been set up 
as part of this study (Table 22 and 23). 
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Table 22 Pneumococcal vaccine uptake, Minster Practice 1997-1999 
Criteria Standards 1997  1998  1999 
n (%) n (%) n (%) 
   
Coronary disease 60 16/276 (6) 144/312 (46) 148/279 (53)
Diabetes 60 13/124 (10)  79/132 (60) 96/146 (66)
Splenectomy 100 1/2 (50)  2/2 (100) 2/2 (100)
COAD/Chronic asthma 60 13/647 (2) 135/700 (19) 126/419 (31)
Chronic renal failure 60 0/7  (0)  5/9  (56) 9/13 (69)
 
 
Table 23 Influenza vaccine uptake, Minster Practice 1997-1999 
Criteria Standards 1997 
n (%) 
1998 
n (%) 
1999 
n (%) 
   
Coronary disease  60 142/276 (51) 191/312 (61) 179/279 (64)
Diabetes     60  71/124 (57)  86/132 (65) 92/146 (63)
Splenectomy   100  2/2  (100)  2/2  (100) 2/2 (100)
COAD/Chronic asthma 60 158/647 (24) 187/700 (27) 168/419 (40)
Chronic renal failure  60  4/7  (57)  7/9  (78) 11/13 (85)
Over 75s 60 (53) (59)
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5.1.6 Lessons from the pilot study 
The pilot study laid the groundwork for the subsequent multip t
randomised controlled trial. The pilot pr
s but was excluded from ised dy.
 research methodology hich ucati eval
f the practice team the patie were in e chan
ot study  three m nen ion
rates and ded in th  a pract rv
prove vaccination rates in high-risk patients. There were a number of important issues 
nd lessons learnt from the pilot study that impacted on the subsequent investigations and 
theoretical framework for this thesis. 
 
The cross-sectional survey in patients attending for influenza vaccination provided an 
assessment of patients’ knowledge and beliefs about influenza and pneumococcal 
 were a num of ke h arised here and 
elow. Many patien spond ur aw  
articularly pneu If t eard  
dge had lly co ar t  
ce of know ge. Patien re pos ccin t 
s to be at increased ris m respiratory infections were  likely to a t 
eumococcal vaccination in addition to influenza vaccination.  
 
The audit of vaccination rates together with a combination of organisational changes was 
ractice audit s udies and 
actice was subsequently included in the 
multipractice audit the random  controlled stu  It employed 
an action , w included ed on, change, uation, and 
involvement o  and nts who volved in th ge (Hart 
and Bond 1995). The pil  had ain compo ts, a cross sect al survey, an 
audit of vaccination inclu e latter ice based inte ention to 
im
a
vaccination. There ber y findings, w ich are summ
expanded b ts re ing to the s vey were un are of these
vaccinations, p mococcal vaccination. hey had h about the
vaccination, this knowle usua me from prim y care staff, bu the media was
also an important sour led ts who we itive to va ation or fel
themselve k fro  more ccep
pn
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successful in improving vaccination rates. The changes were directed at increasing 
practitioners’ and patients’ awareness and knowledge of vaccines, reminders for frontline 
clinical staff, a team approach, together with audit and feedback of performance. 
 
The questionnaire had a high response rate for this type of survey of 73.8%. Factors that 
may have helped to increase the response rate included the fact that it was from the 
general practitioner and that the questionnaire was handed to eligible patients by the 
practice reception or clinical staff (Smith et al. 1985). The high response rate would in 
itself have helped to reduce bias (Goudy 1976). However, the chosen sampling frame and 
the use of a self-completion questionnaire may have led to a number of biases. The 
sampling frame was chosen to include all patients who received influenza vaccination in 
the autumn of the pilot study since these patients should also have been eligible for 
pneumococcal vaccination. It was expected that these patients would be more positive to 
vaccination, by virtue of already accepting one, than the general population. This 
included patients who received the vaccine at the surgery or at home but would have 
excluded patients who refused influenza vaccine. Therefore patients in the sample would 
have been more positive to vaccination than all those eligible for influenza vaccination.  
 
Risk groups for influenza and pneumococcal vaccination were virtually identical at the 
time of the pilot study except for the recommendation to immunise residential, nursing 
home and other patients in long stay institutions. Institutionalised patients were therefore 
excluded from the survey although a number of these patients may have been eligible for 
pneumococcal vaccination by virtue of being in a risk group. It is difficult to predict 
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whether these patients would have been more or less positive in their attitudes to 
vaccinations, although there is a notion that the elderly tend to be more accepting of 
medical advice in general and vaccine recommendations in particular.  
 
That there was a degree of bias towards more positive attitudes to vaccination in the 
sample was reflected in the high degree of agreement with attitude statements related to 
prevention and vaccine safety. However, this sampling strategy was adopted precisely 
because these patients were more likely to accept vaccination. Thus, although the results 
may not have been generalisable to the whole practice population they were apposite to 
the group that were most likely to accept pneumococcal vaccination and who we intended 
to target. Other possible sources of bias include respondent bias related to ability to read 
and write. Prestige or social desirability bias and acquiescent bias were taken in to 
account by the use of a balanced questionnaire. Limited resources precluded an analysis 
of non-responders although this would have been desirable (Lydeard 1991). 
 
Overall, about half the patients receiving influenza vaccination were in a risk group, 
mostly chronic chest or heart disease and diabetes, and so were eligible for pneumococcal 
accination. Although one could argue that this shows that the practice policy for v
influenza vaccination did not fit well with Department of Health guidance (Department of 
Health 1997) at the time it may also have reflected practical problems with the guidelines. 
Although influenza vaccination was recommended for those with specific medical 
indications and institutionalised patients there was evidence at that time supporting a 
policy of vaccinating all patients aged over sixty-five (NHS Centre for Reviews and 
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Dissemination 1996) and research from the United States demonstrating the vaccine’s 
cost-effectiveness even in healthy adults (Nichol et al. 1995). In the United States 
Medicare had been funding influenza vaccine for all patients over sixty-five years and 
ad demonstrated this to be a cost-effective use of resources (Nichol et al. 1994). Experts 
chronic heart 
isease, diabetes, splenectomy (absent spleen), chronic renal disease, chronic liver 
h
in the United Kingdom were also arguing for a change to an age based policy around this 
time (DiGuiseppi 1996). General practitioners, although positive in their attitudes to 
guidelines in general, were also concerned that guidelines might stifle innovation and 
preferred to use them flexibly to suit the needs of patients in line with changing evidence 
(Siriwardena 1995). With the considerable financial penalties for practices that purchased 
but did not use vaccine there was justifiable scope for more lax interpretation of the 
guidelines based on the evidence.  
 
However, almost half (49.1%, n=551) of the patients from a random sample undergoing 
influenza vaccination in this study did not fall into a high-risk group such as 
d
disease, immune system suppression or institutionalisation. Similar results had been 
found contemporaneously in Gwent (South Wales), with a quarter of all influenza vaccine 
doses being given to patients at low risk as defined at the time (Watkins 1997). If 
pneumococcal vaccination had been offered to all patients receiving influenza vaccine 
then half of these patients would have been inappropriately immunised. As well as being 
medically unjustified this would waste valuable resources of medical time and vaccine.  
 
Attitude towards vaccination, self-identification as high-risk and intention to be 
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immunised had been shown in previous studies to predict subsequent vaccine uptake. 
Subgroup analysis of responses in the pilot study showed that patients in at-risk groups 
did indeed have more positive attitudes to vaccination and in particular pneumococcal 
vaccination than those who were not in a risk group. Patients with more positive attitudes 
to vaccination and preventive health were more likely to agree to have pneumococcal 
vaccination than those who were not in a risk group. As the majority of patients in a 
random sample (79%, n=108) were also good at identifying whether they were at risk the 
notion of targeting patients who were being immunised for influenza appeared to be a 
good method for getting initial coverage of pneumococcal vaccination. This was 
subsequently used as an effective element of our strategy for improving pneumococcal 
vaccination rates. The downside of this approach was that a proportion of patients (21%, 
=108) were unable to identify whether they were in a risk group and would have 
  
n
inadvertently received or overlooked the vaccine unless other methods to inform them or 
prevent inappropriate vaccination were used. 
 
The guidelines for pneumococcal vaccination at the time of the pilot study recommended 
vaccination at routine consultations, after discharge from hospital and when immunising 
against influenza vaccination. The pilot study integrated and built on this approach as a 
method of targeting influenza and pneumococcal vaccination to patients in high-risk 
groups in the practice. National guidelines changed significantly during the course of the 
subsequent research and this presented a number of problems that will be addressed later.
 
Studies had also shown that recommendation for vaccination by a health worker was a 
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key factor that influenced uptake (Centers for Disease Control and Prevention 1988). 
Agreeing a practice policy had also been shown to improve vaccination rates. We found 
the development of a practice guideline to be a useful educational tool for practice staff 
and enabled a clear and consistent message to be given by doctors, nurses and reception 
staff recommending vaccination to suitable patients. A poster display all year round for 
pneumococcal vaccine and expanded to include influenza vaccine to coincide with the 
winter influenza campaign was used to increased patient awareness and encourage uptake 
of the vaccines. Vaccination reminders on records, prescriptions or appointment lists 
were other methods that could have been but were not in the pilot. 
 
The difficulties that were encountered in running this type of programme were similar to 
those for running any successful immunisation programme. These included identifying 
and targeting eligible patients, which required a good, preferably computerised, chronic 
disease register. Correctly estimating vaccine requirements, good stock control and 
torage of vaccines were found to be vital. Nursing and medical time to inform patients 
e practice.  
s
and vaccinate and opportunity costs required good organisation of available nursing time 
and sufficient nursing hours to provide such a programme. On the plus side the 
vaccination programme demonstrated good risk management, particularly in vaccinating 
patients with an absent spleen who were at high-risk of serious complications from 
pneumococcal infection, improved preventive care through higher vaccine rates for other 
high-risk patients in accordance with current recommendations and generated income for 
th
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Clinical audit of immunisation rates proved to be an effective and acceptable component 
of monitoring and improving vaccine uptake. The audit of immunisation rates conducted 
in this study showed a good uptake in high-risk groups but would have tended to 
overestimate uptake because of denominator deficiencies. The pilot study helped to 
develop a sound audit methodology, which would be used as a component of the later 
studies. The other aspect of the process of health care delivery that improved as a result 
of the pilot project was teamwork. Although it appeared that teamwork improved in 
general, it particularly improved in respect of the influenza and pneumococcal 
vaccination programme. Various elements of the change management process benefited 
amwork in the organisation. The discussions of practice policies with all the staff at 
ring and encouraging performance. These lessons were applied to the later 
tudies. 
te
primary health care meetings improved input into and ownership of the practice policies, 
guidelines and operational matters relating to influenza and pneumococcal vaccination. 
Clinical staff were also clear about their own responsibilities in delivering the vaccination 
programme.  
 
In summary the pilot study, including the patient questionnaire, demonstrated the 
importance of promoting awareness of influenza and pneumococcal vaccination through 
poster and media campaigns, leaflets and prescription reminders, recommendation from a 
doctor or nurse and encouraging pneumococcal vaccination during the influenza 
campaign. Patients were good at identifying whether they were at risk. A team approach 
with excellent organisation was important with audit and benchmarking being a good 
way of monito
s
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5.2 Lincolnshire-wide multipractice study: multipractice audit to assess 
influenza and pneumococcal vaccination uptake in high-risk groups 
5.2.1 Participating practices  
Twenty-one practices took part in both phases for diabetes and fourteen of these for 
coronary heart disease and splenectomy. All the practices that undertook the baseline 
assessment completed both phases but a number of practices joined for the second phase. 
Although a number of practices joined the audit at the re-evaluation phase these were not 
included in the analysis. Practices who participated in both phases of the audit were 
reflective of practices across Lincolnshire in terms of partnership and list size (Table 24).  
5.2.2 Presentation of data  
Practice performance was compared with standards that practices set themselves 
(expressed as a median standard in Table 25). A paired t-test was used to compare mean 
accination rates between the two phases and assess improvement in performance. v
Improvements in vaccination uptake occurred in coronary heart disease, diabetic and 
splenectomy patients for both vaccinations (Table 25). 
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Table 24 Lincolnshire wide multipractice study: characteristics of practices 
Char
practices n (%) 
(n=22) 
practices n (%)  
 (n=105) 
p value
participating (in both phases of audit) compared to all Lincolnshire practices 
acteristics Number Participating All Lincolnshire χ2 
     
List size <3000 
 
5 (23) 22 (21)  
 3000-6000
 
10 (45) 33 (31)  
 6001-9000
 
5 (23) 32 (30) 0.53 
2 (9) 18 (17)  
 7-11 0 8 (8)  
 >9000 
 
Number of partners 1-3 
 
16 (73) 63 (60)  
 4-6 
 
6 (27) 34 (32) 0.32 
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Table 25 Lincolnshire wide multipractice study: vaccination uptake 
cine and risk Vaccination   Vac
grou
 
p uptake 
(Nu
practices) 
Pha
% 
(Range: 
min, 
max) 
s
%
(Ran
min
max) 
 
hase 1, 
hase 2) 
 CI) 
ignificance 
lue, 2-
tailed t-test) 
mber of se 1 Pha e 2 
 
Median
Standard 
ge: 
, 
(P
P
Mean 
improvement 
(95%
S
(p va
      
Influenza vaccine 
uptake in CHD 
(n=14) 
63.6 
(30,87) 
74.4 
(38,100) 
80, 80 10.8 (5.3 to 16.1) 0.001 
    
Pneumococcal 
vaccine uptake in 
CHD (n=14) 
31.1 
(1,74) 
58.6 
(16,89) 
68, 75 27.5 (12.6 to 42.3) 0.002 
    
Influenza vaccine 
uptake in diabetes 
(n=21) 
62.1 
(43,88) 
70.6 
(50,100) 
80,80 8.6 (1.5 to 15.7) 0.02 
     
Pneumococcal 
vaccine uptake in 
diabetes (n=21) 
35.2 
(0,76) 
64.0 
(5,100) 
75, 80 28.8 (17.2 to 40.3) <0.001 
     
Influenza vaccine 
uptake for 
splenectomy 
patients (n=14) 
66.1 
(20,100) 
83.4 
(43,100) 
90,100 17.3 (4.8 to 29.8) 0.01 
      
Pneumococcal 
vaccine uptake for 
splenectomy 
patients (n=14) 
 
79.6 
(33,100) 
95.6 
(67,100) 
95,100 15.9 (1.8 to 30.1) 0.03 
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Table 26 Lincolnshire wide multipractice study: organisational strategies used by 
prove  pneumococcal vaccination at baseline 
onse (n=21) 
practices to im
 
 influenza and
Practice resp
Organisational strateg No y Yes 
 n % n % 
Did you discuss the inf n m ary care 
team last year? 
 1 (5)luenza vacci ation program e in your prim 19  (90) §§§§§§§§§§
Did you discuss the pneu l vac  progr r primary care 
team last year? 
15 (71) 5 (24) 
Do you have practice guideli es for influenza vaccination? (90) 1 (5) 
ce gu r l vac (19) 
ou have a dedicated vaccine refrigerator? 
 
17 (81) 3 (14) 
ne refriger e an i mom (10) 
ient r n s  17 (81) 3 (14) 
Do you purchase vaccine fro  your suppl s at a discount (95) 0 (0) 
od f nt es? (0) 
ou conduct dedicated clinics for influenza vaccination? 19 (90) 1 (5) 
t dedicated  for pn occal va  (57) 
imul dm of influenza and pneumococcal 
 
19 (90) 0 (0) 
 your practice team ke influ ococ  
Doctors 17 (81) 3 (14) 
Practice nurses 18 (86) 2 (10) 
District nurses 20 95) 0 (0) 
Health visitor (10) 18 (86) 
 
computeri ase (m y) regis (14) 
19 (90) 1 (5) 
puter prescription reminders for vaccinations? 
 
11 (52) 9 (43) 
id you have a poster campaign for influenza vaccination last year? 19 (90) 1 (5) 
Do you contact and liase with nursing homes regarding winter vaccinations?
  
 
20 (95) 0 (0) 
Do you provide printed advice about vaccination e.g. side effects? 
 
11 (52) 9 (43) 
Do you use call and recall letters for influenza or pneumococcal vaccination? 
 
7 (33) 13 (62) 
Have you audited the success of uptake of influenza or pneumococcal 7 (33) 13 (62) 
mococca cination amme in you
n  
 
Do you have practi
 
Do y
19
idelines fo pneumococca cination? 16 (76) 4 
Does this vacci
 
Do you have suffic
 
ator hav n-built ther eter? 18 (86) 2 
efrigeratio pace for your needs?
m ier ? 
 
Do you have a meth
 
Do y
 
20
o or stock c ro cinl of vac 20 (95) 0 
Do you conduc
 
Do you undertake s
vaccine when appropriate?
 
 clinics eumoc ccination? 8 (38) 12 
taneous a inistration 
Which members of
vaccination: 
underta enza/pneum cal    
2 
Do you have a 
 
Do you have a computeri
 
Do you use com
sed dise orbidit ter? 17 (81) 3 
sed vaccine register? 
D
 
 
§§§§§§§§§§ Missing data accounts for percentages not adding up to 100. 
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vaccination in at risk groups before? 
Figure 13 Lincolnshire wide multipractice study: methods used by participating 
general practices to increase influenza and pneumococcal vaccination rates 
lene  o  high-
ination status. 
mputer records so all staff have instant 
isplay posters prominently in reception area before vaccination programme. 
 reception area. 
formation promoting vaccinations to repeat prescriptions. 
Target letters to high-risk patients. 
Offer open clinics for vaccinations. 
 PHCT m t n Introduce 
ccination of high-risk patients. 
ns. 
Registers 
Develop accurate registers for coronary disease, diabetes, sp ctomy and ther
risk groups. 
Check vaccination status at new patient medicals. 
Maintain records and registers of vacc
Keep manual records of vaccination as well as co
access to data. 
 
Patient reminders 
D
Information leaflets in
Attached in
 
Practitioner protocols and reminders 
Increase staff awareness within the practice i.e. keep on ee ing age da. 
protocols for va
Use reminders on computer screens to prompt clinicia
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5.2.3 Effect of change 
Participating practices used a range of techniques to improve immunisation rates at the 
of the study (Table 26). Whereas most practices discussed their influenza 
eir 
lthcare teams fewer practices addressed the issue of pneumococcal 
 dedicated clinics for pneumococcal 
puterised vaccine register and the 
 
 awareness and liased with nursing homes to vaccinate institutionalised 
atients fewer used prescription reminders or call and recall letters. Despite practices 
 vaccine registers few practices had undertaken an audit of influenza 
as used to 
curred in practices as a result of the audit. These 
(Figure 13).  
5.2.4 Implications of the countywide multipractice audit 
ch took the form of a quality improvement study 
 audit, feedback and written advice on 
tial and significant changes in 
accination rates. The audit demonstrated that practices could achieve influenza and 
pneumococcal vaccination rates for disease-specific risk groups comparable to current 
beginning 
vaccination programme and had practice guidelines for influenza immunisation with th
primary hea
vaccination. This was reflected in the lack of
vaccination. Most participating practices had a com
majority also had disease registers. Although most practices used poster campaigns to
increase patient
p
stating that they had
or pneumococcal vaccination rates. A semistructured postal questionnaire w
survey organisational changes that oc
examples of good practice were shared with other primary care teams 
 
The countywide multipractice audit, whi
(Moss and Thompson 1999), showed improvements in influenza and pneumococcal 
vaccination uptake in high-risk groups using
strategies for organisational change. There were substan
v
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national targets for influenza vaccination. The study also showed that practices were able 
to demonstrate improvement in outcomes rather than process. 
 
This was a multipractice audit in volunteer practices. For diabetes, one-fifth of the 
practices in Lincolnshire participated in both cycles. Although it was disappointing that 
more practices did not participate, and that those who did were likely to be more 
motivated to change, the level of uptake was not surprising given previous participation 
rates in countywide multipractice audits and other demands in the health service at the 
time. The data were independently analysed but relied on information sent by practices. 
Although anonymity of practice and patient was preserved there was a possibility of bias. 
We could not account for secular trends. The analysis demonstrated the capability and 
extent to which participating practices were able to improve performance with the aid of 
audit, feedback and written advice. Although practices did not achieve the median 
standards that they set they did exceed national targets for influenza vaccination and 
achieved comparable levels of pneumococcal vaccination.  
 
s was a finding that invited The improvement in vaccine uptake in the high-risk group
further analysis. In particular, it was clear that the audit methodology and feedback of 
anonymised vaccination rates to practices was welcomed by participating practices. Only 
a third of the practices had undertaken an audit of influenza or pneumococcal vaccination 
previously. It was clear from the organisational strategies that practices stated that they 
used at baseline and after the first phase of the audit that there were opportunities to 
employ additional interventions that had been shown in previous studies to increase 
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vaccination rates. Despite the considerable efforts to increase influenza and 
pneumococcal vaccination rates many patients remained unvaccinated at the end of the 
ampaign for many of the reasons discussed above (see 3.5 to 3.8).  c
 
It was not clear to what extent factors known to promote vaccine uptake had been 
promoted by individual practices although the semistructured survey showed that 
practices had implemented change as a result of the project. Practices were encouraged to 
promote increased knowledge of the vaccine and positive attitudes to vaccination through 
various methods including recommendation from a general practitioner, all of which were 
known to be good predictors of vaccination uptake. Although practices did claim to use a 
variety of methods to achieve this, it was not clear to what extent they succeeded. This 
information could have been gleaned from the use of qualitative methods, either 
observation of practices or interviews, but was precluded by lack of resources. 
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5.3 West Lincolnshire Primary Care Trust study: multipractice audit to 
assess influenza and pneumococcal vaccination uptake in high-risk 
groups 
 occurred 
r influenza vaccination of patients over 65 years with the mean vaccination rate across 
the trust of 73.0% exceeding the following year’s national target of 70%. The primary 
care trust achieved high rates of influenza and pneumococcal vaccination in patients with 
coronary heart disease, diabetes and splenectomy. Median standards set were similar for 
both phases of the audit (Table 28). 
5.3.1 Participating practices and presentation of data 
We compared practice performance for each criterion in the two phases of the audit. 
There were high levels of participation with 24 out of 39 practices in both phases of the 
audit. Practices who participated in the audit were reflective of practices across the trust 
in terms of partnership and list size (Table 27).  
 
There were improvements in vaccination rates for patients over 65 and patients with 
coronary heart disease and diabetes but not those with a history of splenectomy who 
already had high initial vaccination rates. The greatest improvement of 24.0%
fo
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Table 27 West Lincolnshire PCT study: characteristics of practices participating 
Char
practices n (%) 
n=24 (%) 
PCT practices  
n = 39 (%) 
p value
compared to all West Lincolnshire Primary Care Trust practices***********
acteristics Number Participating All West Lincs χ2 
     
List size <3000 
 
7 (22) 9 (23)  
 3000-6000
 
11 (34) 14 (36)  
 6001-9000
 
11 (34) 13 (33) 0.99 
 >9000 
 
3 (9) 3 (8)  
Number of partners 1-3 
 
21 (67) 27 (69)  
 4-6 
 
10 (31) 11 (28) 0.94 
 7-11 1 (3) 1 (3)  
 
*********** The p values indicate that participating practices were similar to non-participating practices with 
respect to list and partnership size.  
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Table 28 West Lincolnshire PCT study: improvement in vaccination uptake of 
practices taking part in both phases of the audit 
 Vac
uptake 
 
 cination   
n = number of 
practices 
part
Phase 1 
% 
(Ra
m
max) 
Phas
%
Ran
min
max) 
dian 
Standard 
(Phase 1, 
Phase 2) 
n 
improvement 
 CI) 
Significance 
(p value, 2-
tailed t-test) icipating nge: 
in, 
(
e 2 Me
 
ge: 
, 
Mea
(95%
      
Influenza 
vaccination uptake 
in CHD (n=20) 
58
(41,
70, 70 4.4 to 24.0 <0.001 
     
Pneumococcal 
vaccination uptake 
in CHD (n=19) 
26
(6,
70, 70 9.3 to 20.0) <0.001 
     
Influenza 
vaccination uptake 
in diabetes (n=21) 
57
(32,
74.
60,1
75,70  (10.2 to 23.6 <0.001 
     
Pne
vaccination uptake 
in diabetes (n=20) 
53.
(6,86) 
70, 70 4.8 to 22.0) .004 
     
Influenza 
vaccination uptake 
in splenectomy 
patients (n=18) 
70
(0,1
76.
(0,100) 
100,100 2.5 to 14.7) .155 
     
Pneumococcal 
vaccination uptake 
in splenectomy 
patients (n=17) 
81
(0,100) 
83.
(0,100) 
100,100  (-4.3 to 7.8) .546 
      
Influenza 
vaccination uptake 
in over 65 year 
olds (n=24) 
 
48.9 
(26,90) 
73.0 
(62,90) 
60,60 24.0 (19.7 to 28.4) <0.001 
.3 
100) 
77.
(63,1
5 
00) 
19.2 (1 ) 
 
.9 
69) 
41.
(9,6
5 
9) 
14.6 (  
 
.6 
100) (
5 
00) 
16.9 ) 
 
umococcal 40
(3,88) 
.2 5 13.4 (  
 
.6 
00) 
6 6.1 (-  
 
.7 4 1.8
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5.3.2 New developments and findings from the Primary Care Trust audit 
The countywide study showed that practices were able to improve vaccination rates 
through participation in a multipractice audit, feedback of performance and written advice 
 organ c at ha hown to im vaccinat
f this  eth as appli w prim
organisation, the P  Ca t (PCT). Incorporating the audit into the clinical 
ance program f the increas ipatio f this
porate an educational intervention to consenting practices as part of a cluster 
control udy. g the ationa  chan
ination of all over sixty-five year olds and above in addition to patients in 
sk groups. T ange olicy pr  a nu t had
 methodology had to be changed to include patients aged sixty-five years 
er. Secondly ad t consid ther aign would 
 results of the randomised controlled study to the extent that the study would 
be unnecessary or fail to show any benefit. It was felt that any effects of a natio al 
 flu ccination to a greater extent than pneumococcal 
nd this was subsequently shown to be true. 
s that participated in this study demonstrated that they could exceed national 
goals for influenza vaccination rates for patients aged 65 year old and above. In addition, 
patients in disease risk groups were also vaccinated to national targets levels for influenza 
encouraging
Because o
isational hange th d been s
odology w
prove ion rates. 
ary care success a
rimary
similar m
re Trus
ed to a ne
govern
was to incor
me o trust ed partic n. Another aspect o  study 
randomised 
include vacc
led st Durin study n l guidelines were ged to 
high-ri
addressed.  
his ch  in p esented mber of issues tha  to be 
 
Firstly the audit
and ov
confound the
, it h o be ered whe the national camp
 n
campaign would
vaccination a
affect in enza va
 
The practice
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vaccination. This was an important aim over and above the need to immunise patients 
over sixty-five years (Nguyen-Van-Tam et al. 1998). 
 
This was a multipractice audit in volunteer practices conducted in the context of the 
national influenza vaccination campaign. The majority of practices, 32 out of 39, in the 
primary care trust participated in the audit. The study, as for the countywide audit, could 
not account for secular trends or the Hawthorne effect and participating practices may 
have been more enthusiastic about vaccination compared to those who did not participate. 
Although the national influenza campaign was likely to have had an important effect on 
influenza vaccination rates, the increase in pneumococcal vaccinations rate was unlikely 
to have been affected. 
 
It was important to consider the various methods that the practices employed to overcome 
barriers to vaccination. A number of evidence-based interventions were used to improve 
immunisation rates. Practices combined audit and feedback with a number of other 
interventions. National media and local newspaper drives were used to increase patient 
awareness and foster positive attitudes towards influenza vaccination. Practices used 
leaflet and poster campaigns to increase awareness for both influenza and pneumococcal 
vaccination amongst patients attending the surgery. In addition to recommendation from 
general practitioners and nurses during consultations, patient reminders were mailed to at-
risk patients (through a health authority initiative providing extra funding for reminder 
letters to patients) and also sent to patients as messages on repeat prescriptions. Financial 
incentives to general practitioners, which showed some success in influenza vaccination 
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programmes in the United States, were also a significant part of the government initiative 
during this study (Department of Health 2000c) with an item of service fee for every 
accination given to patients over 65 years. 
ncontrolled study in a self-selected group of practices there were 
gain significant improvements in vaccine uptake in high-risk groups. The lack of a 
v
 
Finally practices were given advice on standardised Read codes for diseases using a 
simple desktop reference, computer templates for management of diabetes and coronary 
heart disease which included influenza and pneumococcal vaccination as a prompt and 
information on search strategies to monitor vaccination uptake during the vaccination 
season to ensure that they would maximise rates. 
 
Although this was an u
a
control group may have led to an overestimate of any effect of the intervention by not 
taking into account the influence of secular trends, i.e. changes over time, or the 
Hawthorne effect, i.e. the tendency of organisations to improve performance simply by 
virtue of being observed. The study also suggested that adult vaccination rates might also 
be used as a performance indicator for primary care organisations, as was previously 
suggested (McColl et al. 2000). The opportunity was used to superimpose an educational 
intervention onto this multipractice audit as part of a randomised controlled study 
investigating the effect of an educational intervention to practice teams.  
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5.4 Cluster randomised controlled trial of an educational outreach visit to 
improve influenza and pneumococcal vaccination uptake in high-risk 
groups 
arch network. This may have been due 
 large part to the fact that these practices were already taking part in a multipractice 
dy. However, it 
was likely that these features would be correlated with baseline vaccination rate and that 
they would have been accounted for by a spread in baseline vaccination rate. Baseline 
(phase 1) and follow up (phase 2) vaccination rate ranges were also similar for primary 
care trust and collaborative research network practices. Practices included in the study, 
Thirty practices took part in this study which was, as described earlier, partly nested 
within the primary care trust study. Participating practices were similar to non-
participating practices with respect to partnership size, list size, dispensing status and 
rurality (Table 29). The twenty practices from the primary care trust were significantly 
more likely to participate than those from the rese
in
audit of influenza and pneumococcal vaccination rates as part of an annual clinical 
governance programme. There was no reason to believe that patients or practices from the 
primary care trust differed from practices in general and indeed it has been shown that 
patients from the Trent Focus Collaborative Research Network were similar to other 
general practice patients (Hammersley et al. 2002) in terms of morbidity, mortality and 
hospital admission rates. However, research network practices may have been 
unrepresentative of practices because data quality, disease registers and willingness to 
participate in research were a prerequisite for membership. Other patient, organisational 
or quality measures such as deprivation, training status, age or qualifications of clinical or 
other staff were not collected and this was a potential weakness of the stu
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whether in the intervention or control group, indeed had a wide range of baseline 
 
Practices were randomised to intervention or control groups depending on their baseline 
vaccination rates in the high-risk groups under consideration (Table 30). 
vaccination rate for influenza vaccination in diabetic patients (as baseline rates for each 
vaccination and risk group were correlated) so that baseline vaccination rates were similar 
for both groups. Baseline characteristics of intervention and control practices were similar 
in respect of numbers of partners, list size, rurality and prevalence of coronary heart 
disease, diabetes, splenectomy and patients aged sixty-five years and over (Table 31). 
However, intervention practices were significantly more likely to be non-dispensing. 
 
Practices in both study (intervention and control) groups were also similar in their stated 
strategies for improving vaccination uptake at baseline. This was assessed by means of a 
postal questionnaire to each practice. Items included questions on strategies that were 
likely to improve influenza and pneumococcal vaccination rates such as practice 
guidelines on vaccination, discussion within primary care teams, disease and vaccine 
registers, patient reminders such as poster campaigns, prescription reminders, call and 
recall letters and organisational policies such as dedicated vaccine refrigerators, 
vaccination clinics, stock control systems and previous audit of vaccination uptake (Table 
32). 
 
Practice performance was compared at baseline (August 2000) and six months after the 
educational intervention took place. The educational visit was carried out in October 
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2000, two months after the baseline assessment and at the beginning of the influenza 
vaccination campaign. Only one control practice did not submit data for splenectomy 
atients because they lacked a computer register for this group of patients. Improvements p
in vaccination uptake occurred in coronary heart disease, diabetic and splenectomy 
patients for both vaccinations and in both intervention and control groups. Baseline 
uptake was lower for pneumococcal vaccination than influenza vaccination. Median 
targets set by practices for the audit were at or higher than national targets for patients 
aged 65 and over. Significant improvements occurred in the intervention group compared 
to the control group for pneumococcal vaccination in coronary heart disease and diabetic 
patients (Table 33).  
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Table 29 Randomised controlled study: characteristics of participating compared 
with non-participating practices 
Characteristics  Participating 
practices 
Non-participating 
practices 
Chi 
square 
(n = 30) (n = 61) 
     
Practice CRN 10 42 p = 0.002 
 PCT 20 19  
Number of  1 6 10  
Partners 2-3 14 22 p = 0.38 
 4-6
†††††††††††
‡‡‡‡‡‡‡‡‡‡‡
 7 26  
7+ 3 3  
ist size <3000 7 (23.2) 8 (13.1)  
 3000-5999 11 (36.7) 18 (29.5) p = 0.39 
 6000-8999 8 (26.7) 23 (37.7)  
 ≥9000 4 (13.3) 12 (19.7)  
Dispensing  13 (43.3) 16 (25.8) p = 0.46 
Location Rural or semi 
rural 
12 (40.0) 16 (25.8)  
 Suburban or 
city 
18 (60.0) 46 (74.2) p = 0.17 
 
L
 
 
††††††††††† Trent Focus Collaborative Research Network 
‡‡‡‡‡‡‡‡‡‡‡ West Lincolnshire Primary Care Trust 
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Table 30 Randomised controlled study: baseline vaccination rate ranges of 
participating practices 
V eaccination rat  range at baseline  
High risk group Intervention pra
M , maxim
Control s (%)
Minimum, maximum 
ctices (%)
inimum um 
practice
 
Influenza vaccina
ptake in CHD 
 
39,80 
 
41,87 tion  
u
 
Influenza vaccination  
diabete
32,84 40,97 
nfluenza vaccination  
uptake in splenectomy 
0,100 33,100 
nfluenza vaccina
ptake in over 65
 
34,67 26,76 
neumococcal va n 
D 
11,53 6,69 
Pneumococcal vaccination 
ptake in diabete
 
22,77 8,88 
neumococcal vaccination 
uptake in splenectomy 
0,100 50,100 
uptake in s 
 
I
 
I tion  
u  year olds 
P ccinatio
uptake in CH
 
u s 
P
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Table 31 Randomised controlled study: characteristics of participating 
practices§§§§§§§§§§§
Characteristics  
a
n =
Intervention Control  
practices  pr
n=15 (%) 
ctices  
 15 (%) 
    
Practice CRN************  5 
PCT†††††††††††† 10 10 
umber of partners 1 2 3 
2-3 7 5 
4-6 6 3 
  3 
ist size <3000 2 (13) 5 (33) 
00-5999  (47) 4 (2
999 5 (33) 3 (20) 
  (7) 3 (2
CHD 3.66 3.60 
Diabetes 2.38 2.52 
Splenectomy 0.076 0.11 
Over 65 16.1 15.9 
5
 
N
 
 
 7+ 0
L
 30  7 7) 
 6000-8
 >9000
Prevalence (%) 
1 0) 
 
 
 
 
 
§§§§§§§§§§§ There were no significant differences between intervention and control groups using Chi square. 
************ Trent Focus Collaborative Research Network 
†††††††††††† West Lincolnshire Primary Care Trust 
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 Table 32 Randomised controlled study: baseline organisational strategies used 
intervention and control practices to improve influenza and pneumococ
by 
cal 
vaccination  
tion 
s 
ontrol 
actices 
     
Organisational strategy  No    No      
 Interven
practice
Yes
 C
pr
 Yes
Did you discuss the influenza vaccination programm
your primary care team last year? 
 0‡‡‡‡‡‡  1      e in 14 ‡‡‡‡‡‡  12 
Did you discuss the pneumococcal vaccination progr
 your primary care team last ear? 
 2  3      
ular primary c eetings? 11  3  11  2      
Do you have practice guidelines for influenza vaccination? 10  4  10  3      
o you have practice guidelin eumococcal 
vaccination? 
10  4  10  3      
refrigerator? 14  0  12  1      
oes this vaccine refrigerator n in-built thermometer? 12  2  12  1      
o you have sufficient refrige space for your needs? 
 
12  2  11  2      
o you purchase vaccine from suppliers at a discount? 14    13        
o you have a method for sto trol of vaccines?
 
13  1  12  1      
o you conduct dedicated clinics for influenza vacci on? 12  2  11  2      
you conduct dedicated clinics for pneumococcal 3  11  2  11      
rtake simultaneous administration of inf
and pneumococcal vaccine when appropriate? 
14  0 12  1      
hich members of your pract ke Do 13  1 12  1      
fluenza/pneumococcal vacc  nurse 14   13        
                 District nurses 13  1  12  1      
 Heal 5  9 4  9      
you have a computerised disease (morbidity) register 13  1  1      
o you have a computerised v ster? 
 
13  0 11  2      
rescrip nders for 9  4  3      
Did you have a poster campaign for influenza vaccination 
st year? 
13  1  13  0      
you contact and liase with nur
inter vaccinations? 
14  0  12  1      
o you provide printed advice .g
effects? 
8  6  8      
o you use call and recall lett za or 
eumococcal vaccination? 
9  5  4      
Have you audited the success of uptake of influenza or 
eumococcal vaccination in at risk groups before? 
6  8  9  4      
amme 12 
in  y
 10 
Do you hold reg
 
are team m
 
D es for pn
Do you have a dedicated vacc
 
ine 
D
D
 have a
ration 
D
D
 your 
ck con  
D
Do 
nati
vaccination? 
Do you unde luenza  
W
in
ice team underta
ination:   Practice
ctors  
s 
 
 
                th visitor
? 
 
 12 Do 
 
D accine regi  
Do you use computer p
vaccinations? 
tion remi  10 
la
Do sing homes regarding 
w
D
 
 about vaccination e . side  4 
D
pn
ers for influen  9 
pn
 
‡‡‡‡‡‡‡‡‡‡‡‡ Missing data explains totals less than 15 for intervention or control practices 
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and control practices at baseline and six months after the educational 
n 
 
Table 33 Randomised controlled study: improvement in vaccination uptake of 
intervention 
interventio
Vaccination 
uptake 
  
 
 
n = n
each gr
dia standa  
set (Ph   
Phase 2) 
Mean 
improvement 
(%) 
 
§§§§§§§§§§§§
F 
(95% CI) 
umber of patients in Phase 1 Phase 2 Me
oup at phase 2 (%) (%) 
n rd
ase 1,
Risk 
ratio
      
Influenz
in CH
  
Inter ,70 18.1 06 (0 12
Cont 13.1 
  
Influenza vaccination uptake 
in dia
     
Inter 70,75 15.5 07 (0 16
Cont 0 12.0 
  
Influenz
in sp
  
Inter 1 16.1 22 (0 93
Cont 0,1 2.9 
   
Influenza vaccination uptake 
in over 65 year olds 
  
Inter ,60 20.7 99 (0 02
Cont .1 60,60 25.4 
  
Pneum
uptake in
 
Inter ,70 14.8 23 (1 34
Cont 82) 33.2 39.7 70,70 6.5  
  
Pneum on 
uptake in diabetes  
     
Inter 70,70 15.5 18 (1. 8, 1.29) 
Cont ,75 6.8 
   
Pneum
uptak
 
Intervention (n=62) 79.0 85.5 100,100 6.5 0.96 (0.65, 1.42) 
Control (n=107) 86.0 90.7 100,100 4.7  
      
a vaccination uptake   
D  
ention (n=3025) 58.0 76.1 70
 
v  1.  .99, 1. ) 
rol (n=3182) 59.4 72.5 70,75  
    
betes 
vention (n=2059) 58.9 74.4  1.  .99, 1. ) 
rol (n=2268) 58.2 70.2 70,8
   
 
 
a vaccination uptake   
lenectomy 
vention (n=62) 64.5 80.6 100,
 
00 1.  .78, 1. ) 
rol (n=107) 55.1 58.0 10 00  
   
   
vention (n=13633) 48.6 69.3 60 0.  .96, 1. ) 
rol (n=13947) 44.7 70
   
 
 
ococcal vaccination 
 CHD 
    
vention (n=3025) 30.6 44.8 70
rol (n=31
 1.  .13, 1. ) 
   
ococcal vaccinati
 
vention (n=2059) 43.3 58.8 
rol (n=2268) 40.6 47.4 70
1.
 
0
  
ococcal vaccination 
e in splenectomy 
   
 
 
 
 
. §§§§§§§§§§§§ From the Poisson regression controlling for initial level and stratification
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A semistructured questionnaire after the visit showed the range of approaches by 
which practices augmented their existing organisational strategies (Figure 14). This 
uded aware ra formation leaflets in the 
ting room a ll paigns (both local and 
onal) for in za e teams also encouraged
titioner rem rs such as templates and vaccine prom ealth
essionals to advise high-risk patients to be immunised. Fin p te
e also modified to increase vaccination rates using improve cc
age, risk registers and call-recall systems and better access through special clinics, 
e vaccination for the housebound by community staff and vaccine clinics in 
ing homes.  
1 Discussion of results from the randomised controlled study 
s study showed that an educational outreach visit to primary health care s
n improvement in pneumococcal vaccination rates in patients with coronary he
ase and diabetes. It was not possible to demonstrate an improvement in influenza 
cination rates or vaccination rates in splenectomy patients as a result of the 
rvention. However, vaccination rates were generally bet  the er tion 
tices for all treatment groups, except for those aged sixty-fi d
ough the effect size of the vention in the randomi o
uenza and pneum c ation in diabetes and c a
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There were a number of reasons why the study demonstrated improvements for some 
high-risk groups and vaccines and not others. The most obvious, given the marked 
increase in vaccination rates in both the intervention and control groups, was that the 
national and local campaigns for influenza vaccination of patients aged sixty-five and 
above might have swamped any effect of the educational visit. The national 
vaccination campaign, which coincided with this study, used media advertising 
together with financial incentives, consisting of a fee for service for each vaccine 
administered to the target age group.  
 
There was also a massive nationwide health education campaign using television and 
other media to raise public and professional awareness. Local media campaigns and 
initiatives were also encouraged by the Department of Health. In Lincolnshire this 
took the form of a radio and newspaper promotion. The local health authority also 
provided an additional financial incentive to encourage invitation of patients for 
vaccination, in which general practitioners were paid a fee for each patient in the 
target age group invited for and subsequently vaccinated. Overall, these campaigns 
were highly successful in improving vaccine uptake as demonstrated by the primary 
care trust audit.  
 
Splenectomy patients were numerically a small group. They had a much greater 
vaccination rate at baseline, particularly for pneumococcal vaccination. This may have 
been because of the medicolegal imperative to vaccinate this risk group. As a result 
our study was underpowered to demonstrate significant improvements in this subset.  
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Factors increasing the validity of the results were the careful design of the study, 
(Education Group for Guidelines on Evaluation 1999; Begg et al. 1996) 
randomisation by practice dependent on baseline immunisation rates, analysis of 
clusters and the absence of dropouts.  
 
 This study lends support to the trend towards practice based multidisciplinary 
education for general practice teams as a method of improving delivery of care and 
outcomes for patients. This is likely to be particularly so where an intervention 
volves more than one professional group or benefits from a team approach.  
alysis with sufficient clusters, matched for baseline characteristics 
nd allowing for clustering in the sample size calculation and analysis (Ukoumunne et 
 
ave affected the study’s validity were generation of the allocation sequence, 
allocation concealment, double blinding and follow-up. If any of the first three steps 
in
 
Practice based education has been shown to improve the process of care in some 
studies (Feder et al. 1995) whereas we have demonstrated improvement in one 
particular outcome of care, specifically pneumococcal vaccination rates in high-risk 
groups.  
 
Methodological issues that were considered in conducting this study were appropriate 
recognition of the cluster, in this case the general practice, as the unit of intervention, 
allocation and an
a
al. 1999a).  
 
There were also a number of potential methodological traps. The significance of the 
results was dependent on other aspects of the methodology. Key features that may
h
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were inadequately performed this would have led to an exaggeration of the 
intervention effect (Kjaergard et al. 2001). The allocation sequence was decided after 
appropriate statistical advice. Practices after being arranged in order of baseline 
pneumococcal vaccination rate for diabetic patients were allocated to intervention or 
ontrol group depending on the toss of a coin. Practices therefore had an equal chance 
er, the 
vestigator had no means of predicting which practices would respond well or less 
, and ideally conducted at a site remote from the investigator, to avoid bias 
orgerson and Roberts 1999). 
ths given adequate resources.  
c
of being allocated to either group.  
 
There was no attempt at allocation concealment, i.e. to separate the process of 
allocation to intervention or control group from the investigator. Howev
in
well to the educational intervention. Indeed, initial matching and stratification had 
corrected for the baseline variable of vaccine uptake, which was most likely to affect 
subsequent performance. However, it would have been better that allocation was 
concealed
(T
 
Blinding or double blinding were not possible in this type of study. It may have been 
possible to blind an investigator undertaking the analysis to the identity of practices 
and which study group they were in. Follow up could have been extended to longer 
than six mon
  
The costs of the intervention were not formally evaluated. Costs would have included 
healthcare and non-healthcare costs (Johnston et al. 1999) based on additional 
resource use and unit or marginal costs. Healthcare costs included costs of the 
education, additional vaccines administered and future health service costs due to 
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patients living longer. Costs to the practice included time for team members to meet 
with the outreach visitor. However, this cost was minimised by integrating visits into 
primary health care team meetings. There may also have been additional meetings or 
discussions stimulated by the educational intervention. Costs of the educational 
intervention included time to prepare the presentation (at the rate of about three hours 
preparation time overall), travel time and an hour per practice for delivery of the 
ducational outreach. The marginal costs of additional influenza and pneumococcal 
ent of time spent receiving the vaccination. Patients 
ving longer as a result of the vaccine may also have generated future health service 
ts to related effects are described as a cost-
fectiveness analysis. Further work needs to be done to address the cost effectiveness 
e
vaccinations administered in the intervention practices, over and above those in the 
control practices, would have included vaccine and item of service costs, staff time to 
administer the vaccines, other administration costs (vaccine ordering, stock control, 
refrigeration, receptionist to arrange appointments) and running costs of providing 
weekend or other special clinics. There may have been additional consultations 
generated after vaccination because of side effects or illness indirectly related to or 
made worse by vaccination. Non-health service costs may have included patient travel 
costs and the costs to the pati
li
costs. Effectiveness of the additional vaccines administered, in terms of hospital 
admissions, illness or deaths prevented could have been estimated from previous 
research. Costs and effects presented separately constitute a cost-consequence 
analysis, whereas the ratio of additional cos
ef
of this approach. It may be argued that the incentive payments for influenza 
introduced by the government and previously used successfully in the United States 
(Kouides et al. 1998) were more effective at improving influenza immunisation rates 
but it is not clear whether this may have been at a higher cost than the effect of the 
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educational intervention on pneumococcal vaccination. Since any educational 
intervention or programme would have both direct costs and opportunity costs for 
healthcare professionals, patients and society, a cost benefit analysis would have 
provided information on whether this type of intervention should be undertaken with 
regard to competing priorities (Brown et al. 2002). Lack of resources precluded such 
an analysis.  
 
This study demonstrated that education delivered to practice teams, addressing areas 
relevant to practice and using audit, feedback, discussion of barriers to change and 
how to overcome these may lead to improved outcomes for patients. 
5.5 Conclusion 
The fieldwork demonstrated improvements in vaccination rates in high-risk groups in 
participating practices. The methods included (a) a pilot study employing action 
research in a single practice to implement a number of organisational changes using a 
team approach (b) audit and feedback with written educational materials to practice 
teams on effective interventions across several practices across a county, (c) audit, 
feedback and written advice in several practices across a primary healthcare 
organisation underpinned by a regulatory agreement as part of the trusts’ clinical 
governance framework (d) an educational outreach visit to primary care teams to 
implement a set of interventions tailored to barriers in each practice.  
 
The largest increases in vaccination rates occurred in the uncontrolled before and after 
studies, which included the pilot study and multipractice audits. In the pilot study for 
example, vaccine rates increased by about 10% for influenza and 40-50% for 
pneumococcal vaccination for coronary heart disease and diabetes. In the audit studies 
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influenza vaccination rates increased by 10-15% and pneumococcal vaccination rates 
by 20-40% for the same risk groups. The comparable figures for the randomised 
controlled study were that influenza vaccination rates increased by about 10% (similar 
to controls) and pneumococcal vaccination by 15% (compared to 7% in controls). 
 
Although it could be argued that the volunteer practices in these studies were more 
otivated to increase vaccination rates than those practices that did not participate the 
as of a similar or 
greater magnitude to the large increase in influenza vaccination rates in patients aged 
rticipating practices as a result of the huge 
m
wide diversity of practice types and large numbers of practices that took part 
supported the validity of these improvements in performance. It was interesting that 
the increase in pneumococcal vaccination rates in the audit studies w
sixty-five years and over that occurred in pa
national vaccination campaign. This comparison suggests that motivated practice 
teams can produce similar increases in vaccination rates using simple interventions to 
improve teamwork compared to large and costly national initiatives. 
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CHAPTER 6 DISCUSSION 
nce 
l and related themes in the modernisation agenda of the British 
ain elements in 
the diffusion of innovations as the innovation itself and its communication over time 
to members of a social system (Rogers 1995). Rather than a single innovation this 
series of studies involved two similar and closely related innovations (sometimes 
termed an innovation cluster) of influenza and pneumococcal vaccination that allowed 
comparison between the two health technologies. The communication of these 
innovations occurred at various levels through the healthcare system, which included 
primary care, and how this occurred is examined. The methods of communication and 
implementation were innovations in themselves and this enabled a further layer of 
study. The opportunity was taken to systematically observe the change in influenza 
and pneumococcal vaccination rates over time, rather than using a cross-sectional 
6.1 Introduction 
At the beginning of the twenty-first century education, quality and performa
continue to be centra
health service (Department of Health 1998a). This thesis set out in previous chapters 
to investigate these fundamental themes and interrelationships. The discussion, by 
considering existing theoretical frameworks and examining findings from the 
preceding field studies seeks to develop a conceptual model for understanding the link 
between education, quality and performance and to examine the potential for 
educational interventions for primary care.  
 
The thesis is essentially a diffusion study or a study of how a new idea is adopted. 
However, there are a number of key differences and special conditions that distinguish 
this work from previous diffusion studies. Rogers describes the four m
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method with a single point in time, as has been the case for many previous diffusion 
studies. Finally the social system that was being studied was primary care, a setting 
many respects. The primary care setting was highly 
 1999). The field studies embraced this 
educational interventions as a method for 
in high-risk groups?”  
methods? 
that is unusual in 
professionalised, having a structure with a mixture of hierarchical and non-
hierarchical relationships between professionals and consisting of a number of general 
practices and community nursing teams that function as interdependent but virtually 
independent organisations. Qualitative studies have shown that innovations diffuse 
slowly and unpredictably across professional, structural and cultural barriers and that 
a model based on professional ownership of change through continuing professional 
development might be more successful in implanting change than alternatives such as 
financial and contractual levers (Ferlie et al.
model of professional ownership by using 
promoting change. 
 
The following research question was proposed in the introduction to this thesis (1.1): 
“How and to what extent do educational interventions improve the performance of 
primary healthcare teams in increasing influenza and pneumococcal vaccination rates 
 
The discussion considers a number of closely related subsidiary questions: 
 Did the educational methods employed in the field studies improve performance? 
 How did the outcome of interest (i.e. improved vaccination rates) affect these 
 Under what circumstances is education more effective at improving performance 
when directed at primary care teams compared with individual practitioners? 
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 Which features of the education are important to successful outcomes? 
 What special features does general practice offer as a substrate for education?  
 
The analysis also looks at educational interventions compared with other methods of 
improving outcomes such as financial incentives or contractual levers. Organisational 
systems to improve performance at different levels of the health service, ranging from 
individual general practices to primary care trusts to national systems are examined. 
How these organisational systems could be disseminated, whether they succeed or fail 
to address promoters and barriers to vaccination and how they may be improved are 
considered. The lessons from these studies for diffusion of innovations and adoption 
of new techniques for improving performance in primary care and the National Health 
Service are explored. The discussion also deals with the relevance of these studies to 
current trends in multidisciplinary practice-based learning. It explores the potential of 
ducational outreach as a method of learning for primary health care teams as well as 
enges for education and educational research in healthcare. 
 
u
spe fluenza and pneumococcal vaccinations in high-risk groups. To 
d
out  are 
e
the wider opportunities that this may provide for educational initiatives in the 
developing health service. The discussion by drawing these questions and concepts 
together seeks to position them in the context of current practice and future 
opportunities and chall
6.2 A conceptual framework  
The studies described in earlier chapters have demonstrated the effectiveness of
ed cational interventions to primary care teams for improved health outcomes, 
cifically in
un erstand the complexity, range and effects of interventions in improving health 
comes three conceptual frameworks are drawn on. These frameworks
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examined, combined and reformulated to form a new model that seeks to reconcile the 
 its 
usefulness in describing and classifying a number of important components, this type 
u what mechanistic in the way it implies cause and 
findings from the fieldwork and other literature. 
 
In the first framework to be considered, interventions are classified according to the 
target of the intervention (e.g. patients, providers, or systems), the type of intervention 
(e.g. education, reminders, feedback), or the social theory (e.g. social influence, 
marketing) that underpins the intervention (Stone et al. 2002). This framework 
(Figure 15) conveniently describes many of the different intervention types that were 
operating in the field studies and begins to explain how and why they affected their 
targets. It also begins to show how one intervention type, for example a media 
campaign, can potentially affect more than one target.  
 
A criticism of this framework is that it does not consider the outcome of the 
intervention or the evidence base for it despite the importance of these factors 
demonstrated in the field studies. The use of influenza and pneumococcal vaccination 
as outcomes directly affected the educational method used to promote them, and this 
is discussed below (see 6.3.1). The role of evidence is highlighted in the next 
conceptual model and explored in more detail later (see 6.4). Also, despite
of str cture by being linear and some
effect does not fully convey the complex interactions between the elements. Another 
drawback of the model is that it portrays the targets of the intervention as passive 
recipients when in fact patients, providers and systems are also agents of change in the 
process. Therefore, Stone’s model, although a useful starting point, fails to adequately 
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show the complicated relationships and interactions between the various intervention 
types, targets or agents of change.  
 
As an example, in the randomised controlled study, media campaigns targeted at 
patients also affected healthcare professionals, both directly and indirectly. The 
campaign directly affected practitioners by increasing their awareness of the new goal 
of vaccinating patients aged sixty-five and above. Indirect effects were also noticeable 
through the observed increased patient demand for vaccination by patients aged sixty-
five years and over and the effect that this patient demand had on practitioner 
awareness.  
 
Another instance of the interaction between interventions was that financial incentives 
specific learning about these issues from literature, media and team discussions.  
to health workers to some extent determined whether practices sent reminders to 
patients. However, other factors, such as previous experience within the organisation, 
determined whether practices used patient reminders at all, and if so whether they did 
this by sending letters to patients, used reminders linked to repeat prescriptions, 
telephoned patients directly or employed a combination of methods. The factors that 
determined which interventions were used and how they were applied are an example 
of organisational learning (Carroll and Edmondson 2002). These factors were linked 
to previous practice (i.e. whether patients were usually telephoned or written to in the 
past), belief systems (what practitioners believed was most effective and appropriate 
from previous experience), feedback (how practices compared with their peers and 
particularly how results compared with peers who might have being employing 
different strategies), relative costs (of using alternative arrangements) as well as 
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Figure 15 Conceptual framework for interventions to improve adult vaccination 
rates (adapted from Stone et al. 2002) 
Target Intervention type 
Patient(s) Patient education (leaflets, posters, advice) 
 Media and advertising  
 Patient reminders 
 Financial incentives to patients 
  
Provider(s) Practitioner education 
 Practitioner prompts: reminders, recall 
 Financial incentives to health workers 
 Media and advertising 
 Teamwork 
 Feedback 
  
System (practice, primary care Team based education (organisational learning)  
organisation, national health Practitioner prompts: reminders, recall 
service) Media and advertising 
 Teamwork 
 Feedback 
 Policy (practice, national) 
 Regulation 
  
Theoretical basis  
Social theory underlying Social influence 
intervention types Marketing & outreach 
 Active learning 
 Visual appeal 
 Barriers and facilitators 
 Teamwork 
 Management support 
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 The previous model failed to acknowledge the outcome of the intervention or its
underlying evidence base as an element. 
 
A useful model which does include evidence 
as a key component is the Promoting Action on Research Implementation in Health 
PARIHS) framework (Rycr nts 
f this model are evidence, context a ce includes not only the 
trength of the science in relation to t ked but also takes 
to account patient need and the acceptance of the evidence by professionals and 
atients. The context describes the set in this case 
accination, is delivered. This inclu iduals 
e vaccine and the v ation programme, together with their 
ulture, which refers to the motivation and beliefs of the individuals and 
health policy as part of this context. 
e various t  internal or 
 to the organisation, that are u  health technology. These 
omponents are discussed in relation t  studies and literature later (see 6.4 to 
.7). 
f this model are tha it recognises the importance of evidence and 
ight affect the belie ctitioners. Also, by having 
ese groupings of evidence, context a nables us to see more clearly the 
or interaction within and between them ework 
 that the centrality of the patient, he recipient and the motivator for 
accination uptake is not adequa maly is that 
health policy, from the experience of the field studies, is more easily seen as an 
intervention or facilitator rather than part of the context. The context, in this regard, is 
Services ( oft-Malone et al. 2002). The three compone
o nd facilitation. Eviden
s he research question being as
in
p ting in which the health technology, 
v des the organisations, teams and indiv
involved in delivering th accin
c
organisations. Rycroft-Malone also includes 
Facilitation incorporates th ypes of interventions, which may be
external sed to implement the
c o the field
6
 
The advantages o t 
moreover how it m fs of patients and pra
th nd facilitation e
possibilities f . A drawback of this fram
is  both as t
increasing v tely addressed. Another ano
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better used to describe the various organisations and individuals involved in 
delivering vaccinations and as we have seen, this should also include the patients who 
are being targeted to receive vaccination. 
 
Both these models, whilst recognising that the various components interact, provide 
little explanation of how they might do so. The third model, that more fully considers 
this interaction, is based on complexity theory. This theory has been explored in the 
primary care setting by Miller and others in the Unites States (Miller et al. 1998). The 
model sees general practice, its users, and health professionals, together with its 
supporting organisations (or the ‘context’ in the previous model) as a complex 
adaptive system. Complex adaptive systems could be seen as ever changing webs, 
containing many organisms and threads, each interacting uniquely with one another 
and each affecting the whole structure, leading to change in the system, sometimes in 
an unpredictable manner. The potential changes in the web depend on its initial 
boundaries (organisational mission, priorities and history), the agents within it 
(patients, practitioners, health workers, pharmaceutical representatives, administrators 
tc.) who are both targets and initiators of change, their pattern of interaction e
(relationships), the immediate surroundings (neighbouring or related complex 
adaptive systems existing in the same environment), together with wider influences 
(from the health organisations, national bodies, culture, finances and regulation) 
(Miller et al. 2001).  
 
This theory depicts more accurately the complex relationships between patients, 
practitioners and organisations and their different belief systems, motivations and 
cultures that begin to accurately describe the primary care settings in which the field 
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studies were conducted. This model, however, lacks the detail of evidence, context 
and facilitation, together with the specific interventions described in the previous 
frameworks, needed to show how and why vaccination performance improved in 
ese studies. 
e providers, such as general practitioners and nurses, as well as 
eing individual agents also function within larger teams, general practices, 
th
 
Taken together, these conceptual frameworks help to describe the various elements, 
serve to emphasise that the different elements are closely interwoven and, as each 
agent learns from and influences the other, are all underpinned by learning. 
Combining elements of Stone’s model, the PARIHS framework and complexity 
theory therefore leads us to a model that more closely represents the findings 
described in the fieldwork.  
 
In this new model (Figure 16) the three main elements are the context, interventions 
(or facilitators) and evidence. The context includes the change agents or various 
individuals and organisations involved in producing changes in performance (items 
shown within circles). This ranges from the patient, the provider (healthcare 
professional) working in a general practice team to the various supporting 
organisations such as the primary care trust and Department of Health. The outcome 
of interest and evidence are also shown (both as triangles). The overlap between 
providers and organisations is depicted by the overlap between their respective 
circles. This is becaus
b
community nursing teams, primary care trusts or at even higher organisational levels 
of the health service. The interactions between the components that form the context 
are shown as dashed arrows. 
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r nature to the right of the rhomboid. These 
 types and the specific interventions themselves are predominantly, and it 
 such as primary care. Professionals, because of 
petence and expertise are likely to be highly 
The final element, represented at the top of the diagram by a diamond, is the 
intervention or facilitator of change. The specific interventions are shown in boxes 
and where they impact on the various change agents are shown as solid arrows. The 
interventions are also classified as to thei
intervention
will be argued most importantly, educational in their nature. They are educational in 
that they mostly involve learning, questioning (or iteration) and interaction. 
Interaction occurs between the agents, interventions and outcomes in an organic and 
complex way rather than in simple linear manner (Fitzgerald et al. 2002). The 
importance of education lies in the fact that learning is fundamental to change in a 
highly professionalised organisation
their background of learning, com
influenced by rationality, and although political influences may also be a significant 
factor in change these can also be seen as part of the learning process. The model also 
acknowledges that the various change agents, particularly providers and professionals 
but also patients are able to influence the intervention types through feedback. 
Although practitioners within primary care organisations will learn from various 
sources, including their patients, the organisation and professionals within it 
ultimately have the power to block change from occurring. 
 
This model, its components and interactions are now examined in greater depth in 
light of the fieldwork and other evidence from the literature. 
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Figure 16 Diagram c esentation of con u a o o e ti e prevention 
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6.3 Education for teams 
6.3.1 Influenza and pneumococcal vaccination as outcomes 
The effect of using influenza and pneumo cal vaccination rates a tcomes and 
how usin ese specific outcom  impacted
methods that organisations employed to improve performance are an important area 
for consideration and analysis.  
 
Successful immunisation programmes required a coordinated team approach. The key 
t  involved in vaccine delivery  onstrated in the field studies to be the 
p ary healthcare team. Other tea it and clinical rnance groups 
were also operating to improve v  but this was at a level further 
r ved from the patient. It followe t the most appropriate educational 
m od to i ve vaccination rates should be one directed at teams rath
i iduals a ore specifically the primary healthcare team as a whole ra
single professional group within it. The educational methods used in this series of 
studies, which ranged from action research in the single practice pilot study, audit and 
f ack across many practi i ltipractice audit studies, to an educational 
outreach intervention for practice healthcare teams in the rando d controlled 
s , each loped this id r teams and the notion of teamwork for 
i oving nation rates. This idea accords with previous evidence advocating a 
t  approach to vaccine implement n (Tannenbaum et al. 1994). The concept of 
t work is further developed below
 
 
coc
 on both the interventions used and the 
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 (see 6.3.2). 
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Using vaccination rates as an outcome also affected the type and scope of 
equently employed. Vaccination is a preventive 
ly unwell, population 
nt of acute or chronic illness. The interventions used 
lso depended on the response of the target population to these techniques. 
ged specific types of organisational 
hange. Teams tended towards a systems approach and multifaceted strategies to 
ffect organisational change. How and why this happened is described next.  
interventions that practices subs
procedure and because it is targeted at patients who are not acute
strategies such as identifying the target group, increasing awareness of benefits, 
reducing concerns and fears, and systematically or opportunistically inviting those in 
the high-risk population to attend for vaccination differ somewhat from the individual 
approaches required for treatme
a
  
This can be seen, for example, in the differences that were shown between influenza 
and pneumococcal vaccination rates. The pilot study, showed, for example, that 
patients and practitioners were relatively more aware of influenza than pneumococcal 
vaccination. Between and during the field studies awareness of influenza vaccine also 
increased amongst both groups due to successive local and national media campaigns. 
As a result, many practitioners explicitly stated in their written feedback that they 
concentrated greater efforts in raising awareness of pneumococcal vaccination 
amongst patients through poster campaigns and leaflets than promoting influenza 
vaccination awareness. This was borne out by the results of the fieldwork where all 
the studies showed lower baseline rates and a greater increase in pneumococcal 
vaccination uptake compared to influenza vaccination.  
 
The use of vaccination rates as outcomes, as well as lending itself to a team approach 
and particular kinds of intervention, also encoura
c
e
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6.3.2 Learning in teams 
The notion of the primary healthcare team as the target of educational interventions in 
the field studies warrants further consideration, both from a theoretical and practical 
point of view. From a theoretical standpoint, the importance of systems change in 
improving medical care is encapsulated in the mantra of the quality improvement 
movement, ‘every system is perfectly designed to get the results it achieves’ (Nolan 
1998). The crucial organisational structure for delivering vaccines is the primary 
healthcare team itself and those systems operating at this level. From a practical 
rspective, we have seen how previous research had confirmed that organisational or 
hown previously to be linked 
 good preventive care (Hulscher et al. 1997a). As well as lack of these factors, 
pe
system change was most likely to result in an improvement in health outcomes 
(Gyorkos et al. 1994; Stone et al. 2002) and that such changes, which invariably 
involved the whole team, were best implemented using a team approach (Clemmer et 
al. 1998). Historically, many practices had used just such a team approach to develop 
other successful vaccination programmes, for example for childhood immunisation, 
and would therefore be familiar with a multiprofessional approach. 
 
Factors that were seen in the field studies to encourage teamwork were regular 
primary care team meetings, good communication within the practice and clear role 
and task definition for team members through discussion, delegation and written 
protocols. These same organisational factors had been s
to
conflicts between professionals in some practices undermined good teamwork and 
this was mentioned in discussions around practice barriers to vaccination during the 
educational outreach visits. 
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The educational outreach intervention demonstrated that team members meeting with 
uality of care is to 
e improved.” Both these ideas were developed in the field studies and are considered 
Effective teamworking was especially demonstrated in those practices that were able 
to improve vaccination rates. Various members of such practice teams were delegated 
specific roles in their vaccination programmes. Practices determined these roles and 
their operationalisation through discussion of previous practice, appraisal of the 
evidence (such as patient reminders and provider prompts) and how it could be 
applied locally, recognising the needs of particular patient groups such as nursing 
home and housebound patients, and analysis of resource issues including availability 
a facilitator to discuss, learn about and coordinate their approach to vaccination could 
improve vaccination rates. Learning in teams helped practitioners to share knowledge, 
both evidence-based and practical. It also enabled teams to understand the processes 
required for effective vaccine delivery and encouraged them to develop systems 
where individuals could contribute in a coordinated way to the outcome. Good 
teamwork was therefore essential to improve vaccination rates. The notion of 
interdisciplinary education to improve teamwork (Cunningham 1997) and the 
importance of teamwork in delivering high quality care has previously been 
recognised (Stevenson et al. 2001; Campbell et al. 2001b). Stevenson (2001) 
suggested that, “Experimental studies are required to determine whether the 
development of teamwork enables practice teams to identify and overcome 
systematically the obstacles to improved quality of patient care that face them.” 
Campbell (2001b) stated that good teamworking was a “key part of providing high 
quality care” and that teamworking “may need specific support if q
b
further below.  
6.3.3 Supporting and developing teamwork 
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of time, personnel and funding. Sometimes, the development of practice systems was 
informal and implicit rather than by using explicit methods to formally analyse and 
map the process (Plsek 1997). However, the end result was conceptually the same 
with practices designing a process with clearly defined tasks and roles for delivering 
the vaccination programme. 
 
Practice managers usually organised and directed the programme, ordered sufficient 
vaccines, negotiated discounts with pharmaceutical companies, addressed stock 
control issues and systems, and arranged for patient and prescription reminders, poster 
displays and leaflets in the surgery. Practice nurses helped develop the protocols for 
administering the vaccines, decided which patients should or should not be 
vaccinated, informed and persuaded appropriate patients to have the vaccine, gave 
vaccine shots, recorded vaccine details in patient records, managed the stock control 
process, ensured that the ‘shock box’************* was stocked in case of allergic 
reactions to the vaccine and set up dedicated vaccine clinics at the surgery and in 
nursing homes. District nurses fulfilled similar roles to practice nurses but were also 
required to administer vaccines in the patient’s home or residential homes. Doctors 
and nurses also reminded high-risk patients to have the vaccine and persuaded those 
who were reluctant of the benefits of vaccination as well as occasionally 
administering vaccines opportunistically. Receptionists checked whether patients 
were in high-risk groups, handed out vaccine information leaflets, set up dedicated 
clinics, informed patients about vaccine clinics and booked appointments for 
vaccinations. Many of these roles were interchangeable between team members and 
indeed involved different members in the various practices (Table 34). 
 The ‘shock box’ was a box containing adrenaline to be given by intramuscular injection, 
 
*************
together with a number of other drugs and instructions for their use in the unlikely event of a severe 
allergic reaction to the vaccine.  
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Table 34 Process mapping for adult vaccination programme 
Process Concept Method Team member 
    
Evidence Assimilation and 
appraisal of evidence for 
vaccination per se or 
process  
Reading 
Course 
Lecture 
 
Clinician (nurse more of
than GP) 
External facilitator 
process 
ten 
Communication Lead discussion of Primary healthcare team 
meeting 
Partnership meeting 
Practice manager 
General practitioner 
Nurse (practice nurse, district 
nurse, auxiliary nurse or 
health visitor) 
Whole team 
practice data) 
Identification Identification of high-risk Age-sex register IT ‘clerk’ 
vaccination Telephone 
provider together Home visit Patient 
Home 
nurse) 
External facilitator 
Delegation Coordination of activities Nomination or self selection Practice manager  
Clinician 
Supply Ordering sufficient supply 
of vaccine 
Incremental (based on 
previous uptake) 
Systematic (based on 
Derived (estimate from 
national data) 
Practice manager  
Nurse 
Storage Storage of vaccine Dedicated vaccine 
refrigerator 
Practice manager 
Nurse 
groups Disease register 
Vaccine register 
Self-identification 
Patient 
Patient 
reminder 
Strategies to 
communicate need and 
invite patient for 
Posters, leaflets, 
prescription reminders 
Letters 
Receptionist 
Provider 
prompt 
Device to remind 
practitioner to advise or 
deliver vaccine 
Template reminders 
Protocols, guidelines 
IT ‘clerk’ 
Receptionist 
Clinician 
Arrival Bringing the patient and Attendance at surgery Receptionist 
Clinician 
Check-in Recognising the patient Previous knowledge 
Visit chart 
Drop-in 
Appointment 
Receptionist 
Clinician 
Setting Place of vaccination Surgery 
Nursing or residential home 
Clinician 
Timing Timing of vaccine clinic Saturday clinics 
Week-day nurse clinic 
Opportunistic (doctor or 
Practice manager 
Clinician 
Complications Dealing with serious 
complications 
Shock-box 
Resuscitation training 
Clinician 
Feedback Monitoring and feedback 
on success of vaccination 
programme 
 
Vaccination rates from audit 
  
Audit staff 
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All of these professional activities needed to be organised, harmonised and 
tised for a successful vaccinatio mme, a feature th ted in 
dies (M 20 w
was therefore an nt determinant of the success of the vaccination programme. 
The whole tea tioning well to ial to 
vaccination programme and each member, either through individual failure or through
a lack of teamworking was a potential barrier to improved perform
Other fa a
As well as teamwork and organisatio eral and specifically related to 
tion prog er of o d have a nd 
erf ti ied. Thes  previous 
knowledge of and belief in vaccination and the specific vaccines in question, as well 
ial fact the s of general practitioners 
to invest in vaccines and the vaccinatio These features as well as affecting 
 perform ve  
response to the at they ect to, readiness to change having 
een re rta to chan terature 
review and experimental studies (Cohen   
 
ctices th se of bei ay 
have enjoyed better teamwork, been m terested in tackling their vaccination 
es and  i m n uptake. 
Non-participating practices m red from primary healthcare teams that 
were less functional, with poorer participation, and less committed to innovation 
(West and Wallace 1991). This ability of organisations to change, sometimes termed 
systema n progra at has been no
other stu angtani and Roberts 
 importa
00). The quality of team ork in the practice 
m func gether were cruc the success of the 
 
ance. 
6.3.4 ctors affecting perform nce 
n, both gen
vaccina rammes, a numb ther factors coul ffected baseline a
subsequent p ormance in the prac ces being stud e include
as financ ors, which affected ability or willingnes
n process. 
baseline ance could also ha impacted on practices ability to change in
interventions th were subj
already b cognised as an impo nt factor leading ge in the li
et al. 1994).
The pra at participated in the  studies, by virtue ng volunteers, m
ore in
programm  more willing to adopt
ay have suffe
nterventions to improve i munisatio
‘reflexivity’ in this context (Firth-Cozens 1998), is one of a number of features of 
teams that has been shown to lead to sustained quality improvement (Hearnshaw et al. 
1998). 
 
It is possible that the methods used in this study might have had less impact if they 
were imposed on less motivated or reluctant practices and this needs to be considered 
when assessing the generalisability of the findings. However there were a number of 
reasons to believe that the participating practices were representative and that the 
findings from the field studies were generalisable. There was a high degree of 
participation of practices in the primary care trust and these practices were similar to 
other practices in the county in terms of list or partnership size. There was also 
considerable variation in baseline vaccination rates, which may have reflected 
practices’ patchy initial enthusiasm for vaccination, and this suggested that not only 
those practices previously enthusiastic for vaccination were participating. 
rowing sophistication amongst 
ractitioners as to how they dealt with guidance and recommendations. One 
6.4 Evidence, understanding and motivation 
Uncertainty, doubts, controversy or confusion surrounding the evidence for 
vaccination were seen to affect the adoption of this evidence by both practitioners and 
patients in the field studies. There appeared to be a g
p
practitioner during the educational outreach visit for example, who had read the 
relevant chapter from Clinical Evidence (Marrie 2001), a recently published and 
widely publicised synopsis of evidence compiled by the British Medical Journal for 
busy doctors to keep up to date, wanted to discuss whether pneumococcal vaccine was 
effective. In written feedback he also reported that he had concluded from his reading 
that “[there was] little evidence that [pneumococcal vaccination was] cost effective 
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except in Chronic Obstructive Pulmonary Disease” and decided to focus his efforts on 
this risk group rather than the groups investigated as outcomes for these studies. 
Similar concerns were expressed during some of the other educational visits and this 
as an area of controversy that was openly aired as part of the outreach. Despite these 
 have been 
described in other studies (Fitzgerald et al. 1999). These included strength of 
plementation, accordance with 
w
doubts many practices still went along with national guidance and previous 
experience to conduct a pneumococcal vaccination programme. 
 
The tension between evidence and practice demonstrated here and in other studies 
(Freeman and Sweeney 2001) may also have increased when evidence conflicted with 
tacit knowledge based on experience (Ferlie et al. 1999). This tension was seen to 
affect the implementation of influenza and pneumococcal vaccination programmes as 
shown by the differences in performance between practices and varying attitudes of 
individual practitioners towards vaccination. Factors concerned with evidence that 
were likely to enhance adoption of vaccination were confirmed here and
evidence, discussion of benefits and harms, ease of im
norms and values of practitioners, acceptability and satisfaction amongst patients 
together with cost neutrality or savings. Barriers to implementation, on the other hand, 
included complexity of decision-making or implementation, requirement for new 
knowledge or skills, changes in organisation or routines and negative reactions in 
patients.  
 
In relation to the strength of evidence it is interesting to compare and contrast the 
situation for influenza and pneumococcal vaccination. There was little evidence from 
the studies presented here that practitioners questioned the value of influenza 
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vaccination. As a result, there tended to be good agreement amongst general 
practitioners, other primary healthcare staff and patients that influenza vaccination 
was a good thing. The situation for pneumococcal vaccination was less clear and this 
was evidenced in the written comments from the practitioner above and other 
comments during discussions with doctors and nurses during the educational outreach 
visits. Controversy and uncertainty around pneumococcal vaccination was well 
ublicised and this conflicting evidence had given rise to confusing advice to general 
ccal vaccination and although the evidence for pneumococcal vaccination 
as less clear, there was continued support for it from national guidelines, endorsed 
p
practitioners. Those practitioners who questioned the effectiveness of pneumococcal 
vaccination also identified cost-effectiveness as an issue. This area of controversy was 
also raised during the educational outreach visits. Practitioners had become more 
familiar with the different ways of expressing outcomes and the advantages of 
expressing outcomes as absolute risk reductions or numbers needed to treat rather 
than relative risk reduction. Although not all general practitioners understood these 
terms (Young et al. 2002) awareness of evidence-based concepts had gradually 
increased. In general, the discussions with study participants during educational 
sessions showed that they believed in the cost-effectiveness of influenza vaccination 
although at times this seemed to be more influenced by national recommendations 
than a detailed understanding of the evidence. 
 
The case made for influenza vaccination was therefore far stronger than that for 
pneumoco
w
by the pharmaceutical industry and some of the research evidence. Uncertainty about 
evidence, in this case conflicting ideas about the benefits of pneumococcal vaccine 
may have been a factor affecting baseline and subsequent performance (Tomlin et al. 
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1999). In all the studies presented here, for example, baseline rates were lower for 
pneumococcal than for influenza vaccination and the greatest increase in vaccination 
rates was for influenza vaccination for patients aged sixty-five and over, which was 
the group that received most attention from the national vaccination campaign. 
6.5 Educational method and performance 
6.5.1 Impact of educational method on performance 
Before any other consideration, for an educational intervention in health care to be 
effective it needs to educate to implement health technologies that have shown 
themselves to be effective in improving health. Allowing for problems described 
above this was demonstrably the case for influenza and pneumococcal vaccination.  
 
Next, it is important to consider the relative advantages and disadvantages of the 
educational methods that were employed in the field studies and weigh these up 
against alternative methods of improving outcomes. The earlier multipractice audit 
studies appeared to demonstrate improvements in vaccination rates comparable to 
those of the randomised controlled study. If this were true one could argue that a 
complex intervention such as educational outreach was unnecessary and that the same 
utcome might have been achieved more cost-effectively with a more simple o
approach using audit, feedback and written advice.  
 
However, this conclusion fails to take into account secular trends and other 
confounding factors, which might have partly or wholly explained the improvements 
in vaccination rates resulting from written advice, audit and feedback used in the 
multipractice audit studies. Secular trends were shown in studies conducted at around 
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the same time as the field studies, with year on year improvements in vaccination 
rates in risk groups of around 2.5 to 5% (Lewis-Parmar and McCann 2002). Audit and 
feedback or education through written information were unlikely to have effected 
change unsupported by other strategies (Davis 1998; Freemantle et al. 2000). 
Although one could not directly compare the effects of the field studies described here 
ure, a general conclusion could be 
 in the randomised controlled 
he randomised controlled study showed that educational outreach to healthcare 
n shown to work in the pilot and 
ultipractice audit studies. The role of the educational facilitator was important. 
with each other or with other studies from the literat
drawn that the improvement in the intervention practices
trial more accurately represented the true effect of the intervention, in this case 
educational outreach, whereas the effects of audit, feedback and written advice in the 
multipractice audit studies also included secular trends. 
  
T
teams did improve performance, at least for pneumococcal vaccination. The 
theoretical and practical basis for this approach and the reason for this method being 
unsuccessful in some settings have been described above (see 3.10). The likely basis 
for success of educational outreach intervention in the randomised controlled study in 
improving outcomes for pneumococcal vaccination, on the other hand, was that it 
focused on a simple outcome, built on the knowledge and experience of the team 
members, addressed barriers to change and advocated practical methods for 
improvement and overcoming barriers that had bee
m
Certain features may have been key to the effectiveness of the educational facilitator. 
These included the similar professional and primary care background to learners, so 
called homophily. Expertise, credibility, professional and social status were also 
important. The quality and effort of contact with primary care teams, with particular 
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emphasis on seeing problems from the learners’ perspective and relating to their 
concerns was also essential (Rogers 1995). Social learning theory emphasises the 
importance of learners modelling change on practical examples of success brought by 
the facilitator and this was another technique that was actively employed.  
 
The field studies did not compare the benefits of uniprofessional versus team-based 
education, and this forms a potential area for future investigation. 
6.5.2 Overcoming barriers to change 
The notion of addressing barriers to change has formed the basis for many educational 
intervention studies. The field studies conducted as part of this thesis also sought to 
address this fundamental issue. In the pilot study this was achieved using an action 
research methodology addressing barriers in one practice. In the multipractice audits 
there was an attempt to overcome obstacles to change by using written information 
and advice to practices on various methods and techniques of improving vaccination 
rates. However, this did not allow specific difficulties for individual practices to be 
addressed directly but provided written information that addressed the common 
barriers. The educational intervention in the randomised controlled study, on the other 
hand, was designed to identify and address barriers to change by means of a facilitated 
discussion with practice teams.  
 
This approach has a theoretical basis in the ideas of ‘forcefield analysis.’ In forcefield 
theory reducing forces resisting change is considered to be more effective than 
strengthening driving forces (Lewin 1947). Identifying and overcoming barriers to 
change has previously been recognised as important (Grol 1997) and effective 
(Cranney et al. 1999) in changing doctors behaviour. Practice teams, in the field 
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studies here identified a number of barriers to implementing their immunisation 
programmes. Individual, team and organisational barriers to change became apparent. 
These included barriers relating to patients such as lack of awareness, failure to self-
identify as high-risk, fear of side effects including contracting influenza or doubts 
bout effectiveness. There were also barriers arising from practitioners’ lack of 
, time, stress or lack 
of motivation, appropriate resources and systems (Cabana et al. 1999). Practitioners 
also cited the difficulties of overcoming patient beliefs and the importance of avoiding 
conflict (Tomlin et al. 1999) to maintain a good doctor-patient relationship as a 
barrier (Freeman and Sweeney 2001). Practice or system factors including lack of 
reminders, protocols, audit, feedback, call and recall, vaccine supply storage and stock 
control and access may also have been responsible for poor uptake.  
 
Educational outreach in the randomised controlled study provided an active rather 
than passive way for teams to identify barriers to change and begin to try and address 
these within their own practice. The role of the educational outreach visitor was to try 
and facilitate this situation specific approach rather than impose an external set of 
barriers and solutions. This approach also recognised the professional dominance 
model of behaviour change and acknowledged that identifying and modifying tacit 
expert knowledge and promoting ownership of the process of change amongst the 
individual professionals within teams was a key factor in influencing change (Ferlie et 
al. 2000). The success of this method contrasts with the limited effect of passive 
approaches to overcoming barriers using generic methods (Flottorp et al. 2002). 
a
awareness or familiarity with the vaccines, doubts about vaccine effectiveness or 
guidelines, missed opportunities to vaccinate because of workload
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6.5.3 Single vs. combined methods for implementing change 
The studies that contribute to this thesis used a variety of methods to increase 
vaccination rates rather than employing a single technique. The educational outreach 
intervention, in particular, encouraged practices to use a range of different but 
complementary approaches to achieve higher influenza and pneumococcal vaccination 
rates. Interventions like this, which involve several components combined together, 
are often termed complex or multifaceted interventions. The use of such complex 
interventions, directed at a number of barriers, has been suggested to be more likely to 
lead to change (Hulscher et al. 2001) than a single intervention. 
 
The rationale for this seems understandable and intuitive. Given the number and 
complexity of process elements and team members involved, together with the range 
of possible barriers to implementing a successful immunisation programme, it 
llowed that encouraging practices to employ a combination of strategies in 
ilitate 
the communication and teamwork required.  
fo
developing their programmes would be more effective than concentrating on a single 
intervention.  
 
Moreover, to employ a complex intervention, certainly in the context of increasing 
influenza and pneumococcal vaccination rates, also required good teamworking and 
communication, at the least to identify how and by whom in the team each of the 
interventions would be undertaken. It could be argued that educational outreach was 
the most effective method for helping teams to implement this type of complex 
intervention because it used an approach that was appropriate to the practice teams’ 
history, working practices and existing systems and at the same time helped fac
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 However, this mechanistic approach failed to explain the unpredictability of 
healthcare professionals and systems in producing outcomes, which as shown in these 
studies led to substantial differences in performance between practices. This 
unpredictability can be explained by returning to chaos theory and the theory of 
complex adaptive systems that was touched on earlier in the discussion (Kelley and 
Tucci 2001). In this theory healthcare professionals are agents within the complex 
adaptive system. They are highly adaptable elements of the system, which 
individually and through their relation with other elements lead to unpredictable 
hanges. Inputs or interventions in such systems characteristically produce non-linear 
rofit motive, response to patient demand, the need to prevent future 
ork by reducing influenza and influenza-related illness, personal and team needs to 
Another notable feature was the short duration of the educational intervention used in 
the randomised controlled study. This was a time limited facilitative approach with 
the educational outreach visit lasting only up to an hour in each practice. The use of 
c
or disproportionate effects because of ‘strange attractors’. Strange attractors are 
hidden or ill understood motivations, which in addition to the normal facilitators (or 
‘attractors’) and barriers of change continuously produce ‘emergent’ or new 
behaviours that bring about change in a seemingly random or unpredictable way. A 
number of these strange attractors may have been operating in the field studies. These 
included the p
w
demonstrate a successful influenza vaccination programme in competition with other 
practices and a myriad of other possibilities. These hidden and unpredictable factors 
begin to explain the wide differences between practices’ baseline and final 
vaccination rates. 
6.5.4 Intensive versus brief methods of educational outreach 
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brief focused education delivered over such a short timescale contrasts widely with 
With regard to influenza and pneumococcal vaccinations and similar preventive care 
or disease management processes in primary care it can be seen how it is possible for 
brief interventions to be used to great effect. Where the competencies required to 
deliver the particular outcome are likely to be already present within the primary care 
the idea that more intensive interventions over a longer period might be more likely to 
effect change in health outcomes. However, the evidence for prolonged intensive 
interventions is controversial.  
 
This can be illustrated by comparing the approach taken in the randomised controlled 
study described here with other studies that have used more intensive efforts at 
outreach. Training packages in other educational outreach intervention studies have 
varied from single short sessions delivering focused education lasting one hour 
(Benincasa et al. 1996) to repeated visits over many weeks (Hulscher et al. 1997b). 
Although some prolonged educational interventions have been successful, for 
example to improve adolescent health care (Sanci et al. 2000), it does not always 
follow that an intensive educational approach using leads to success (King et al. 
2002). The largest study of intensive educational outreach (for cardiovascular 
prevention in general practice in the Netherlands) did show improvements in the 
process of care but at a cost of 25 (13-59) visits or 31 (10-96) hours per practice to 33 
practices. Even with this degree of input, training and discussion with individuals and 
practice groups, 5 of the 33 practices showed only very limited improvements in 
process and this was due to interpersonal conflicts, problems of teamworking or 
illness (Hulscher et al. 1998).  
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team, it seems more appropriate for the educational process to focus on enhancing 
existing knowledge and capability within the team rather than using external expert 
resources to teach specific competencies (Fraser and Greenhalgh 2001). In other 
words, it may be more productive for an educational facilitator to support learners to 
nd their own solutions to problems thus increasing their capability or the extent to 
6.5.5 Meeting educational objectives 
One of the advantages of educational outreach, as used in the randomised controlled 
study, was that it allowed practice teams and members of them to articulate their own 
learning needs during the process (Grant 2002). In the pilot study learning needs were 
generated iteratively throughout the project. It was assumed that the knowledge and 
skills to improve influenza and pneumococcal vaccination rates was a learning need of 
practices participating in the multipractice audits and the randomised controlled study 
since they had volunteered to participate. In the audit studies, learning needs of 
practices were assumed to centre on the audit process as well as evidence for the 
vaccines and their delivery. The use of a general practice trainer, experienced in small 
group methods, as the educational resource may have helped to elicit learning needs 
in the randomised controlled study. Practices stated that they welcomed the 
educational visit at the time. Even though the visit did not lead to a significant 
improvement in influenza vaccination uptake in intervention compared to control 
practices, one health visitor who had attended the educational outreach session in her 
practice, upon hearing of the results during a later presentation, felt that the visit “had 
fi
which they can ‘adapt to change, generate new knowledge, and continue to improve 
performance.’ Using brief small group methods with reflective learning and feedback 
on performance rather than providing intensive or lengthy educational programmes 
shows practice teams how they can continue to learn for themselves. 
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contributed to the successful influenza vaccine programme the previous year” in her 
practice. An important part of the educational session was to discover individual and 
organisational barriers specific to the general practice team, and to address the 
learning needs of participants to overcome these. This was achieved through 
discussion of the baseline audit results, comparison with standards that practices had 
set themselves and the performance of other participating practices, a review of 
current practice and a facilitated group discussion on the main issues for individuals 
and practice teams on overcoming barriers to change and improving performance 
using evidence based strategies. 
 
Practice teams were encouraged to develop their own solutions to the problem of 
improving vaccination rates through small group discussion. Individual team 
members were able to share their personal strategies for responding to specific 
difficulties, for example when addressing patients’ beliefs about mild viral infections 
occurring around the same time as influenza vaccination. Most practitioners preferred 
a rational explanation, e.g. that the two events were coincidental, whereas one nurse 
preferred to tell patients that the infection signified ‘that the vaccine had taken’. The 
practice team, as a complex adaptive system, was therefore able to generate its own 
ideas and solutions to the problem of increasing vaccination rates and this was a 
significant part of the educational process (Fraser and Greenhalgh 2001).  
6.6 Alternatives to education 
We should also compare the effects and appropriateness of educational interventions 
for healthcare workers with other methods of improving outcomes. One of the 
problems encountered in the fieldwork was to differentiate between the effects of 
practice-based educational interventions and the various national and local initiatives 
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that were being used to promulgate awareness of and ideas around increasing 
influenza vaccine uptake.  
6.6.1 Direct health promotion to the public through the media 
The most dramatic increase in influenza vaccination rates in the randomised 
controlled study was for patients aged sixty-five years and above. The national media 
campaign in the autumn of 2000 was likely to have raised awareness amongst patients 
and practitioners and this was likely to have led to an increase in vaccination rates 
given the previous evidence (Grilli et al. 2000). This may have been partly through a 
direct effect, rather appropriately in this case termed the hypodermic needle model 
(Rogers 1995). It might also have been due to a two-step process in which the media 
affected opinion leaders, both patients and practitioners, to directly influence the rest 
of the population to have the vaccine. Considerable publicity was also given to 
influenza following the winter admission and bed crisis around 1999/2000 and this 
was thought to be partly inflamed by government and media exaggeration of the 
extent of the influenza epidemic or non-epidemic as it later turned out to be (Abbasi 
2000). Although there were alternative and arguably more likely explanations for the 
winter bed crisis, such as hospital bed blocking due to deficiencies in discharge 
procedures and social services during the Christmas period (Vasilakis and El Darzi 
2001) this additional adverse publicity may have fuelled patient fears and also 
contributed to the success of the campaign.  
 6.6.2 Financial incentives 
Financial incentives were also used to support the national influenza vaccination 
programme and were also likely to have played a significant part in the improvements 
in influenza vaccination rates in the primary care trust and randomised controlled 
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studies. These inducements were introduced in 2000 for the winter of 2000/2001. In 
addition to a national incentive paid directly to general practitioners* administered to 
those aged sixty-five years and above, there were a number of local initiatives. In 
Lincolnshire this took the form of an extra incentive payment to practices†. General 
practitioners overwhelmingly welcomed these fees, which were introduced to help 
general practices implement call and recall systems and were over and above any 
profits from discount purchasing of vaccines. Practitioners were ambivalent in their 
attitudes to pharmaceutical companies, who produced and sold these vaccines, and 
their representatives. On the one hand they welcomed help with vaccine supply and 
purchase but on the other hand some were suspicious about the profit motive of 
companies and their promotional material. Some were at ease with the accepted 
practice of buying vaccines at a discount and legitimately claiming back the higher fee 
whereas others were worried about maximising profits from dispensing vaccines 
when these might adversely affect indicative prescribing budgets.   
 
Financial incentives linked to vaccination targets had had a remarkable effect in 
improving childhood immunisation rates in the United Kingdom (Salisbury 1998) and 
some settings in the United States (Morrow et al. 1995) and they had also been shown 
to work with influenza vaccination (Kouides et al. 1998). However, financial 
incentives for practitioners do not invariably lead to change, and this is particularly so 
*
offer. 
administered by the primary care organisation. 
‡
 
 £6.50 per vaccination. 
† £1.50 for each patient aged sixty-five and over invited for vaccination that subsequently took up the 
‡ The indicative prescribing budget is the amount of money allocated to a practice each year for the cost 
of drugs prescribed to their patients. The budget, although nominally allocated to the practice, is 
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when an incentive conflicts with practitioners beliefs about the effectiveness or 
appropriateness of particular interventions (Wee et al. 2001). 
 
Some practices in the randomised controlled study used low cost incentives for 
patients, such as a ‘coffee morning’, to encourage patients to attend for vaccination. 
Financial incentives for patients were not used beyond this although this tactic had 
been shown to be effective (Giuffrida and Torgerson 1997).  
 
Overall financial incentives were likely to have had a positive effect in supporting 
practitioners’ efforts to improve influenza vaccination rates.  
6.6.3 Performance targets 
Policy changes underpinning the national vaccination campaign were also likely to 
have impacted on the field studies. The introduction of national targets for influenza 
immunisation supported by the national advertising campaign and financial incentives 
for general practitioners had a marked effect on influenza vaccination rates in patients 
aged sixty-five years and above.  
 
Although national targets for childhood immunisations had been used since the new 
contract for general practitioners and national targets for influenza and pneumococcal 
vaccination had also been in place in the United States since the early 1990s it took a 
decade for targets to be introduced for influenza vaccination in the United Kingdom 
with targets still not in place for pneumococcal vaccination. The national target, when 
2000/2001 was for sixty-five per cent of elderly aged sixty-five 
bove to be vaccinated against influenza.  
it was introduced in 
and a
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Performance targets, at least for childhood vaccinations, seem to have drawn grudging 
g general practitioners’ 
comes, the attitudes of general practitioners seem to be hardening against linking 
6.6.4 Clinical governance 
 and to some extent the randomised controlled study 
epartment of Health 1998a).’ Despite the many 
omplex definitions, explanations and confusion around what clinical governance 
 quality care with clear lines of 
 
found serious professional misconduct against two Bristol heart surgeons and the medical director of 
acceptance by many general practitioners and practice managers. However, with 
negative patient attitudes increasing, particularly in relation to measles, mumps and 
rubella vaccine after recent media scares on a possible link with autism and Crohn’s 
disease, and falling immunisation rates directly affectin
in
income to targets. 
The primary care trust audit
recruited practices within the trust as a voluntary part of a clinical governance 
programme. Clinical governance has been described as a ‘framework through which 
NHS organisations are accountable for continually improving the quality of their 
services, safeguarding high standards by creating an environment in which excellence 
in clinical care will flourish (D
c
really means, it is essentially a combination of two basic ingredients, namely quality 
and accountability. The concept of quality includes the many quality improvement 
strategies that could and have been used to improve performance, many of which have 
already been described above in relation to improving adult vaccinations. 
Accountability, a concept arising most significantly from the Bristol enquiry and 
Kennedy report*, reaffirms the idea that everyone in a healthcare organisation is both 
responsible and accountable for delivering
* This was the high profile General Medical Council professional conduct committee hearing which 
the unit where they worked together with the subsequent public enquiry conducted by Professor Ian 
Kennedy. 
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accountability running through organisations and ultimately to chief executives of 
trusts.  
6.6.5 Combining other methods 
Combining together these alternatives to educational methods such as media 
campaigns and financial incentives underpinned by national policy, targets and 
ar to have a significant effect on influenza vaccination 
These processes can be viewed from various perspectives ranging from the general 
or 
clinical governance did appe
resulting in an average 20-25% increase in vaccination rate in those aged sixty-five 
years and over in the randomised controlled study. This was achieved at a 
considerable cost however, compared to the educational intervention, which achieved 
a 15% increase in pneumococcal vaccination rates with a brief educational 
intervention.  
6.7 The organisational perspective 
There are a number of lessons from these studies for primary health care and related 
health service organisations. Firstly, the process of implementation of influenza and 
pneumococcal vaccination did not follow the linear process from initiation through to 
implementation described by Rogers (1995). The processes of agenda setting (whether 
and to what extent to implement vaccination programmes), matching (fitting a 
programme to the existing structure) to redefining (modification), clarifying (defining 
the role of the organisation) and routinising where the programme becomes integral to 
the work of the organisation did not follow in an orderly sequence.  
 
practice unit to primary care trusts to regional and national levels. How these systems 
succeed or fail to improve care and how this may be addressed through systems 
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policy initiatives are discussed next . 
Preventive procedures, illustrated here by influenza and pneumococcal vaccination, as 
well as many other processes in primary care are delivered through primary healthcare 
teams. The primary care team forms the basic organisational building block for 
delivery of most primary care services. Such teams are multidisciplinary and often 
lack a hierarchical structure. This lack of hierarchy is exemplified by general 
practitioner partnerships, which are based on consensus decision-making, general 
practitioners’ relationships with attached staff employed by community or primary 
d staff in practices to function with 
s, 
 studies presented here and the wider literature, therefore presents an elegant 
of individuals in teams to block efforts 
at change, a key ingredient was that participants should have ownership of the 
educational process. Educational interventions that fail to acknowledge the expert 
6.7.1 Primary health care teams 
care trusts, and the capacity of many employe
considerable independence. Individuals in these teams often come from diverse 
backgrounds and the practices in which they work are characterised by complex 
interdependent structures and systems (Fitzgerald et al. 1999).  
 
For services to be delivered effectively and for innovations to be adopted requires a 
multidisciplinary team approach characterised by interprofessional dialogue and a 
shared approach to implementation. An educational approach to innovation enables 
teams to meet, discuss and agree on how to bring about change. Education for team
both from
way to deliver organisational change. The educational methods used, which included 
setting clear objectives, using appropriate methods and applying an assessment tool 
such as audit to feed results back to teams, were fundamental to achieving a 
successful outcome. Because of the potential 
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knowl dge of participants, whiche  ignore professional power or are seen as a 
At the next organisational level the primary care organisation or trust also played a 
key role in helping practices to achieve improvements in influenza and pneumococcal 
vaccination rates. This came about through a variety of means, which included setting 
local priorities and targets for vaccination rates, providing systems for audit and 
feedback, enabling practices to benchmark against each other, sharing good practice 
by providing appropriate education, training and forums for discussion, 
communicating these elements and providing leadership. With the large numbers of 
practices involved the primary care trust was also able to provide practical help such 
as bulk purchasing vaccines at a discount.  
 
The use of a quality agreement between the practices and the trust as part of clinical 
governance arrangements, together with funding to support this underpinned local 
policy to improve vaccination rates in practices in the primary care trust (Siriwardena 
and Middlemass 2000). Written agreements linked to financial incentives, like this, 
were also being used to drive quality improvements in other primary care trusts 
(Campbell et al. 2001a). Positive methods rather than sanctions are favoured to 
engage general practitioners particularly in the prevailing climate within primary care 
of increasing workload and poor morale.  
 
There is emerging evidence that providing community care services under the 
umbrella of primary care trusts, combining nursing, medical and social service 
convenient means of attempting to micromanage the performance of doctors or other 
healthcare workers are likely to be subverted and fail. 
6.7.2 Primary care trusts 
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representation together with management on the boards of these organisations will 
strengthen and promote the shared agenda of primary care in delivering services 
(Wilkin et al. 2001). However there are also signs, particularly in relation to 
implementation of complex interventions and budgetary control that primary care 
trusts are failing to deliver. This may be partly because primary care organisations 
have failed to understand the nature and complexities of the change management 
process.  
nce and national targets from the Chief 
edical Officer (Department of Health 2001a) and Department of Health. Patient 
service. These include the importance of 
eveloping appropriate models for research into complex interventions and the issue 
6.7.3 National systems 
As well as clinical governance being endorsed on a national scale, a number of other 
nationwide systems were put in place to improve influenza and pneumococcal 
vaccination rates. This included a high profile media campaign for patients. For 
primary care there was the annual guida
M
leaflets and posters together with additional financial, administrative and educational 
support were funded nationally but provided through primary care trusts. The central 
support therefore consisted primarily of a national media campaign and a number of 
other interventions aimed at supporting local implementation.  
6.8 Implications for educational research in health 
The studies here demonstrate a number of challenges and opportunities for 
educational research in today’s health 
d
of cost-benefit in educational research.  
 
Complex interventions are particularly difficult to evaluate because of the problems of 
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identifying, documenting and reproducing the intervention. The literature review 
helped shape the theoretical framework; the pilot study was used to develop the model 
and provided an exploratory trial using action research methods; the multipractice 
audit studies helped define various components of the multifaceted intervention for 
improving vaccination uptake and clarified the outcomes of interest and their 
measurement using qualitative and quantitative methods; the randomised controlled 
study provided definitive evidence of improvement in outcomes. The final phase of 
long-term implementation seeks to discover whether an intervention can be 
reproduced in other settings over the longer term (Campbell et al. 2000a). It is also 
concerned about continuing demand for the intervention, sustainability of outcomes 
and possible adverse effects. Time and resource constraints precluded extension of the 
fieldwork to examine long-term effects. 
 
By using a combination of methods the studies here both highlight and address some 
of the problems of educational research. These include the relative advantages and 
disadvantages of uncontrolled and experimental designs, the specific methodological 
difficulties of randomisation, confounding, bias, and blinding as well as more general 
ux 2002b). 
 and the attitudes, knowledge and behaviour 
s in response to the educational outreach visit in the intervention 
issues relating to reliability, validity and generalisation (Pridea
 
Other methods such as a case study approach or other qualitative methods, including 
focus groups or interviews, would have been valuable in examining in detail the 
reactions to the educational intervention
of practice team
practices or to the audit, feedback and information provided to both intervention and 
control practices.   
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One important area that was not fully addressed by this research was cost-
effectiveness. This was simply because the resources for a full health economic 
analysis was not available. Clearly for educational interventions to be cost-effective 
the target of the educational intervention needs to be cost effective also. Though this 
may have been so for influenza vaccination, it was less clear for pneumococcal 
vaccination (see 6.4). An economic evaluation would have added to the research, by 
using cost-effectiveness analysis to help decide which approach should be used, or 
cost-benefit analysis to determine whether a particular approach should be used at all 
rather than directing resources elsewhere (Brown et al. 2002). Unfortunately, as 
rown et al. (2002) demonstrated there is a general lack of high quality cost analysis 
nd costs of 
nidisciplinary versus multidisciplinary research, using an appropriate context, good 
B
being built into educational interventions. Although there was a limited analysis of the 
potential costs involved as part of the randomised controlled study (see 5.4), this 
research was unable to address in detail the issue of cost-effectiveness or cost-benefit. 
 
One area for future research would be to explore the different outcomes a
u
evidence and robust outcomes. 
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 CHAPTER 7 CONCLUSION 
work is associated with quality of care (Campbell et al. 2001b; Stevenson et al. 
ight be supported to improve outcomes of care for 
patients. The notion of practice based multidisciplinary education to improve 
teamwork and delivery of healthcare to patients (Cunningham 1997; Toghill 1998) is 
not new. However, effective interprofessional learning is more than different 
professional groups sitting at the same lecture. It encompasses a clear aim to improve 
quality of care for patients, a focus on patients’ unmet needs and professionals’ 
educational needs, an opportunity for healthcare workers to learn from, with and 
about each other, and interprofessional collaboration to improve the service provided 
7.1 Education, teams and outcomes - current practice and future 
trends 
Directing educational interventions to primary care teams is crucial where teamwork 
is an important aspect of delivery for specific healthcare interventions. One of the 
most important features of interventions in the field studies was that they were 
directed at primary healthcare teams. There are strong arguments for developing 
paradigms that develop and strengthen the relationship between organisational 
learning, practice systems designed to deliver better healthcare and outcomes that 
realistically measure organisational performance. 
 
With increasing evidence from the studies here together with others that effective 
team
2001) and that multidisciplinary learning enhances teamwork, it is vital that primary 
care organisations and funding bodies for higher professional education should reflect 
on how this type of learning m
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to patients (Headrick et al. 1998). The concept of education for multidisciplinary 
teams focused on patient care relevant to the learning and development needs of the 
healthcare organisation is therefore rightly central to current policy developments in 
 
e 
e) where practices’ work is covered by out-of-hours groups or their 
and opinion leaders, from within and outside the organisation, to be available to larger 
with individual learning needs, allowing sufficient participation and discussion or 
primary care education (Department of Health 1998b; Department of Health 1998a).  
There is also increasing potential for learning to occur at other levels in primary care. 
The recent trend towards protected learning time schemes at primary care group level 
enables larger groups of practices to address shared educational needs. These 
schemes, which originated from the TARGET (Time for Audit, Review, Guidelines, 
Education and Training) format in the Yorkshire region of the United Kingdom, are 
an extension of the notion of primary care education centres first expounded by Smith 
(Smith 1998). The advantages of this format are that learning is done in protected tim
(i.e. work tim
equivalent; it opens boundaries between people in healthcare and enables wider 
groups of practices, practitioners and administrators to share experience of good 
practice; there is a forum for regular interaction between innovators, opinion leaders 
and their peers; it also allows economies of scale which enables experts, innovators 
groups. There are also opportunities for this type of educational activity to address 
problems of interprofessional communication and patient pathways between primary 
and secondary care (Marshall et al. 2002). On the downside, depending on how the 
schemes are organised, there may be problems within these larger groups for dealing 
adequate time to enable practice teams to develop their own systems. 
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It may be argued that the concept of the learning organisation has been eroded by 
rhetoric and lack of clarity surrounding it. The original description as a place where 
“people continually expand their capacity to create the results they truly desire, where 
new and expansive patterns of thinking are nurtured, where collective aspiration is set 
ee, and where people are continually learning how to learn together” (Senge 1990) 
 organisational 
arning needs using a variety of methods, the attributes of which have been discussed 
fr
although laudable seems high on philosophy and low on relevance in today’s far from 
Utopian health system. We begin to see how the example of influenza and 
pneumococcal vaccination demonstrates in a practical and understandable way the 
concept of the learning organisation. The educational triangle, which has objectives 
(related to learning needs), methods (of innovation diffusion) and assessment (of 
knowledge, attitudes and beliefs, skills and outcomes) as its three points, is a useful 
concept here. For a learning organisation to occur an organisational learning need 
must be apparent to the stakeholders. Learning needs often derive from innovative 
health technologies resulting from research or transfer from other settings. They also 
arise through demonstrable patient need, either from patients themselves or through 
demonstration of a competence-performance gap. These needs may be nationally 
driven (national guidance on influenza and pneumococcal vaccination), locally 
derived (multipractice audits showing variations between practices and low 
vaccination rates overall) or both (winter pressures). For a learning need to be 
effectively addressed the outcome arising from learning should be clear, specific, 
measurable, applicable and acceptable in terms of relative efficacy, side effects and 
cost to patients, practitioners and healthcare organisations. Learning organisations 
then become groups of individuals, that are interconnected in some way but which 
may change over time, that seek to identify and address specific
le
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above, and who are prepared to measure their results. For learning organisations to be 
successful they need to understand what they might achieve, in which situations to try 
and how best to go about it. Learning organisations were arguably seen to operate at 
practice, local, regional and national levels in relation to influenza and pneumococcal 
vaccination. 
7.2 Summary 
Educational interventions were effective at improving influenza and pneumococcal 
vaccination rates in high-risk groups. Educational approaches for quality 
improvement in primary health care accord with the highly professionalised nature of 
primary healthcare teams and the complex nature of the processes and outcomes that 
they are trying to achieve. Learning in teams is particularly important when the 
process or outcome require a team approach, although this is increasingly becoming 
the norm in many aspects of healthcare delivery. Perhaps the ultimate goal is to 
develop effective organisational learning in primary care (Fox and Bennett 1998), to 
promote an understanding and culture of lifelong learning for organisations and their 
individual members and to transform primary care organisations into real learning 
organisations (Watkins and Marsick 1993) where learning is translated into improved 
processes for staff and better care and outcomes for patients. Future research should 
deal with differences in outcomes and costs of unidisciplinary versus 
multidisciplinary research, using appropriate contexts, evidence and outcomes.  
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